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ABSTRACT 
 
Introduction 
As neurological symptoms of transient ischaemic attack (TIA) subside, it is assumed that 
patients return to their “normal” health state. Patients are managed according to their risk of 
stroke and “success” is measured by time to clinic, prescription of prophylactics and 
prevention of further cardiovascular episodes and/or death. Very little attention has been 
given to patients’ psychological well-being, cognitive functioning and physical functioning. 
The aim of this thesis was to examine these outcomes after TIA. 
Methods 
A systematic review was conducted to amalgamate and critique existing literature on health 
outcomes after TIA. A longitudinal, controlled cohort study (FACE TIA) was then designed 
to develop the evidence base further and examine interaction effects between cognition, 
feelings of affect and physical function in all patients referred to TIA clinics. The pilot results 
were analysed and discussed as part of this thesis. 
Results 
Fourteen publications, out 2007 generated by the initial search, were included in the 
systematic review. Evidence from these studies suggests that cognitive impairment and 
depression are higher in TIA patients than age-matched healthy individuals. However no 
evidence was found to suggest that basic daily functioning is compromised in TIA patients. 
The majority of studies were underpowered and used cross-sectional analysis. The FACE TIA 
trial is ongoing however the results of the pilot study are consistent with previous research. 
Feelings of depression were significantly higher in TIA patients (n=104) compared to healthy 
controls (n=30), but similar to levels of depression in other patient groups (possible TIA 
(n=71), TIA “mimic” (n=41) and minor stroke (n=18)). This suggests that depression may be 
related to the experience of suffering a stressful event, rather than the cardiovascular event 
itself. Analyses also revealed that certain types of cognitive impairment were more prevalent 
in TIA patients (n=40) than published norms taken from a “healthy” population. Furthermore, 
increased anxiety and depression appeared to be associated with reduced independence and 
increased cognitive impairment.  
Discussion 
 It is unclear how much of the observed association between cerebrovascular disease and 
cognitive dysfunction is mediated by cardiovascular risk factors, and/or whether TIA has a 
direct causal relationship. Regardless, such deficits could impact of the patient’s overall 
quality of life and their ability to learn, understand and remember new information, and adopt 
new health behaviours aimed at reducing stroke risk. Patients diagnosed with TIA may benefit 
from cognitive screening. Results into depression suggest that all patients attending TIA 
clinics may benefit from increased emotional support, regardless of their diagnosis. Further 
research should be directed at assessing the feasibility of screening patients for cognitive 
impairment and depression after referral to TIA clinics, and developing/evaluating 
interventions to facilitate patients whose screen is positive.   
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CHAPTER 1 
BACKGROUND 
1.1 Defining Transient Ischaemic Attack  
Hankey & Warlow (1994) defined Transient Ischaemic Attack (TIA) as,  
“an acute loss of focal brain or monocular function with symptoms lasting less than 24 hours 
and which is thought to be due to inadequate cerebral or ocular blood supply as a result of low 
blood flow, arterial thrombosis, or embolism”. Only symptoms lasting longer than this were 
felt to represent tissue infarction and be considered a “completed stroke”. There is a certain 
amount of controversy surrounding the somewhat arbitrary 24-hour threshold distinguishing 
TIA from stroke. Levy (1998) showed that the likelihood of symptoms resolving completely 
within 24 hours was less than 15 percent if symptoms lasted more than 1 hour. Thus, 
suggesting that symptoms lasting more than 1 hour are more likely to represent completed 
strokes than TIAs. 
Advances in neuroimaging, particularly diffusion weighted MRI (DWI), have improved our 
understanding of the pathophysiology of TIA and highlighted an inconsistency between the 
concept of TIA (ischemia causing transient symptoms but no infarction) and the classic time-
based definition of TIA.  A pooled analysis of DWI-studied patients revealed cerebral 
infarction in a clinically relevant location in approximately one third of patients with 
classically defined TIA (Shah et al., 2007). The median duration of symptoms was longer 
among patients with DWI abnormality than those without DWI abnormality suggesting that 
stroke and TIA form a continuum rather than two distinct entities of cerebrovascular disease. 
Following such revelations, a shift from the arbitrary definition of TIA to tissue-based 
definitions was proposed. In 2002 the TIA Working Group re-defined TIA as: “a brief episode 
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of neurological dysfunction caused by focal brain or retinal ischemia, with clinical symptoms 
typically lasting less than one hour, and without evidence of acute infarction” (Albers et al., 
2002). 
1.2 Pathophysiology of Ischaemic stroke/TIA 
The brain has a high demand for oxygen and glucose to function. Cerebral ischemia caused by 
vascular occlusion leads to a depletion of substrates within minutes. This is further 
compounded by the accumulation of toxicmetabolites (Mergenthaler et al., 2004). Neuronal 
damage is mild and reversible if flow is restored within a few hours. In these circumstances, a 
diagnosis of TIA would be given. The terms TIA and minor stroke are often used 
interchangeably. However, in explicit terms, stroke (cerebrovascular infarction) results from a 
series of metabolic processes which ensue if the blood flow is not re-established to the 
ischaemic area. Saver (2006) calculated that ischaemic stroke patients loose, in the absence of 
treatment, an average of 1.9 million neurons per minute. He paralleled this to 3.1 weeks of 
accelerated aging. The rate and extent of infarction however, will differ substantially 
depending on various factors including location and extent of vessel occlusion, degree of 
collateral blood supply, blood pressure, blood volume and degree of ischaemic 
preconditioning (Kidwell et al., 2003).  
1.3 Epidemiology 
1.3.1 Incidence 
Transient Ischaemic Attack (TIA) affects a huge proportion of the population. The  most 
robust study of TIA incidence in the UK is the Oxford Vascular study (OXVASC), carried out 
between 2002 and 2005 (Giles & Rothwell, 2007). When standardised to the 2005 population 
of England, the annual incidence rate of probable and definite TIA was 1.08 (0.95–1.21) and 
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the annual incidence rate of incident-definite TIA was 0.54 (0.44–0.63) per thousand. This 
translates into approximately 54,610 definite or probable TIAs and 26,280 incident-definite 
TIAs respectively in that year alone (Giles & Rothwell, 2007). 
These figures are slightly higher than those reported in the Oxfordshire Community Stroke 
Project, carried out between 1981 and 1986, which reported annual incidence rates of 0.35 
(0.30–0.40) per 100,000 for TIA (Dennis et al., 1989). This may reflect improved methods of 
case ascertainment in the OXVASC study. Equally, it may reflect an increased number of TIA 
patients seeking medical advice due to increased awareness of TIA as a medical emergency. 
Campaigns aimed at the general public like FAST (Face, Arms, Speech, Time) (Department 
of Health, 2007b), are likely to have triggered more individuals to recognise the symptoms of 
TIA and seek medical attention.  Following recommendations for all front-line staff to be 
trained to recognise TIA and stroke symptoms, as part of the Department of Health’s 
commitment to improving services for TIA and stroke (Department of Health, 2007a), 
practitioners ability to identify and act on TIA may have also improved. Diagnostic tools such 
as ROSIER (Recognition Of Stroke In the Emergency Room) (Department of Health, 2007b), 
and slogans like “time is brain” may have facilitated this. 
Following the introduction of the quality and outcomes framework (QOF) in 2004 it is likely 
that the reporting TIA and minor stroke by practitioners improved, again contributing to the 
apparent increase in incidence of TIA. QOF is a voluntary incentive scheme for GP practices 
in the UK that rewards practices for how well they register, monitor and care for patients with 
different conditions, including stroke and TIA. 
The mean age for patients experiencing their first ever TIA was reported by OXVASC to be 
73 with a standard deviation 13 years (Giles & Rothwell, 2007). This is comparable to results 
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published from the Oxfordshire Community Stroke Project (Dennis et al, 1989), which 
reported highest incidence of TIA in the 75–84 age group. 
It is suggested that there were approximately 150,000 new referrals to TIA clinics in England 
in 2005 with suspected TIA (Giles & Rothwell, 2007).  Definite and probable TIA and stroke 
were found to account for only 62% of these referrals. The fact that many people with a 
suspected TIA turn out to have other diagnoses reflects the considerable challenge faced by 
GPs in accurately diagnosing TIA.  
Although standardised admission rates for stroke in Oxfordshire are similar to mean overall 
rates in England, caution should be taken when generalising the results of these incidence-
based studies to the rest of the country as the deprivation and ethnic mix of Oxfordshire may 
be very different. 
Incidence (i.e. the number of people experiencing a first or recurrent TIA per year) is of 
interest because this has a bearing on initiation of treatment and secondary prevention. The 
prevalence (i.e. the number of people who have a history of a TIA) is also relevant as it 
highlights a group of people who may be living with the consequences of TIA and are 
receiving ongoing treatments including medical management and behaviour modification. 
1.3.2 Prevalence 
Extensive searches of electronic databases of medical literature revealed no UK-based 
prevalence studies of TIA. Current estimates for commissioning, planning and prioritizing 
healthcare, summarized in the Health Care Needs Assessment (Mant et al., 2004), are based 
on a Dutch study carried out between 1990 and 1993 (Bots et al., 1997). This population-
based study of 7,983 individuals revealed a TIA prevalence of 1.9% in subjects aged 55-64 
years, 3.5% in subjects aged 65-74 years, 4.3% in subjects aged 75-84 years and 5.1% in 
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subjects over 85 years. About half of these subjects were classified as having had non-specific 
TIAs. 
1.4 Forming a diagnosis  
The diagnosis of TIA is currently based on clinical judgement, formed by subjective 
assessment of risk factors and symptoms.  
1.4.1 Risk factors 
Modifiable risk factors are the same as for completed stroke and  include atrial fibrillation, 
hypertension, smoking, diabetes mellitus and ischaemic heart disease (Mant et al, 2004). 
People may be at higher risk of stroke owing to inherent factors that cannot be altered, such as 
age, sex, family history and ethnicity.  
1.4.2 Symptoms 
Typically the symptoms associated with TIA arise suddenly, with maximal onset and last for 
only a short duration (Mant, 2011).  Symptoms can be classified as “focal” and attributed to 
dysfunction to an arterial territory of the brain, or “non-focal” where cerebral symptoms 
cannot be anatomically localized. Symptoms most likely to predict a stroke or TIA include 
sudden change in speech, visual loss, diplopia, numbness or tingling, weakness or paralysis, 
and non-orthostatic dizziness(Goldstein & Simel, 2005). These are all focal symptoms. Non-
focal symptoms, such as headache, confusion and loss of consciousness do not suggest a 
stroke or TIA unless they are clearly accompanied by focal symptoms (Warrior & 
Prabhakaran, 2009).  
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1.4.3 Diagnostic difficulties 
Forming an accurate diagnosis of TIA is notoriously difficult. Agreement between assessors 
has been shown to be as low as 50% (Tomasello et al., 1982), and a high percentage of 
patients referred with suspected TIA are subsequently found to have a non-cerebrovascular 
diagnosis when assessed by stroke specialists (Dawson et al., 2009). In a recent cohort study 
of consecutive patients referred to TIA clinics over 5 years (Fonseca & Canhão, 2011), a 
specific diagnosis was not established in almost a quarter of patients, even after extensive 
investigation. In part diagnostic difficulties arise from the heterogeneity of TIA symptoms 
and variety of conditions that can mimic a TIA such as seizure, sepsis, metabolic 
disturbances, space occupying lesions, syncope and delirium and others (Dawson et al, 2009; 
Fonseca & Canhão, 2011; Goldstein & Simel, 2005; McArthur et al., 2011). Accurate 
diagnosis also relies on patients’ ability to accurately recall their symptoms which would, by 
nature of the syndrome, have been short lived.  
Although imaging modalities can significantly improve the clinical decision making and care 
of TIA and stroke patients, it is not always necessary and the results can be misleading. 
Infarcts, that are visible in brain scans are not always symptomatic and often go unnoticed, so 
called “silent strokes” (Lim & Kwon, 2010). In practice brain imaging is only recommended 
for diagnostic purposes when TIA is suspected yet vascular pathology is uncertain. For 
treatment purposes MR diffusion and perfusion imaging techniques have become 
indispensable for characterizing and dating acutely ischaemic tissue. Providing the critical 
time window has not lapsed, it can be used to identify individuals at risk of stroke who will 
benefit from thrombolysis (Ricci, 2000). Likewise, carotid imaging can be used to identify 
candidates for carotid endarterectomy (National Institute for Health and Clinical Excellence, 
2008). 
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1.5 Management of Transient Ischaemic Attack and minor-stroke 
National stroke guidelines and audits recommend that people with suspected TIA or minor 
stroke are immediately started on 300mg aspirin (daily) and managed according to their risk 
of further stroke (National Institute for Health and Clinical Excellence, 2008). Johnston and 
colleagues (2007) established and validated a tool, named ABCD2, to predict the risk of stroke 
after TIA. The ABCD2 evaluates five risk factors (age, blood pressure, clinical features, 
duration and diabetes) and is scored out of seven.  
Patients that are considered to have a high risk of stroke (an ABCD2 score of four or more, or 
more than one TIA in a week) should receive specialist assessment and investigation within 
24 hours of symptom onset.  For lower-risk patients specialist assessment and investigation 
should be performed as soon as possible and definitely within 1 week of onset of symptoms. 
In both cases measures for secondary prevention should be introduced as soon as the 
diagnosis is confirmed. Measures are usually aimed at managing hypertension, diabetes, atrial 
fibrillation, cholesterol and obesity through medication (e.g. antithrombotics and statins) and 
lifestyle advice (e.g. diet, exercise, smoking and alcohol advice). Carotid endarterectomy 
(CEA) is only advocated, within 2 weeks of symptom onset, in patients with symptomatic 
carotid artery stenosis of 50–99% (according to the North American Symptomatic Carotid 
Endarterectomy Trial criteria), or 70–99% (according to the European Carotid Surgery 
Trialists’ Collaborative Group criteria). 
“Success” with this group (that is patients with suspected TIA) appears to be measured in 
terms of time from event to clinic, prescription of prophylactic medications and prevention of 
further cardiovascular episodes and/or death. Given that TIA is associated with a very high 
risk of stroke (relative risk of 80, 95% confidence interval: 34–158) in the first month 
following the event (Dennis et al., 1990), this is hardly surprising. 
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Evidence for the role of rehabilitation after TIA is lacking and stroke-unit care is only 
advocated for those with a diagnosis of stroke. National stroke guidelines were developed by 
the Intercollegiate Working Party for Stroke, members of which were nominated by 
professional organisations and societies to give wide representation from all disciplines, 
including the views of patients and their families. Based on available evidence, the 
Intercollegiate Stroke Working Party  (2008), recommend that a multidisciplinary assessment 
including assessment of consciousness level, swallowing, pressure sores risk, nutritional 
status, cognitive impairment, communication and the patient’s needs in relation to moving 
and handling should be undertaken within 24–48 hours of admission for stroke. They 
acknowledge the importance of physiotherapists and occupational therapists in co-ordinating 
therapy to improve movement performance and address difficulties in activities of daily living 
following stroke. Within the first month of stroke the Intercollegiate Working Party highlight 
a need for screening patients for emotionalism, anxiety and depression. They state that 
“mood” should be kept under review and antidepressant should be considered as a possible 
treatment. The Edinburgh Consensus Conferences on stroke also support the use of 
antidepressants for depression or emotionalism, as well as psychological therapies; support 
mechanisms (including patient and carer support groups) after stroke (Mant et al., 2004). 
1.6 Research Proposal 
1.6.1 Rationale  
While the physical, cognitive and psycho-social consequences of ischaemic stroke are 
extensively documented, as evidenced in the NICE guidelines (Swain et al., 2008), rather less 
is known about the consequence sequelae of TIA. This is hardly surprising given that TIA is 
defined in terms of “symptoms that resolve without obvious lasting damage” (Department of 
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Health, 2007b). Where there is data the emphasis tends to be on medical management and 
survival, reflecting the current focus of treatment for this group; the prevention of major 
stroke.   
As discussed earlier, the boundary between TIA and stroke is not clear cut and it is possible 
that healthcare needs of people diagnosed with TIA and minor stroke are being overlooked. 
The World Health Organisation ‘‘biopsychosocial model’’ defines health as “a state of 
complete physical, mental and social well-being and not merely the absence of diseases and 
infirmity”. This has led to increased recognition that healthcare evaluations should 
incorporate patients’ perspectives and include self-report health rating scales as well as the 
inherent survival statistics and referral times.  
Using Q-methodology, Spurgeon (2011) studied patients’ experiences of TIA. Q-
methodology involves the development of a series of heterogeneous statements which capture 
subjective experiences. These statements are ranked by participants according to their own 
perspectives or experiences (Q-sort). The resulting Q-sorts are then subjected to correlation 
and factor analysis. Spurgeon (2011) identified eight themes that were pertinent to the 
experiences of TIA patients: lack of knowledge/awareness of TIA; life impact; anxiety; 
interpersonal impact; depression; physical consequences; cognitive avoidance (denial) and 
constructive optimism. Eminent comments including, “my memory did suffer quite a 
bit.....It’s better now, but still hasn’t returned to what it was before”; “I wonder whether I will 
ever be able to function normally again”, “the worry stopped me sleeping and functioning 
properly”; “I felt so very low for ages” and “I definitely felt I was a burden on my family” 
were particularly alarming.  These personal experiences suggest that TIA is not as transient as 
once perceived.  
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The emergence of physical, psycho-social and cognitive sequalae of TIA warrants further 
attention, to see if the subjective experiences identified here translate to the wider TIA 
population, especially when potential influential factors are controlled. 
1.6.2   Aim 
A review will be conducted to systematically look for research which has investigated 
whether or not individuals who are diagnosed with TIA make a full physical and emotional 
recovery after the neurological symptoms subside. The extent and quality of research will be 
scrutinised and, if limited, a cohort study will be designed to better understand the 
consequences of TIA and provide clinically significant evidence to support the presence or 
absence of functional, cognitive and emotional impairments after TIA.   
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CHAPTER 2 
SYSTEMATIC REVIEW 
2.1 Aim 
The aim of this systematic review was to analyse the results from any existing quantitative 
literature that used patient based outcome measures, psychosocial tests or clinical diagnoses to 
assess functional, emotional and/or cognitive outcomes after Transient Ischaemic Attack 
(TIA). 
2.2 Scoping search 
To avoid repetition, a scoping search was conducted across the Cochrane Database of 
Systematic Reviews and the Database of Abstracts of Reviews of Effects (DARE), to identify 
any existing reviews that addressed the same aims as the proposed review.  It was intended 
that any existing reviews would be updated, not repeated. 
2.2.1 Findings of scoping search 
No existing reviews were identified that addressed functional, emotional or cognitive 
outcomes after TIA.   
2.3 Report strategy 
This review has been conducted in accordance with the ‘Meta-analysis of observational 
studies in epidemiology: a proposal for reporting’ (MOOSE) statement, (Stroup et al., 2000) 
which provides a checklist for reporting meta-analyses and observational studies in 
epidemiology. The review also conformed to recommendations of the STROBE 
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(STrengthening the Reporting of OBservational studies in Epidemiology) guidelines (von Elm 
et al., 2008). 
2.4 Methods 
2.4.1 Search strategy 
The following electronic databases were searched: MEDLINE (1948- May 2011), EMBASE 
(1947-May 2011), PsycINFO (1987-May 2011), HMIC (1979-May 2011), CINAHL (1982-
May 2011), Science citation Index (1991- May 2011) and the Cochrane library (1991-May 
2011). Grey literature, including unpublished trials and ongoing research was also searched 
for through the Stroke trials registry, the UK Stroke Research Network and reference lists of 
relevant articles. The search strategy, formulated in MEDLINE (Appendix 1), was adapted 
with the help of an experienced medical librarian to make it applicable to the other databases. 
2.4.2 Eligibility criteria 
 
Table 1: Criteria for including studies in the review  
Item Criteria 
Study design  cohort (prospective or retrospective) 
 case-control  
 
Study group  persons with a confirmed diagnosis of TIA and no prior 
stroke 
 
Comparison 
group 
 
 ipsative (comparison of pre- and post-TIA data) 
 normative (comparison with published norms or control 
data)  
NB. Only individuals without a cerebrovascular diagnosis were 
considered to be adequate controls.  
 
Outcomes  measures of cognitive function (e.g. memory, attention, 
executive function) 
 measures of ‘affect’ (e.g. anxiety, depression, quality of 
life) 
 measures of physical function (e.g. activities of daily 
living) 
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2.4.3 Identification of relevant trials 
References yielded by the search strategy were merged in Reference Manager 11, and 
duplicates were subsequently removed. Two authors (NB and LH) independently screened all 
abstracts and titles to decide whether the full text should be sought. A third reviewer (CS) 
was consulted in the case of any disagreement. If discrepancy or indecision about eligibility 
of studies persisted following discussion, the full text was sought. Two authors (NB and GJ) 
independently examined the full text to make a final decision on their inclusion. Similarly, if 
no consensus was met a third reviewer (CS) had the casting vote. 
2.4.4 Data extraction 
Two authors completed a data extraction form for each study meeting the inclusion criteria. If 
the study design, methodology and/or data from published reports were unclear an effort was 
made to contact study authors to provide clarification.  
2.4.5 Assessing methodological quality and risk of bias 
Bias is defined as an error in the design or execution of a study, which produces results that 
are consistently distorted in one direction because of non-random factors. 
A systematic review by Sanderson et al (2007)  highlighted the lack of a single obvious tool 
for assessing quality and susceptibility to bias in observational epidemiological studies. 
Consequently, for this systematic review, the items of checklists reviewed by Sanderson were 
pooled, until saturation was reached, then refined to make them more specific to the needs of 
this systematic review, all the time keeping in mind the STROBE (STrengthening the 
Reporting of OBservational studies in Epidemiology) guidelines (von Elm et al, 2008). The 
items used to assess risk of bias in this review are summarised in Table 2, together with 
scoring the criteria. Rather than using an arbitrary scoring system, the quality of each study 
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was discussed against set criteria. This transparency, endorsed by Cochrane, allows the reader 
to come to their own conclusions about possible sources of bias.  The methodological quality 
of the included studies was assessed by two independent reviewers (NB, GJ). 
Table 2: Risk of bias scoring criteria 
Category Score “1” Score “o” Score “9” 
Design Cohort study (therefore able to infer 
causal relationship) 
Cross-sectional data collection Not enough information to judge/ not 
clear 
Recruitment method of 
TIA group 
Consecutive or random Incentivised recruitment or subject to 
manipulation  
Not enough information to judge/ not 
clear 
Case diagnosis Neuro-imaging (++), standardized 
clinical assessment (+) or medical 
notes  used to diagnose TIA 
Self-report  Not enough information to judge/ not 
clear 
Recruitment method of 
control group 
Consecutive or random Incentivised recruitment or subject to 
manipulation  
Not enough information to judge/ not 
clear 
Were groups comparable 
at baseline for important 
characteristics? 
Professional opinion (take into account “matching”, inclusion criteria and 
statistical differences at baseline). If important statistical differences were 
factored into analysis e.g. Regression, score “1”.  If important statistical 
differences were not factored into analysis, score “0” 
Not all potential confounders were 
addressed. 
Were all subjects assessed 
using the same procedure 
and if longitudinal, were 
the same measures used at 
follow-up? 
Yes No Not enough information to judge/ not 
clear 
Were outcome measure 
choices appropriate? 
Professional opinion (consider citations given for appropriateness, reliability, 
validity, responsiveness, precision, interpretability, acceptability or feasibility of 
outcome measures; evidence of inter/intra-rater reliability checks;  measures of 
internal consistency; measurement to exposure in different ways) 
Not enough information to judge/ not 
clear 
Were interviewers and 
data collectors blind to the 
case/control status of study 
subjects and to the 
hypothesis being tested?  
Outcome measures self-completed by 
the participant or, if interviewer 
administered, evidence of blinding 
Outcome measures administered by 
an un-blinded interviewer  
Not enough information to judge/ not 
clear 
Participation rates ≥80% <80% Not enough information to judge/ not 
clear  
Attrition No loss to follow-up, similar between 
groups or handled appropriately in the 
analysis 
Loss to follow-up significantly 
different between groups and handled 
inappropriately in the analysis 
Not enough information to judge/ not 
clear  
NB. For cross-sectional analyses score 
as “n/a” 
Missing data No missing data, similar between 
groups or handled appropriately in the 
analysis 
Missing data significantly different 
between groups and handled 
inappropriately in the analysis 
Not enough information to judge/ not 
clear  
Was the study designed to 
have sufficient power to 
detect the effect(s) of 
interest?  Were the 
numbers achieved? 
Evidence of sample size planning or 
power calculation prior to recruitment, 
and target numbers achieved 
 
Lack of evidence or admittance that 
neither a sample size nor power 
calculation were performed, or target 
numbers were not achieved 
Not clear 
Were confidence intervals 
provided in the analyses?    
Yes No n/a 
Did the report avoid 
selective reporting of 
results or inappropriate 
use of methods to achieve a 
stated or implicit 
objective? 
Major results directly related to the a 
priori hypothesis under investigation;  
significant and non-significant results 
reported in a balanced fashion or, if 
protocol available, intended and 
reported analyses match up  
Evidence of “data dredging”; 
unbalanced reporting of results  
n/a 
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2.4.6 Data Analysis 
Due to the heterogeneity of studies a meta-analysis of results was not possible. Consequently 
a synthesis of study findings are presented and discussed. 
2.5 Results 
2.5.1 Study selection 
Two thousand and seven titles and abstracts, generated from initial search, were screened. 
Full texts were sought for 55 of these publications, in addition to 15 publications identified 
through reference chaining. These 70 publications were reviewed by two independent 
reviewers. Agreement between reviewers was high; both independently identified the same 13 
publications for inclusion. A further 9 publications were identified by just one reviewer. 
Following discussion 1 of these was included in the review and the remainder were rejected. 
Thus, 14 publications were included out of the 70 full texts reviewed. Fifty six publications 
were excluded for the following reasons: Five articles were published in a foreign language, 7 
articles turned out to be reviews and for the remaining articles, the study population (n=29), 
objectives (n=9), design (n=3) or outcome measures (n=3) did not meet the inclusion criteria 
for this review. More detailed reasons for exclusion, by publication, can be found in Table 3.   
2.5.2 Data extraction 
A summary of the 14 included publications, detailing 12 different studies, can be found in 
Table 4. The three publications by Rao et al (1999; 2001; 2002), all refer to the same study 
and are therefore presented together. 
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Table 3: Summary of excluded studies 
Reference 
 
Reason for exclusion Detail 
(Acciarresi et al., 2006) Study population did not meet brief Stroke patients only (no TIA) 
(Albright et al., 2009) Study objectives did not meet brief experimental study comparing weekend with weekday admission 
(Bakker et al., 2003) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
History of minor stroke in 27% TIA group and presence of 
ischaemic lesions on MRI in 68% TIA group. 
(Barnes et al., 2006) Study objectives did not meet brief Association between depressive symptoms mild cognitive 
impairment 
Presence of TIA reported at baseline but no TIA group as such 
(Berger et al., 2005) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
TIA and stroke analysed together 
(Cohen et al., 2011) Study objectives did not meet brief Highly selective cohort, studying the effects of patent foramen 
ovale closure on functioning, depression and anxiety 
(Coutts et al., 2008) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
TIA and minor stroke analysed together 
TIA group contaminated by stroke recurrence during follow-up  
(Crisostomo et al., 2003) Study objectives did not meet brief Analyzed association between clinical characteristics and DWI 
scans in TIA patients 
(Delcker et al., 2000) Study objectives did not meet brief Timing of transcranial Doppler monitoring on the microembolic 
signals and their possible prognostic value on the outcome of TIA 
or stroke symptoms  
(Daffertshofer et al., 2004) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
No non-stroke comparator 
22% TIA group had a history of prior stroke/TIA and 22% showed 
infarct on scan. 
No non-stroke comparison group 
(Devuyst et al., 2002) Study population did not meet brief Highly selective cohort 
Inclusion defined by Degree of basilar artery stenosis (included 
TIA & stroke) 
No non-stroke comparator. 
(Elwan et al., 1994) Study population did not meet brief stroke patients only (no TIA) 
(Fagan, 2008) Review Review 
(Falconer et al., 2010) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
TIA and stroke  analyzed together 
No comparison group 
(Ferriero et al., 2006) Study population did not meet brief stroke patients only (no TIA) 
(Ferro & Crespo, 1994) Study design did not meet brief No non-stroke comparator 
(Flossmann & Rothwell, 2003) Review Review outcomes (survival and recurrent CV events) do not match 
brief  
(Fonarow et al., 2010) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
Prior stroke not excluded 
(Frih et al., 2004) Publication language French 
(Giles & Rothwell, 2007) Study objectives/outcomes did not meet brief Rate of recurrent stroke in suspected TIAs or strokes managed as 
outpatients versus inpatients  
(Haacke et al., 2006) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
No non-stroke comparator 
TIA and stroke analysed together  
no non-stroke comparator 
 
(Hankey, 1993) Study outcomes did not meet brief Outcomes are survival and coronary/cerebrovascular events  
(Hankey, 2003) Review Review outcomes (cerebrovascular/ coronary events) do not match 
brief  
(Hankey et al., 2007) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
Study design did not meet brief 
Highly selective cohort 
TIA and stroke analysed together 
Prior stroke not excluded in participants labelled as TIA 
No non-stroke comparator 
(Harbison et al., 2009) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
Stroke and TIA analysed together 
(Hardie et al., 2004) Study population did not meet brief Only patients with a definite first-ever stroke were included (no 
TIA) 
(Hart, 2008) Review Review of medical treatment studies 
(Jiang et al., 2010) Publication language Chinese 
(Kerr et al., 2011) Study objectives did not meet brief aimed to determine whether low-SES stroke/transient ischaemic 
attack (TIA) patients have a greater burden of vascular risk 
factors/co-morbidity and reduced health care access  
(Luengo-Fernandez et al., 2009) Study objectives did not meet brief Aimed to compare the effects of access to outpatient clinics 
following TIA and minor stroke on disability (mRS, death) and 
hospital costs 
Stroke and TIA studied as one  cohort 
(Muus et al., 2010) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
No non-stroke comparator 
TIA and stroke analysed together 
No non-stroke comparator 
(Owens et al., 2002) Study objectives did not meet brief Examined the agreement between a self-reported and a 
performance-based measure of function and the ability of each 
measure to predict long-term health outcomes 
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(Pendlebury, 2009) Review Review 
(Pendlebury et al., 2010) No non-stroke comparator No comparison group 
(Pinto et al., 2006) Study population did not meet brief Stroke patients only (no TIA) 
(Pokorski, 1996) Review Review 
(Porsdal & Boysen, 1998) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
No non-stroke comparator 
TIA group included patients with prior stroke  
No non-stroke comparison group 
 
(Rao, 2000) Review Review 
(Rola et al., 2008) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
TIA and stroke analysed together (SDB v no SDB) 
(Rotter, 2002) Publication language Polish 
(Sachdev et al., 2004) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
TIA and stroke analysed together  
 
(Sachdev et al., 2007) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
TIA and stroke analysed together  
 
(Schnider et al., 1996) Publication language German  
(Selvarajah et al., 2008) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
No non-stroke comparator 
No non-stroke comparator 
TIA and minor stroke analysed together 
 
(Silvestrelli et al., 2006) Study population did not meet brief Stroke 
(Suenkeler et al., 2002) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
No non-stroke comparator 
No non-stroke comparator 
TIA and minor stroke analysed together 
 
(Takahashi et al., 2009) Study population did not meet brief Cases were those with memory impairment not TIA. TIA entered 
(as possible confounding variable) into multivariable logistic 
regression to examine risk factors for memory impairment  
(Tham et al., 2002) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
No non-stroke comparator 
No non-stroke comparator 
TIA and minor stroke analysed together 
 
(Vang et al., 1999) Study population did not meet brief Stroke patients only (no TIA) 
(Van Wijk et al., 2006) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
No non-stroke comparator 
No non-stroke comparator 
TIA and minor stroke analysed together 
 
(Van Wijk et al., 2007) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
TIA and stroke analysed together 
(Weimar et al., 2002) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
No non-stroke comparator 
TIA group included patients with prior stroke  
No non-stroke comparator 
(Winter et al., 2009) Study outcomes did not meet brief  
No non-stroke comparator 
Economic outcomes 
No non-stroke comparator (stroke v TIA) 
(Winward et al., 2009) Study design did not meet brief no non-stroke comparator 
(Xie et al., 2006) Study population did not meet brief- unable to 
differentiate between stroke and TIA 
Stroke and TIA grouped together 
(Zhang et al., 2008) Publication language Chinese 
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Table 4: Summary of Included Studies 
Reference (Guyomard 
et al., 2011) 
(Charoenkitkar
n et al., 2009) 
(Bos et al., 
2007) 
(Zinn et al., 
2007) 
(Howard et 
al., 2007) 
(Bossema et 
al., 2006) 
(Xin-rong et 
al., 2005) 
(Hickie et al., 
2003) 
(Walters et al., 
2003) 
(Rao et al., 1999; 
Rao et al., 2001; 
Rao, 2002) 
(Duncan et 
al., 1997) 
(Iddon et al., 
1997) 
Design Prospective, 
case-control 
Prospective, 
cohort 
Prospective, 
population-
based, cohort 
Prospective, 
case-control 
Prospective, 
case-control 
Prospective, 
case-control 
Prospective, 
case-control 
Prospective, 
cohort 
Prospective, 
cohort 
Prospective, case-
control 
Prospective 
case-control 
Prospective, 
case-control 
Location UK (East of 
England) 
Thailand, 
(Bangkok & 
Ayutthaya) 
Holland 
(Rotterdam) 
USA (South 
East) 
USA 
(nationwide) 
Holland 
(Nieuwegein, 
Utrecht) 
China  Australia 
(Dubbo region) 
UK (London) UK (London) USA (Kansas, 
North 
Carolina, NY) 
UK 
(Cambridge & 
Newcastle) 
Recruitment Aug 2008 – 
Nov 2008 
Not specified 1990-1993 Recruitment over 
2..5 year period 
(exact years not 
specified) 
Jan 2003 – 
Mar 2006 
Not specified Jan 2002 – 
Jun 2003 
1988 – 1989 Not specified Not specified 1992 Not specified 
Time of 
recruitment 
relative to TIA 
Recruited at 
clinic (assume 
within 1 week 
of symptom 
onset based 
on current 
guidelines) 
At admission Pre-TIA  
 
Within 10 days 
of event 
Variable Not reported (1 
day before 
CEA) 
Within 72 
hours of 
symptom 
onset 
Pre-TIA Within 15 days 
of event 
Time since first TIA 
categorised as 
more/less than 5 
years but exact 
numbers not 
presented 
 
Not specified Not reported 
(48–72 h 
before CEA) 
Follow-up n/a 3, 10 and 30 
days after TIA or 
minor surgery 
(controls) 
3 follow-up 
surveys 
(1993-1995, 
1997-1999, 
and 2002- 
2004) 
n/a n/a n/a n/a 10 years  6 and 12 
months 
n/a 
 
n/a n/a (only pre-
surgery scores 
meet review 
criteria) 
TIA Group             
 
n 68 52 282 focal 
(TIA); 228 
non-focal 
TNA, and 38 
mixed TNA 
9 818 41 35 19 60 25 184 30 
 
Source of 
participants 
 
Neurovascular 
clinic, 
Norfolk & 
Norwich 
University 
Hospital 
 
Outpatient and 
emergency 
departments of 4 
tertiary hospitals 
 
Community- 
dwelling 
Rotterdam 
Study 
participants 
 
 
Inpatient wards 
at veterans 
affairs medical 
centre 
 
Subset of 
REGARDS 
cohort study 
(commercially 
available lists 
of residents) 
 
Symptomatic 
patients on 
waiting list for 
unilateral 
Carotid 
endarterectomy 
(symptoms inc 
≥1 episode of 
hemispheric/ 
retinal TIA)  
 
Geriatric 
department, 
Urumqi 
General 
Hospital 
(inpatients 
and 
outpatients) 
 
Community 
 
 
 
 
 
 
 
 
 
 
Neurovascular 
clinic 
 
Community within 
catchment of inner 
city teaching 
hospital, on waiting 
list for carotid 
endarterectomy 
 
Academic 
Medical 
Center 
Consortium 
records 
(inpatients); 
United HC 
records 
(inpatients and 
outpatients); 
Bowman Gray 
site of the CV 
Health Study 
(community ) 
 
TIA patients 
admitted to 
Addenbrooke’s 
Hospital for 
unilateral 
carotid 
endarterectomy  
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Reference (Guyomard 
et al, 2011) 
(Charoenkitkar
n et al, 2009) 
(Bos et al, 
2007) 
(Zinn et al, 
2007) 
(Howard et 
al, 2007) 
(Bossema et al, 
2006) 
(Xin-rong et 
al, 2005) 
(Hickie et al, 
2003) 
(Walters et al, 
2003) 
(Rao et al, 1999; 
Rao et al, 2001; 
Rao, 2002) 
(Duncan et al, 
1997) 
(Iddon et al, 
1997) 
TIA Group continued..            
Selection 
criteria 
First ever 
TIA; aged ≥ 
45; No pre-
existing 
cognitive 
impairment 
and/or 
depression; no 
history of 
stroke 
≥24 years; able 
to read & write; 
able to take/ 
respond to 
tests/questions; 
without hearing 
loss, eye 
problems, history 
of substance 
abuse/dependenc
y, Cancer, 
HIV/AIDS, head 
injury, ADHD or 
any other 
neurological 
disorder other 
than TIA; Not on 
meds to alter 
cognitive 
processing; Not 
depressed 
 ≥55 years; 
free from 
stroke, 
myocardial 
infarction, 
and dementia 
at baseline  
 
Follow-up 
ended at 
time of 
outcome 
event 
(Stroke, 
ischaemic 
heart 
disease, or 
dementia) 
end of study, 
loss to 
follow-up or 
death, 
whichever 
occurred first 
 
Ruled out for 
acute stroke; no 
prior stroke 
Not reporting 
stroke but self 
reporting TIA 
(“Were you 
ever told by a 
physician that 
you had a 
ministroke or 
TIA, also 
known as a 
transient 
ischaemic 
attack?”) 
No history of 
minor or major 
stroke (evident 
from medical 
records) 
Right-handed 
male TIA 
patients with 
no other inter-
cranial disease 
visible on CT; 
normal visual 
and auditory 
functions; 
independent; 
no mental 
disorder, 
severe heart, 
lung, liver or 
kidney disease 
Non-
institutionalised 
residents born 
before 1930. 
Those who had 
a clinical stroke 
in the 
intervening 
decade were 
excluded. 
First, isolated 
TIA; MMSE ≥ 
28/30); no 
evidence of 
general/focal 
atrophy on MR 
imaging; no 
clinical/ 
radiological 
evidence of 
established 
stroke; Alcohol 
consumption ≤ 
3 units daily; 
no severe 
hypertension, 
significant 
ischaemic heart 
disease, 
peripheral 
vascular 
disease, or 
carotid stenosis 
History of  ≥ 1 TIA 
and stenosis >70% 
on 1 or both internal 
carotid arteries; on 
waiting list for 
carotid 
endarterectomy; no 
history of stroke or 
clinical evidence of 
stroke during 
preoperative 
screening; no history 
of PVD, drug or 
alcohol misuse, 
Parkinson’s disease, 
head injury, epilepsy, 
carcinomatosis or 
uncontrolled 
metabolic, endocrine, 
or respiratory 
disorders; >65 yrs 
History of TIA 
but not stroke 
Severe carotid 
artery stenosis 
(≥70%) 
no history of 
stroke, no 
depression or 
dementia at 
baseline 
Case 
diagnosis 
Focal 
neurological 
deficit < 24 
hours duration 
of presumed 
vascular 
origin, 
confirmed by 
highly 
experienced 
stroke 
physician 
Clinical 
diagnosis 
confirmed by 
neurologist 
Consulted a 
neurologist, 
GP or 
another 
physician, or 
reported 
event at 
research 
centre 
Clinical 
diagnoses 
verified by 
experienced 
stroke 
neurologist 
 
Clinical 
examination, 
chart review and 
CT scan by 
neurologist 
(where possible 
diffusion 
weighted MRI 
also performed) 
Self-report  Degree of 
carotid stenosis 
assessed with 
duplex 
ultrasonography 
Diagnosis 
conformed to 
classification 
& diagnostic 
criteria for 
Chinese 
National 
conference of 
cerebral 
vessels 
diseases; head 
CT excluded 
other 
intracranial 
diseases 
Hospital 
discharge 
coding against 
usual criteria 
Consultant 
neurologist 
with special 
interest in 
cerebrovascula
r disease; 
reinforced by 
neuro-imaging 
Not clear ICD-9 codes 
(verified by 
medical record 
review) 
Not specified 
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Reference (Guyomard 
et al, 2011) 
(Charoenkitkar
n et al, 2009) 
(Bos et al, 
2007) 
(Zinn et al, 
2007) 
(Howard et 
al, 2007) 
(Bossema et al, 
2006) 
(Xin-rong et 
al, 2005) 
(Hickie et al, 
2003) 
(Walters et al, 
2003) 
(Rao et al, 1999; 
Rao et al, 2001; 
Rao, 2002) 
(Duncan et al, 
1997) 
(Iddon et al, 
1997) 
Comparison Group            
 
n 68 non-
vascular 
controls 
52 non-vascular 
(minor-surgery) 
controls 
5514 non-
stroke/TIA 
controls 
10 “at risk of 
stroke” controls 
16,090 non-
stroke/TIA 
controls 
44 non-
stroke/TIA 
controls 
33 “healthy” 
controls 
44 hypertensive 
& 45 
normotensive 
controls 
26 non-
vascular 
controls 
25 vascular & 25 
orthopaedic controls 
654 
asymptomatic 
individuals at 
a high-risk of 
stroke 
 
30 “healthy” 
volunteers 
Source of 
participants 
Dermatology 
and neurology 
clinics, 
Norfolk & 
Norwich 
University 
Hospital  
Outpatient 
departments  
Community- 
dwelling 
Rotterdam 
Study 
participants 
 
Inpatient wards 
at veterans 
affairs medical 
centre 
Subset of 
REGARDS 
cohort study 
(commercially 
available lists 
of residents) 
Advert in local 
paper 
Patients 
visiting 
hospital for 
physical 
examination 
Community Not stated Community within 
catchment of inner 
city teaching hospital  
On waiting list for 
femoropopliteal 
bypass (vascular) or 
elective THR/TKR 
for OA (orthopaedic) 
 
As TIA group Not stated 
Selection 
criteria 
No vascular 
risk factors or 
evidence of 
vascular 
disease; No 
pre-existing 
cognitive 
impairment 
and/or 
depression 
(matched to 
TIA group by 
age & gender) 
Minor surgery 
patients; no 
known 
hypertension, 
diabetes, 
vascular disease 
or Hx stroke/TIA 
(matched to TIA 
group by age, 
gender & 
education) 
≥55 years; 
free from 
TNA, stroke, 
myocardial 
infarction, 
and dementia 
at baseline. 
Follow-up 
ended at 
time of 
outcome 
event (TNA, 
Stroke, 
ischaemic 
heart 
disease, or 
dementia) 
end of study, 
loss to 
follow-up or 
death, 
whichever 
occurred first 
 
Not specified Not specified No history of 
Cerebro-
vascular or 
psychiatric 
disease 
“Healthy” 
right-handed 
male 
volunteers; no 
history of 
mental 
disorders 
(Matched to 
TIA group by 
age, gender, 
education, 
handedness) 
Hypertensive 
group: using 
hypertensive 
medication at 
baseline 
Normotensive 
group: systolic 
BP<140mmHg 
and diastolic 
BP<90mmHg 
at baseline. 
All groups: 
Non-
institutionalised 
residents born 
before 1930;  
no clinical 
stroke in the 
intervening 
decade  
No history of 
stroke or TIA; 
no evidence of 
general/focal 
atrophy on MR 
imaging; no 
clinical/ 
radiological 
evidence of 
established 
stroke; Alcohol 
consumption ≤ 
3 units daily; 
no severe 
hypertension, 
significant 
ischaemic heart 
disease, 
peripheral 
vascular 
disease, or 
carotid 
stenosis. 
(matched to 
TIA group by 
age & gender) 
Vascular (PVD) 
group: On waiting 
list for 
femoropopliteal 
bypass  
Orthopaedic group: 
elective THR/TKR 
for OA (6-12 months 
before interview); no 
history of PVD 
All groups: no 
history of 
stroke/TIA, 
drug/alcohol misuse, 
Parkinson’s, head 
injury, epilepsy, 
carcinomatosis, 
uncontrolled 
metabolic/endocrine/
respiratory disorders; 
not considered by GP 
or interviewer to be 
too frail, cognitively 
impaired, 
uncommunicative; 
>65 yrs 
Asymptomatic 
individuals 
without 
neurological 
insult, at high-
risk of stroke 
(based on 
ICD-9 codes) 
“Healthy” 
volunteers with 
no depression 
or dementia at 
baseline 
(matched to 
TIA group by 
age and IQ) 
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Reference (Guyomard 
et al, 2011) 
(Charoenkitkar
n et al, 2009) 
(Bos et al, 
2007) 
(Zinn et al, 
2007) 
(Howard 
et al, 2007) 
(Bossema et al, 
2006) 
(Xin-rong et 
al, 2005) 
(Hickie et al, 
2003) 
(Walters et al, 
2003) 
(Rao et al, 1999; 
Rao et al, 2001; 
Rao, 2002) 
(Duncan et al, 
1997) 
(Iddon et al, 
1997) 
Outcome 
Measures 
Cognition 
MoCA (7 
domains): 
(1) visuo-
spatial, (2) 
naming, (3) 
attention, (4) 
language, (5) 
abstraction, 
(6) delayed 
recall, (7) 
orientation 
Cognition 
(1) Necker cube 
pattern control 
test, (2) digit 
span forward 
test, (3) trail 
making A test, 
(4) Barrett 
impulsiveness 
scale, (5) visual 
analogue scale – 
irritability, (6) 
digit symbol 
substitution test, 
(7) digit span 
backward test, 
(8) Hopkins 
verbal learning 
test-revised 
Cognition 
(1) 
Alzheimer 
disease, (2) 
vascular 
dementia 
(standardised 
clinical 
diagnosis) 
Cognition 
Wechsler Adult 
Intelligence 
Scale subtests: 
(1) Digit span, 
(2) Picture 
arrangement  
 
Delis-Kaplan 
executive 
function system 
subtests: (3) 
symbol digit 
modalities test, 
(4) design 
fluency,(5) trail 
making  
 
(6) Hopkins 
verbal learning 
test-revised  
 
HR-QOL 
SF-12: 
Physical 
and mental 
component 
scores 
Cognition 
(1) digit span 
forward test, (2) 
digit span 
backward test, (3) 
dichotic listening 
test, (4) word 
learning test -
immediate recall, 
(5) word learning 
test -  delayed 
recall, (6) word 
learning test –
recognition, (7) 
doors test A, (8) 
doors test B, (9) 
verbal fluency –
letters, (10) verbal 
fluency – 
categories, (11) 
trail making A 
test, (12) trail 
making B test, 
(13) motor 
planning test - 
planning, (14) 
motor planning 
test -  movement, 
(15) finger 
tapping test – 
dominant, (16) 
finger tapping test 
– non-dominant, 
(17) line 
orientation test 
 
Mood  
Dutch shortened 
POMS 
Cognition  
SECF: 
(1) 
orientation, 
(2) memory, 
(3) 
recognition 
span, (4) 
recall 1 
(association), 
(5) long-term 
memory, (6) 
naming of 
animals, (7) 
calculation, 
(8) 
classification), 
(9) copying, 
(10) language, 
(11) recall 2 
(relationship) 
Depression  
(1) CES-D 
tertiles, (2) 
DSM-lV codes, 
(3) MDAS 
Cognition 
MMSE 
1999 & 2002 
publications 
Cognition 
CAMCOG (9 Tests): 
(1) abstract thinking, 
(2) attention, (3) 
calculation, (4) 
language, (5) 
memory, (6) 
orientation, (7) 
praxis, (8) perception 
(recognition), (9) 
MMSE 
 
+ (10) trail-making 
test, (11)  BDCS, 
(12) controlled word 
association test 
 
2001 publication 
Depression  
(1) HRDS, (2) GDS-
15, (3) DSM-IV 
codes, (4) wish to 
die, (5) suicidal 
ideation in past year 
 
Handicap  
(1) London handicap 
scale,  
 
Social support 
(1)social support 
scale 
 
Activities of 
daily living  
(1) BI 
 
Depression  
(1) CES-D  
 
HR-QOL 
(1) MOS-36, 
(2)  TTO 
Cognition 
CANTAB: 
(1) pattern 
recognition, (2) 
spatial 
recognition, (3) 
spatial span, 
(4) spatial 
working 
memory,(5) 
attentional set 
shifting, (6) 
paired 
associates 
learning, (7) 
matching to 
sample 
 
BDCS = Behavioral Dyscontrol Scale; BI = Barthel Index; CAMCOG = the cognitive, self-contained part of the Cambridge Examination for Mental Disorders of the Elderly; CANTAB = Cambridge Neuropsychological Test Automated Battery; CES-D 
= Centre for Epidemiological Studies Depression Scale; DSM-lV = Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; GDS-15 = Fifteen-item Geriatric Depression Scale; HRDS = Hamilton Rating Scale for Depression; HR-
QOL=Health Related Quality of Life; ICD=International Statistical Classification of Diseases and Related Health Problems; MDAS = Mixed Depression and Anxiety Score; MMSE = Mini Mental State Examination; MoCA = Montreal Cognitive 
Assessment; MOS-SF36 = Medical Outcomes Study Short Form 36; POMS = Profile of Mood States; SECF = Scale of Elderly Cognitive Function; SF-12=12 item Short Form; TTO = Time Trade-off utility
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2.5.3 Quality and risk of bias 
The risk of bias of included studies is summarised in figure 1. Scoring sheets showing 
evidence, reasoning and judgement on the quality of reporting and risk of bias for each 
included study can be found in Appendix 2. 
 
Figure 1: Risk of Bias Summary for Included Studies 
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Were groups comparable at baseline for important 
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Were all subjects assessed using the same procedure and 
if longitudinal, were the same measures used at follow-
up? 
            
Were outcome measure choices appropriate? Rel 
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all Rel 
Val 
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Int 
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Rel 
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Were interviewers and data collectors blind to the 
case/control status of study subjects and to the 
hypothesis being tested? 
            
Participation rates 93%  99% 26% >60%     65% 56%  
Attrition             
Missing data             
Was the study designed to have sufficient power to 
detect the effect(s) of interest?  Were the numbers 
achieved? 
            
Were confidence intervals reported in the analysis?             
Did the report avoid selective reporting of results or 
inappropriate use of methods to achieve a stated or 
implicit objective?  
            
 
Key: (please refer to Table 2 for scoring criteria)  Low risk of 
bias 
 High risk of 
bias 
 Insufficient 
evidence to judge 
 n/a 
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2.5.3.1 Design  
The majority of studies included in this review used cross-sectional analysis (Bossema et al, 
2006; Guyomard et al, 2011; Howard et al, 2007; Rao et al, 1999; Rao et al, 2001; Rao, 2002; 
Xin-rong et al, 2005; Zinn et al, 2007). Consequently we cannot be sure of the direction of 
causation.   
2.5.3.2 Recruitment 
Most of the studies used samples of convenience, inviting patients from a particular 
neurovascular clinic (Guyomard et al, 2011; Walters et al, 2003), hospital ward (Xin-rong et 
al, 2005; Zinn et al, 2007), A&E department (Charoenkitkarn et al, 2009) or outpatient 
department (Charoenkitkarn et al, 2009; Xin-rong et al, 2005) that was easily accessible to the 
researcher. In doing so the researcher inadvertently excluded a great proportion of the TIA 
population. Some studies (Guyomard et al, 2011; Zinn et al, 2007) were less prone to bias 
than others as they invited all patients attending the clinic or ward, removing any possibility 
of manipulating the sample. Community samples (Bos et al, 2007; Hickie et al, 2003; Howard 
et al, 2007) and mixed samples (Duncan et al, 1997) would be considered more representative 
of the TIA population as a whole however these studies are more prone to bias associated 
with case diagnosis (discussed below). One study that was particularly prone to sampling bias 
rewarded the control group for their participation (Bossema et al, 2006). Volunteers who are 
incentivised with rewards are likely to exhibit different behaviours to those who are not 
rewarded, and as such they could influence the results of the study. The sampling strategy was 
further compromised here as the selection process was different for cases and controls. In 
terms of extrapolating the results of each study, time relative to TIA should be taken into 
account as patients recruited some time after  their TIA (with no further incidents of TIA or 
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stroke) are likely to represent a healthier sample, leading to underestimations of functional, 
cognitive and emotional impairments.  
2.5.3.3 Participation 
Participation rates varied from poor (26%) (Zinn et al, 2007) to exceptional (99%) (Bos et al, 
2007). Studies in which a higher percentage of people accept invitations to participate are 
likely to be more representative of the target population. Six studies failed to report 
participation rates (Bossema et al, 2006; Charoenkitkarn et al, 2009; Hickey et al., 2009; 
Iddon et al, 1997; Walters et al, 2003; Xin-rong et al, 2005).  
2.5.3.4 Attrition 
Attrition bias can result from a “survival of the fittest” effect or by altering the case and/or 
control group characteristics. Most studies in this review used cross-sectional analysis 
therefore loss-to-follow-up was not applicable. It should be noted however that in one cross-
sectional study (Zinn et al, 2007) a patient was excluded from analysis on the basis of 
severely impaired scores suggestive of stroke. This rejection of data on arbitrary grounds, 
instead of according to previously stated or generally agreed criteria, should be considered 
biased. For longitudinal studies, loss-to-follow-up was less than 20% and similar between 
groups, with the exception of one study (Walters et al, 2003)  which failed to report attrition 
rates or reasons.  
2.5.3.5 Missing data 
Almost all studies have some missing observations however seven of the included studies 
failed to report how complete their dataset was (Charoenkitkarn et al, 2009; Duncan et al, 
1997; Guyomard et al, 2011; Hickie et al, 2003; Howard et al, 2007; Rao et al, 1999; Rao et 
al, 2001; Rao, 2002; Walters et al, 2003). The studies that did report missing data (Bossema et 
25 
 
al, 2006; Iddon et al, 1997; Zinn et al, 2007) were considered to have low risk of bias as 
missing data were similar between cases and controls and shown to be unrelated to the 
diagnosis and/or have no effect on outcome in the analysis. 
2.5.3.6 Case diagnosis 
Case diagnoses of the TIA group varied from self-report (Howard et al, 2007) to standardised 
clinical diagnosis (Charoenkitkarn et al, 2009; Guyomard et al, 2011) to brain scans (Walters 
et al, 2003; Xin-rong et al, 2005; Zinn et al, 2007). Due to the objective nature of brain scans 
they are the only method of completely ruling out stroke. However in terms of transferability 
of results to current clinical practice, standard clinical diagnosis would seem more 
appropriate. As most physicians are conditioned to look for focal symptoms, there is a chance 
that mixed Transient Neurological Attacks (TNAs) or TIA “mimics” may have been wrongly 
categorised as focal TNAs (TIAs). Reliability of clinical diagnosis could be considered higher 
if the diagnosis was formed by a stroke-physician or neurologist as they would be expected to 
have greater experience in forming such diagnoses.  Although clinical diagnosis of TIA is 
largely based on the patient’s ability to recall their symptoms, study groups formed by 
participant’s self-reported history of TIA should be considered a greater risk of  bias due to 
the time delay between the event and entry to the study (recall bias), and  possible denial, 
exaggeration or misunderstanding of the diagnosis.  
2.5.3.7 Confounding Bias 
As TIA is usually predisposed by hypertension and other cardiovascular risk factors, 
observational studies looking at TIA are prone to clinical susceptibility bias, where outcomes 
may be erroneously linked to TIA rather than the predisposing condition or lifestyle e.g. 
smoking. Hypertension in particular has been linked to cognitive decline in previous research 
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(Bishop et al., 2010). To address this potential confounder, many of the studies included a 
cardiovascular control group, who exhibited risk factors for TIA and stroke but had never 
suffered one. Other studies factored cardiovascular risk factors into the analysis e.g. multiple 
regression. Three studies were however considered at risk of clinical susceptibility bias. In a 
study of depression after TIA (Hickie et al, 2003) variables including diabetes, heart disease 
and smoking status were significantly different between groups however as they were not 
addressed in the analysis we cannot attribute the results to TIA alone. In two other studies 
(Iddon et al, 1997; Xin-rong et al, 2005) cardiovascular risk factors were not measured at all. 
In terms of age, gender and other potential confounders eleven out of the twelve studies were 
found to have low risk of confounding bias based on  individual inclusion criteria, “matching” 
of controls to TIA participants, comparability of baseline characteristics or, as with 
cardiovascular risk factors, factoring  variables that were significantly different at baseline 
into the analysis. One study (Xin-rong et al, 2005) was considered at risk of confounding bias 
as inclusion criteria was less strict for the control group (normal visual and auditory functions, 
independence and no sever heart, lung, liver or kidney disease was only specified for the TIA 
group). These factors were not measured at baseline therefore we cannot be sure of their 
extent in the control group. 
2.5.3.8 Assessment procedure 
With the exception of two studies (Duncan et al, 1997; Hickie et al, 2003) cases and controls 
were assessed using the same procedures. In Hickie et al (2003) DSM-IV criteria was only 
reviewed if participants responded positively when asked about symptoms of depression. In 
addition different measures were used to assess depression at baseline and follow-up. 
Consequently any apparent temporal effects of TIA on depression cannot be assured. In 
Duncan et al (1997) participants from one database were interviewed face-to-face and others  
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were interviewed by phone. Phone interviews may have omitted individuals with language or 
cognitive dysfunction, leading to possible sampling bias. To reduce risk of bias the reviewers 
agreed that all participants should have been assessed using the same procedure.  
2.5.3.9 Blinding 
Where outcome measures were administered by an assessor, and that assessor was not blind to 
the case-control status of the participant, they may assertively look for impairments and/or 
classify vague or indeterminate responses negatively, thus overestimating the consequences of 
TIA. Only one study included in this review concealed case-control status to the investigator 
(Bos et al, 2007). Seven studies did not adequately blind the assessors (Bossema et al, 2006; 
Charoenkitkarn et al, 2009; Guyomard et al, 2011; Hickie et al, 2003; Rao et al, 1999; Rao et 
al, 2001; Rao, 2002; Xin-rong et al, 2005; Zinn et al, 2007) and the remaining four studies 
(Bos et al, 2007; Duncan et al, 1997; Iddon et al, 1997; Walters et al, 2003) did not provide 
enough information about whether the outcome measure was self- or interviewer-
administered, and if interviewer-administered, whether the interviewer was “blind”.  
2.5.3.10 Outcome measures 
With the exception of one study (Xin-rong et al, 2005) all studies justified their use of 
outcome measures to some extent. The study by Walters et al (2003) used the Mini Mental 
State Exam (MMSE) to measure cognitive function.  In a seemingly uncompromised sample 
of TIA patients this measure was considered inappropriate by the reviewers due to the 
MMSE’s low ceiling effect.  The use of cut-off points in Zinn et al (2007) was also judged by 
reviewers to be susceptible to bias as it entails the risk of mis-categorisation, which may be 
magnified with small sample sizes.  
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2.5.3.11 Selective reporting 
In one study (Xin-rong et al, 2005) only significant results seemed to be reported. All other 
studies appeared to avoid selective reporting. 
2.5.3.12 Strength of evidence 
Only four studies (Charoenkitkarn et al, 2009; Guyomard et al, 2011; Rao et al, 1999; Rao et 
al, 2001; Rao, 2002; Zinn et al, 2007) showed evidence of sample size planning and one of 
these failed to reach their target (Zinn et al, 2007). Without a pre-determined sample size the 
probability of a statistically significant effect being identified as a clinically significant effect 
could be manipulated by the investigator, in such a way that the desired results could be 
demonstrated. This is further compromised by the lack of reporting and/or referencing of what 
changes in outcome measure scores denote clinically significant changes.  In defence of these 
studies, sample size planning requires prior information which may be lacking as many of the 
outcome measures used have not been tested in TIA populations before. The studies lacking 
sample size calculations could be considered pilot studies. Two studies (Bos et al, 2007; 
Howard et al, 2007), which failed to specify the required sample size prospectively did at least 
include confidence intervals in their analysis, allowing conclusions about the direction and 
strength of results to be made.  
2.5.4 Summary of findings 
The studies identified in this review were extremely varied in terms of design, study 
population, outcome measures and statistical methods (see Table 4).  For cognitive 
assessments alone, seven different test batteries and over twenty individual tests were 
identified. Due to this heterogeneity, a meta-analysis was not possible. The findings of 
included studies are presented, by outcome of interest, in Table 5.  
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Table 5: Results of Included studies 
 
Reference 
 
Nature of deficits reported 
 
Influential variables reported 
Strength 
of 
evidence 
 
COGNITION 
   
(Guyomard et al, 2011) TIA patients were significantly more cognitively impairment than 
age/sex matched non-vascular controls in six out of seven domains 
including visuo-spatial (p<0.0001), attention (p<0.0001), language 
(p<0.0001), abstraction (p=0.009), delayed recall (p<0.0001) and 
orientation (p<0.0001).  
The likelihood of cognitive 
impairment appeared to increase 
with increasing numbers of vascular 
risk factors however the study was 
underpowered for such sub-group 
analysis. 
High 
(Charoenkitkarn et al, 2009) With the exception of irritability (visual analogue scale), all test 
scores covering areas of distractibility, impulsivity, working 
memory and learning and memory, were significantly more 
impaired in the TIA group compared to the non-vascular control 
group ( p<0.05) in terms of group, time and interaction effects.  
Cognitive impairments after TIA 
were found to worsen by day 10 but 
improve between day 10 and day 
30. 
High 
(Bos et al, 2007) No significant differences were found between patients with focal 
TNA and participants without TNA. However patients with non-
focal TNA had a higher risk of dementia (HR, 1.59; 95% CI, 1.11-
2.26), especially vascular dementia (HR, 5.05; 95% CI, 2.21-11.6), 
than participants without TNA. Patients with mixed TNA were 
also at increased risk of dementia (HR, 3.46; 95% CI, 1.72-6.98), 
especially vascular dementia (HR, 21.5; 95% CI 6.48- 71.3) than 
participants without TNA. Adjustment for confounding did not 
materially change these associations. 
 High 
(Rao et al, 1999; Rao, 2002) TIA patients with severe carotid stenosis showed greater global 
impairment on CAMCOG (p<0.05), MMSE (p=0.001), BDCS 
(p<0.05) and FRSS (p<0.001) than non-vascular controls.  
Forty percent of TIA patients showed scores on tests of attention, 
calculation and frontal lobe function lying within the bottom 5% of 
non-vascular control scores. TIA and PVD patients showed similar 
patterns of neuropsychological impairment, but the authors suggest 
that TIA may result in more prolonged cognitive impairment, 
particularly in frontal lobe function.  
Frontal lobe impairment, suicidal 
thinking and age were all 
independent predictors of global 
cognitive impairment in the TIA 
group. 
There was no relationship between 
the MMSE and the length of time 
participants had been suffering 
TIAs but TIA patients scoring < 15 
on the BCDS were more likely to 
have experienced TIAs for 5 years 
or more. 
High 
(Zinn et al, 2007) On average patients with TIA were impaired in 48% of the tests 
completed, compared to 44% for stroke- risk-only patients.  
Larger sample sizes are required to show convincing results. 
  
 
Low 
 
(Bossema et al, 2006) Patients with hemispheric TIA and severe occlusive disease of one 
or both carotid arteries scored significantly worse (p<0.05) than 
“healthy” controls on five of the seventeen test variables, including 
tests of attention (Digit Span forward), verbal fluency (letters and 
categories) and psychomotor speed and executive functioning 
(Trail Making Test B and Motor Planning). Patients with retinal 
TIA and severe occlusive disease of one or both carotid arteries 
also scored significantly worse (p<0.05) than “healthy” controls on 
five of the seventeen separate test variables, including tests of 
visual memory (Doors Test A and B), verbal fluency (categories) 
and psychomotor speed and executive functioning (Trail Making 
Test B and Motor Planning). 
No effect of various vascular risk 
factors, such as hypertension and 
diabetes mellitus, was found on 
cognition. 
 
 
 
Low 
(Xin-rong et al, 2005) TIA patients were significantly more impaired than “healthy” 
controls in terms of immediate, short-term and long-term memory, 
attention, concentration and capability of acquiring information 
(p<0.05).  It is not clear how participants faired on tests that 
assessed spatial and temporal orientation, analyzing and 
synthesizing information and linguistic competence. 
 Low 
(Walters et al, 2003) During the first year after TIA the MMSE declined in 5% of 
participants compared to none of the non-vascular control 
participants. Although not the topic of this review Walters et al 
(2003) also found that patients presenting with a first isolated TIA 
had more than twice the rate of global brain atrophy as age 
matched controls during the year. This increased atrophy rate may 
reflect ongoing tissue damage at a subclinical level and would 
imply that these individuals are at higher risk of progressive 
cognitive decline.  
A positive correlation was found 
between increased rates of cerebral 
atrophy and systolic blood pressure 
(p = 0.02) and diastolic blood 
pressure (p = 0.002). 
 
Low 
(Iddon et al, 1997) No significant differences were found between TIA patients with 
carotid artery stenosis and age-matched controls on any of the 
CANTAB test scores. 
 Low 
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Reference 
 
Nature of deficits reported 
 
Influential variables reported 
Strength 
of 
evidence 
 
MOOD 
   
(Rao et al, 2001) Statistical differences at the level of p<0.01 were found 
between the TIA group (with >80% stenosis) and the 
orthopaedic control group, as measured by the geriatric 
depression scale, modified Hamilton Rating Scale for 
Depression and DSM-IV major depression criteria. No 
significant differences were found between these groups 
on history of depression, family history of depression, 
suicidal ideation or wish to die. The prevalence of DSM-
IV depressive disorder was not higher in the peripheral 
vascular disease group than in orthopaedic controls; 
however mean scores on the geriatric depression scale and 
modified Hamilton Rating Scale for Depression were 
significantly higher in the PVD group. 
Time between first TIA and assessment 
did not have any significance on DSM-
IV depression  
High 
(Duncan et al, 1997) The TIA group were more depressed than the 
asymptomatic control group at risk of stroke, as measured 
by the CES-D, however the differences were not 
significant.  
 Med 
(Bossema et al, 2006) Patients with severe occlusive disease of one or both 
carotid arteries showed significantly less vigor and more 
tension, fatigue and depression than “healthy” controls 
(p<0.05).  The patient group included asymptomatic 
patients as well as symptomatic TIA patients. This may 
have diluted the effect size. 
 Low 
(Hickie et al, 2003) Significantly more new cases of depression were reported 
in the TIA group than in the hypertensive and 
normotensive control groups (p<0.05) during the 10-year 
follow-up period. However, depression was categorised 
differently at baseline and follow-up so the results are 
difficult to interpret.  
 Low 
 
QUALITY OF LIFE 
(Howard et al, 2007) 
 
Participants reporting a history of TIA had a 6.0 point (95% CI: 
5.3 to 6.7) lower physical component summary score than the 
control group with no symptoms of TIA. In the fully adjusted 
model (adjusting for demographics, cerebrovascular disease risk 
factors, exercise, body mass index, and socioeconomic status), 
those reporting TIA had a 3.7 point (95% CI: 3.0 to 4.4) lower 
score. 
TIA participants had an average mental component summary 
score 0.5 (95% CI: : 0.0 to 1.1) points lower than those without 
symptoms with no attenuation after adjustment for confounders 
to a difference of 0.6 with 95% CI:  -0.1 to 1.2) 
  High 
(Duncan et al, 1997) TIA patients reported health states significantly below that of 
asymptomatic individuals on 7 out of 8 domains of the MOS-36, 
including general health, mental health, physical role, social 
function, vitality, bodily pain and physical function. No 
significant differences were found between TIA and 
asymptomatic groups, as measured by TTO (trade-offs between 
time in their current health state and time in excellent health). 
In the regression analysis, Barthel 
Index and diagnosis were the 
strongest and most consistent 
predictors of health status. 
Med 
 
ACTIVITIES OF DAILY LIVING 
(Duncan et al, 1997) No significant differences were found between TIA and 
asymptomatic groups in basic activities of daily living, as 
measured by the Barthel Index. 
 Med 
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2.5.4.1 Cognitive deficits 
Five out of nine studies found that, on average, individuals with TIA had significantly more 
cognitive impairment than non-vascular controls (Bossema et al, 2006; Charoenkitkarn et al, 
2009; Guyomard et al, 2011; Rao et al, 1999; Rao, 2002; Xin-rong et al, 2005). Specific 
domains that were implicated included immediate, short-term and long-term memory 
(including visual, working and learning memory), attention/concentration, orientation/spatial 
awareness/perception, abstract thinking, impulsivity, language (including verbal fluency),  
praxis, psychomotor speed and executive functioning. The three studies that found no 
significant difference in cognition between TIA and non-vascular control groups had not 
performed sample size calculations prior to recruitment (Iddon et al, 1997; Walters et al, 
2003; Zinn et al, 2007) and one of the studies used the Mini Mental State Exam (MMSE) to 
measure cognition (Walters et al, 2003). The MMSE is known to have low ceiling effects and 
is also less sensitive to small changes in cognition. Interestingly, both of the studies that 
compared TIA patients to individuals with cardiovascular risk factors did not find any 
significant differences in cognition between groups (Rao et al, 1999; Rao, 2002; Zinn et al, 
2007). One of these studies, however had a very small sample size of just nine TIA patients 
(Zinn et al, 2007) and is therefore likely to be underpowered to detect any change. The 
correlation between cardiovascular risk factors and cognitive decline is supported by two 
studies through regression analysis (Guyomard et al, 2011; Walters et al, 2003). On the 
contrary, no effect of vascular risk factors, including hypertension and diabetes mellitus, was 
found by Bossema et al (2006). It should be noted that these studies were underpowered for 
regression analysis and the associations therefore lack weight. 
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2.5.4.2 Mood 
One out of four studies found that TIA patients with severe occlusive disease of one or both 
carotid arteries showed significantly less vigour and more tension, fatigue and depression than 
“healthy” controls (p<0.05) as measured by the Dutch shortened Profile of Mood States 
(Bossema et al, 2006). Another study (Hickie et al, 2003) reported that during the first ten 
years after TIA, the number of new cases of major depression was significantly higher than in 
hypertensive and normotensive control groups (p<0.05), however depression was categorised 
differently at baseline and follow-up so the results are difficult to interpret. Rao et al (2001) 
showed that although TIA patients (with >70% carotid stenosis) showed significantly less 
handicap than an orthopaedic control group, the prevalence of DSM-IV major depressive 
disorder was significantly higher in the TIA group. The TIA group also scored significantly 
higher on the geriatric depression scale and modified than the orthopaedic control group, as 
did the asymptomatic vascular control group. The TIA group were more depressed than the 
asymptomatic vascular controls, as measured by the CES-D; however the differences were not 
significant. Similar findings were reported by Duncan et al (Duncan et al, 1997). 
2.5.4.3 Quality of life 
Two studies addressed quality of life after TIA. In one study, on average, participants with a 
history of TIA scored their physical health significantly lower than “healthy” individuals, as 
measured by the physical component summary score of the SF-12 (mean=6.0  points; 95% 
CI=5.3 to 6.7).(Howard et al, 2007) Adjustment for demographics, cerebrovascular disease 
risk factors, exercise, body mass index, and socioeconomic status only partially attenuated 
these effects. Based on previous research, the authors speculate that the observed decline in 
health-related quality of life in TIA patients could translate into a public health burden on the 
same order of magnitude as that imposed by type 2 diabetes. In the same study TIA patients 
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scored their mental health  significantly lower than “healthy” individuals, as measured by the 
mental component summary score (mean=0.5 points; 95% CI=0.0 to 1.1). After adjustment 
for confounding variable the differences in mental score were no longer significant. In another 
study (Duncan et al, 1997) TIA patients reported health states significantly below that of 
asymptomatic individuals on 7 out of  8 domains of the Medical Outcomes Study Short Form 
36, including general health, mental health, physical role, social function, vitality, bodily pain 
and physical function. No significant differences were found between groups when using 
trade-offs between time in present health state and time in excellent health. This emphasises 
the need for careful selection of outcome measures, as some are more sensitive to change than 
others. 
2.5.4.4 Activities of daily living 
One study (Duncan et al, 1997) measured activities of daily living after TIA and found no 
significant differences between TIA and asymptomatic, as measured by the Barthel Index.  
The Barthel Index focuses on dependence in basic daily activities such as toileting and 
washing, which are unlikely to be affected by TIA. Consequently the Barthel Index is likely to 
have a ceiling effect in this population. 
2.6 Discussion 
In this systematic review, the results of 12 studies were analysed to identify cognitive, 
physical and/or emotional outcomes in patients who had been diagnosed with TIA and not 
stroke. Cognitive deficits and depression were significantly higher in TIA patients than age-
matched “healthy” individuals. However, it is unclear how much of the observed association 
between cerebrovascular disease and cognitive dysfunction and/or depression is mediated by 
cardiovascular risk factors. Although cognitive dysfunction and depression were higher in 
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TIA patients than patients at risk of cerebrovascular insult, the differences were not 
significant. In addition, although underpowered, regression analyses suggest that TIA patients 
who exhibited a higher number or higher severity of cardiovascular risk factors were more 
likely to show signs of depression and cognitive decline than TIA patients with fewer or less 
severe cardiovascular risk factors. 
Links between cardiovascular risk factors and cognitive decline have also been expressed in 
non-TIA cohorts: Diabetes mellitus has been shown to have a significant independent effect 
on abstract reasoning and visuo-spatial dysfunction and hypercholesterolaemia has been 
shown to have a significant independent effect on memory dysfunction (Desmond et al., 
1993). Furthermore, hypertension has been associated with cerebral atrophy (Hatazawa et al., 
1984; Salerno et al., 1992) and has been linked to speed of cognition, episodic and working 
memory, and executive function (Saxby et al., 2003). Hypertension is now thought to be an 
independent risk factor for Alzheimer’s disease (Kivipelto et al., 2001) and has also been 
raised as a possible correlate of depression (Krishnan et al., 1994). Minor reductions in blood 
pressure have been associated with improvements in MMSE score and logical memory (Birns 
et al., 2006). A recent review by McGuinness et al (2006) found some evidence that midlife 
hypertension was related to cognitive decline. However, they found no convincing evidence 
that lowering blood pressure prevents the development of dementia or cognitive impairment 
in hypertensive patients without apparent prior cerebrovascular disease. In another review, 
Bakker et al (2000) found evidence to suggest that carotid stenosis may also be a risk factor 
for cognitive impairment. Together, this evidence suggests that cardiovascular risk factors 
may be the cause of cognitive impairment in TIA patients, rather than the insult itself. 
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The majority of studies included in this review used cross-sectional analysis and recruited 
their participants post-TIA. It is therefore difficult to know the temporal relationship between 
TIA and cognitive, physical or emotional impairment.  
To conclude, this review found no evidence to suggest that basic activities of daily living are 
compromised after TIA. However, there is evidence to suggest that many aspects of quality of 
life are significantly lower in TIA patients than in “healthy” individuals, including physical 
function. The results also suggest that TIA patients have more cognitive impairment and 
depression than the general population without TIA. It is unclear how much of the observed 
association between cerebrovascular disease and cognitive dysfunction and/or depression is 
mediated by cardiovascular risk factors, and/or whether TIA has a direct causal relationship.  
2.6.1 Suggestions for future research 
This systematic review has highlighted the need for more research, with larger sample sizes 
that allow further examination of possible mediators such as cardiovascular risk factors. 
Associations between cognition, mood and function, and whether these outcomes are 
predictive of future stroke should also be explored, using longitudinal designs to determine 
the direction of causation. 
Researchers should take advantage of published guidelines such as STROBE to strengthen the 
quality of future research. Where possible, sample size calculations should be conducted prior 
to recruitment and mean differences should be reported with confidence intervals to provide 
more meaningful results. Researchers should endeavour to blind assessors to the diagnosis of 
study participants and a concerted effort should be made to recruit participants on a 
consecutive basis, without incentives. Outcome measures should also be chosen carefully. For 
instance, the Barthel Index has been shown to have a ceiling effect in this population and the 
MMSE has appeared to lack sensitivity. Future studies are therefore advised to examine 
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functional dependence by measuring extended rather than basic activities of daily living. 
Psychological tests that are capable of detecting subtle changes in specific areas of cognition 
should also be used, over and above the MMSE.  
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CHAPTER 3 
COHORT STUDY DESIGN 
3.1 Introduction 
The FACE TIA cohort study arose from the systematic review, to further develop the research 
into residual problems after TIA, namely anxiety, depression, cognition and daily function. As 
well as studying TIA outcomes in relation to healthy control and minor stroke outcomes, 
FACE TIA also studies TIA outcomes in relation to patients with transient neurological 
symptoms not suggestive of TIA. This, so-called “TIA-mimic” population has scarcely been 
studied but represent approximately half of those referred to TIA clinic. In terms of vascular 
risk, TIA mimics have been found to have a poorer outcome than patients at risk of TIA or 
stroke (Cameron et al., 2011). 
The FACE TIA study addresses limitations of previous studies by using a larger (national) 
sample to provide sufficient power to justify any findings. The study is also longitudinal in 
design to allow trends and interactions to be studied over time.  
The study was approved by Birmingham East, North and Solihull Research Ethics committee 
on 30/06/2010 (Ref. 10/H1206/36) and has since been co-adopted by the stroke and primary 
care research networks. It is being funded by the West Midlands Strategic Health Authority 
(WM NMAHP Research Training Fellowship) and the National School for Primary Care 
Research (Monitoring and management of long-term conditions). Sponsorship is provided by 
the University of Birmingham.  
The FACE TIA cohort study is ongoing. The objectives and methods reported here relate to 
the full trial, however only preliminary (baseline) results are reported in Chapter 4. 
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3.2 Objectives 
The objectives of this study were: 
a) To investigate the effect of a clinical diagnosis of TIA on physical function, cognition 
and feelings of anxiety and depression, in relation to minor-stroke, TIA “mimics” and 
“healthy” controls (or population norms). 
b) To examine interaction effects between cognition, feelings of affect and physical 
function. 
c) To examine whether these outcomes change over time and/or are predictive of future 
stroke 
 
Null Hypothesis: After the neurological symptoms of TIA subside, there is no difference 
between TIA patients, minor stroke patients, “mimics” or “healthy” individuals in relation to 
cognition, emotion and physical function. Individuals who are more impaired, (cognitively, 
physically and emotionally) do not have increased risk of stroke, compared to less impaired 
individuals. 
3.3 Trial Design 
This study followed a prospective cohort design with three control groups. To ensure the trial 
was well reported the STROBE guidelines were adhered to (Von Elm et al., 2008). 
3.4 Setting 
Participants were recruited from 12 TIA clinics (hospital sites) and 4 GP practices in the West 
Midlands. The study is now being rolled out to TIA clinics and GP practices in London, 
Yorkshire and the South West.  
39 
 
3.5 Participants 
The main study group (group A), included people attending TIA clinics diagnosed with their 
first TIA. The control groups included: 
 People attending TIA clinics diagnosed with minor stroke (group B) 
 People attending TIA clinic diagnosed as NOT having had a TIA or stroke. This group 
were labelled as TIA “mimics” (group C) 
 Age and postcode matched controls from GP registers (group D) 
3.5.1 Eligibility 
3.5.1.1 Eligibility Criteria  
i. Clinical diagnosis formed by consultant stroke physician or neurologist at the TIA 
clinic Groups A, B, C  
ii. Diagnosis made within 14 days of event Groups A, B, C 
iii. New episode (not follow-up appointment) Groups A, B, C 
iv. Patient deemed able to self-complete postal questionnaires by consultant stroke 
physician or neurologist Groups A, B, C or general practitioner Group D 
v. No past medical history of stroke/TIA (confirmed by GP records and by including a 
screening question on baseline questionnaires) Groups A, C, D 
3.5.1.2 Rational for eligibility criteria 
One of the main criteria for this study was forming clear separation between the different 
clinical diagnoses so we could be confident that the outcomes of interest were not influenced 
by previous cerebrovascular events. Consequently, with the exception of group B, patients 
were not eligible if they had previously been diagnosed with TIA or stroke. Although the 
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reliability of diagnoses can be improved with imaging (as discussed earlier), it is not routinely 
available to all individuals who are seen at TIA clinics. Consequently, to ensure that the 
results were transferrable to current practice, diagnoses were formed by the professional 
judgement of consultant stroke physicians or neurologists at participating clinics. The findings 
of any investigations (including diagnostic imaging) requested at clinic were however 
collected to help describe any covariance in the results.  
To rule out inappropriate referrals, patients diagnosed after 14 days of their event were not 
included in the study. Patients attending follow-up appointments were also rejected to avoid 
repetition of data collection. To minimize the amount of incomplete data, patients that were 
deemed unable to self-complete questionnaires were not invited to participate. However 
patients that were able to communicate their responses indirectly or by other means (e.g. 
verbally or via an interpreter) were not excluded.  
3.5.2 Recruitment and consent 
Groups A, B and C were recruited at participating TIA clinics. Consecutive patients attending 
the clinics were informed about the study and invited to participate if they were judged by 
their consultant/neurologist to meet the selection criteria. A research nurse was made 
available to answer any questions asked by the patient. As the study is not experimental and 
would not impact on usual treatment in any way, participants were given the opportunity to 
consent at their clinic appointment. This was encouraged, to increase recruitment rates and 
therefore achieve a more representative sample. Patients that wanted more time to consider 
participation were given the option of consenting via post. By definition, TIA and minor 
stroke are minor vascular events; therefore potential participants did not have impaired 
capacity to consent. Each participant was given an information sheet with details about study, 
rights to withdraw consent at any stage, and contact details for the research team (should they 
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have any queries about the study after leaving the clinic). A copy of the Participant 
information sheet and consent form can be found in Appendix 3 and 4 respectively.  
Potential “healthy” controls (group D) were identified from GP registers. Eligible patients 
who were found to be a suitable match for the main study group were sent participant 
information and consent forms by post with prepaid return envelope. As with clinic patients, a 
contact telephone number was provided, allowing patients the opportunity to ask questions 
pertaining to the study. If individuals did not respond within three months, it was assumed 
that they did not wish to participate. 
As part of the consent process, permission was sought from participants to inform their GP 
that they were taking part in the study. A copy of the letter that was sent out to inform GPs of 
their patient’s participation can be found in Appendix 5. 
Recruitment of participants at TIA clinics began on 13th September 2010 and recruitment at 
GP practices began on 3rd May 2011. 
3.5.3 Matching controls 
GP practices were chosen based on their postcode meta-data, namely urban-rural indicators 
and indices of multiple deprivation. Participating practices provided the study team with an 
anonymous database containing year of birth, gender and a unique ID for each of their 
patients. For every TIA participant entering into the trial, GP databases were searched at 
random for five age, gender, urban-rural and deprivation matched controls. Following 
approval from their GP, invites were then sent out to the five potential controls. If recruitment 
was unsuccessful the process was repeated. 
Figure 2 illustrates the recruitment pathways in more detail, for participants recruited via TIA 
clinics and GP practices. 
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Figure 2 
 
Pa
tie
nt
 re
fe
rre
d 
to
 T
IA
 C
lin
ic
 
Pa
tie
nt
 as
se
ss
ed
 b
y 
co
ns
ul
ta
nt
 
Pa
tie
nt
 m
ee
ts 
in
cl
us
io
n 
cr
ite
ria
 
Pa
tie
nt
 d
oe
s n
ot
 m
ee
t i
nc
lu
sio
n 
cr
ite
ria
 
Pa
tie
nt
 as
ke
d 
by
 co
ns
ul
ta
nt
 w
he
th
er
 th
ey
 w
ou
ld
 b
e w
ill
in
g 
to
  
ta
lk
 to
 so
m
eo
ne
 ab
ou
t t
ak
in
g 
pa
rt 
in
 a 
q’
ai
re
 b
as
ed
 st
ud
y 
St
ud
y i
nt
er
ac
tio
n 
w
ith
 p
at
ie
nt
 e
nd
s 
Pa
tie
nt
 w
ill
in
g 
 
Pa
tie
nt
 N
O
T 
w
ill
in
g 
 
St
ud
y i
nt
er
ac
tio
n 
w
ith
 p
at
ie
nt
 e
nd
s 
Pa
tie
nt
 sp
ea
ks
 to
 R
N
 
 
RN
 sh
ou
ld
 g
o 
th
ro
ug
h 
Pa
rti
ci
pa
nt
  
in
fo
rm
at
io
n 
sh
ee
t a
nd
 a
ns
w
er
 q
ue
sti
on
s 
as
ke
d 
by
 p
at
ie
nt
s  
Pa
tie
nt
 h
ap
py
 to
 co
ns
en
t t
he
re
 a
nd
 th
en
 
Pa
tie
nt
 n
ee
ds
 m
or
e t
im
e t
o 
co
ns
id
er
 p
ar
tic
ip
at
io
n 
Pa
tie
nt
 d
oe
s n
ot
 w
an
t t
o 
pa
rti
ci
pa
te
 in
 st
ud
y 
St
ud
y i
nt
er
ac
tio
n 
w
ith
 p
at
ie
nt
 e
nd
s 
Pt
 sh
ou
ld
 b
e g
iv
en
 1
 an
d 
2 
to
 ta
ke
 h
om
e.
 
Pt
 sh
ou
ld
 si
gn
 3
 an
d 
co
m
pl
et
e 4
 n
ow
.  
Pt
 ca
n 
ei
th
er
 c
om
pl
et
e 5
  n
ow
 o
r t
ak
e i
t a
w
ay
 to
 co
m
-
pl
et
e a
t h
om
e (
w
ith
 p
re
-p
ai
d 
re
tu
rn
 e
nv
el
op
e)
 
RN
 sh
ou
ld
 co
m
pl
et
e 6
.  
R
N
 sh
ou
ld
 a
ss
ig
n 
pt
 w
ith
 u
ni
qu
e 
id
en
tif
ie
r c
od
e 
an
d 
en
su
re
 th
at
 it
 is
 p
ri
nt
ed
 o
n 
 3
, 4
 a
nd
 5
 a
nd
 6
. 
 
Pt
 sh
ou
ld
 b
e g
iv
en
 1
, 2
, 3
, 4
 an
d 
5 
to
 ta
ke
 h
om
e (
w
ith
 
pr
e-
pa
id
 re
tu
rn
 en
ve
lo
pe
 fo
r 3
, 4
 an
d 
5)
 
RN
 sh
ou
ld
 co
m
pl
et
e 6
.  
R
N
 sh
ou
ld
 a
ss
ig
n 
pt
 w
ith
 u
ni
qu
e 
id
en
tif
ie
r c
od
e 
an
d 
en
su
re
 th
at
 it
 is
 p
ri
nt
ed
 o
n 
 3
, 4
 a
nd
 5
 a
nd
 6
. 
 
U
oB
 st
ud
y t
ea
m
 re
ce
iv
e 
sig
ne
d 
co
ns
en
t f
or
m
 
U
oB
 d
o 
no
t r
ec
ei
ve
  
sig
ne
d 
co
ns
en
t f
or
m
 
St
ud
y i
nt
er
ac
tio
n 
w
ith
 
pa
tie
nt
 e
nd
s 
U
oB
 st
ud
y t
ea
m
 w
ill
 co
n-
ta
ct
 R
N
 w
ith
 u
ni
qu
e i
de
nt
i-
fie
r c
od
e a
nd
 as
k 
fo
r c
lin
ic
 
ba
se
lin
e 
da
ta
 c
ol
le
ct
io
n 
fo
rm
 fo
r t
ha
t p
ar
tic
ip
an
t. 
RN
 sh
ou
ld
 se
nd
 3
, 4
, 5
 (i
f c
om
pl
et
ed
 in
 cl
in
ic
) a
nd
 6
 to
 
U
oB
 st
ud
y t
ea
m
. 
TI
A 
C
lin
ic
 R
ec
ru
itm
en
t P
at
hw
ay
 
K
ey
 
1 
= 
In
vi
ta
tio
n 
to
 P
ar
tic
ip
at
e 
2 
= 
Pa
rti
ci
pa
nt
 In
fo
rm
at
io
n 
Sh
ee
t 
3 
= 
Co
ns
en
t F
or
m
 
4 
= 
D
em
og
ra
ph
ic
 Q
ue
sti
on
na
ire
 
5 
= 
Ba
se
lin
e Q
ue
sti
on
na
ire
 
6 
= 
Cl
in
ic
 D
at
a C
ol
le
ct
io
n 
Fo
rm
 
43 
 
 
Practice searches GP register  for potential control participants  
(those meeting study inclusion/exclusion criteria) 
Practice sends database of anonymous potential control participants to UoB 
study team. Fields should include:  
• Patient identifier code (unique to the GP practice) e.g. EMIS number 
• Patient year of birth 
• Patient Gender 
TIA participants are recruited into 
study from NHS hospital sites 
UoB study team searches GP database for patients that are   
suitable age/gender matches for the TIA group 
UoB study team contacts practice nurse with patient identifier codes 
and ask them to send out invitations to these patients 
Practice sends “invitation to participate”, “participant information sheet”, “consent form”, 
“demographic questionnaire” and pre-paid return envelope to patients. 
Practice should ensure that unique trial ID (provided by UoB team) is printed on the 
consent form and demographic questionnaire. 
UoB study team sends out 
questionnaires to partici-
pants at 0, 3, 6 and 12 
Patient consents to  
questionnaires 
Patient consents to  
questionnaires and  
cognitive screen 
Patient does not return 
consent form or baseline 
questionnaire to  
UoB study team 
UoB study team sends out 
questionnaires to partici-
pants at 0, 3, 6 and 12 
months.  
UoB make appointments 
with participants for  
cognitive screen at 0 and 
12m 
UoB study team conducts 
0 and 12 month cognitive 
screen at GP practice  
Study interaction with 
patient ends 
GP Practice Recruitment Pathway 
 Practice input 
Key 
UoB = University of Birmingham 
GP screens list to make sure invited patients: 
• still meet inclusion criteria  
• have no other extenuating circumstances e.g. terminal illness, recent bereavement etc. 
UoB sends copy of signed consent form to GP practice 
Practice sends patient details (name, address and telephone number) 
to UoB study team. Patient details should correspond with trial ID 
numbers on the consent form.  
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3.6 Data sources/measurement 
Data was collected from medical records, postal questionnaires and direct contact.  
3.6.1 Variables 
Outcome 
(dependent) 
Exposure 
(independent) 
 
Potential confounders 
• Function  • Diagnosis • Age 
• Anxiety  • Gender 
• Depression 
• Cognition 
 • ABCD2 score (stroke 
risk) 
 
The outcome variables were studied in relation to exposure to the four different diagnoses 
making up the study groups. Measures used to capture these outcomes are described in section 
3.6.4. Age, gender and stroke risk were identified as the variables most likely to correlate with 
both exposure and outcome variables. These potential confounders would need to be factored 
into the analysis to minimise threat to internal validity of the study.  
3.6.2 Baseline assessment 
For participants in groups A, B and C, details of their presenting condition, investigations, 
stroke risk and medical management were collected. Stroke risk was predicted using the 
ABCD2 score, derived from the Oxfordshire Community Stroke Project (Dennis et al, 1990) and 
validated in the Oxford Vasular study (Rothwell et al., 2004). The six-point score uses the 
patient’s age, blood pressure, clinical features, duration of symptoms and history of diabetes 
mellitus to predict seven-day stroke risk (Rothwell et al., 2005).  
The proposed “clinic” data collection form was informed by preliminary liaison with 
consultants from TIA clinics in the West Midlands. Discussions were held with participating 
clinics at site set-up visits to ensure these data formed part of the routine assessment. A copy 
of the clinic form can be found in Appendix 6. 
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All participants were asked to self-complete a form yielding information on demographics, 
social history and past medical history. Patients’ perception of their past medical history may 
differ slightly from that documented in medical records. However for consistency across 
groups, patient perception was chosen to reduce potential bias that may have occurred form 
gathering information from different medical sources (GP records for group C and hospital 
records for other groups). 
A copy of the form sent to participant can be seen in Appendix 7. 
3.6.3 Outcome Assessment 
Physical function and feelings of affect were measured using the Nottingham Extended ADL 
Scale (Nouri & Lincoln, 1987) and the Hospital Anxiety and Depression Scale (Zigmond & 
Snaith, 1983) respectively. These were completed by the participant at home and returned by 
post. Questionnaires that had not been returned within two weeks of consent were followed 
up with telephone reminders. Any missing data from postal returns was also sought by 
telephone interview. Cognition was measured using the Birmingham University Cognitive 
Screen (Humphreys et al., 2007). This was administered by trained assessors at the 
participant’s GP practice or own home within four weeks of consent. The cognitive screen 
takes approximately one hour to administer and could be considered burdensome, however it 
was chosen above others as it measures a broad range of cognition. To address the issue of 
burden and increase consent rates the cognitive screen was made optional. BUCS assessors 
were trained by members of the BUCS development team and detailed guidelines were 
provided for guidance and to increase standardisation of administration, interpretation and scoring. In 
attempt to increase intra-rater reliability, a random sample of the completed BUCS 
assessments were marked by a second assessor and any inconsistencies in marking were 
addressed. 
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3.6.4 Selection of Outcome measures 
Patient-based outcome measures (NEADL and HADS) were selected to provide a means of 
addressing patients’ perception of their own health. This has become increasingly important 
with the emergence of patient autonomy in relation to their healthcare. Patient based outcome 
measures are also invaluable for quantifying quality of life and measures of affect, such as 
anxiety and depression, which are of increasing concern as the prevalence of long-term 
conditions increase. The NEADL and HADS were also chosen based on their content and 
psychometric properties for use in stroke and/or TIA populations. 
To find evidence for the psychometric properties of the outcome measures, an electronic 
search was carried out across MEDLINE (1990- July 2011) and EMBASE (1990-July 2011), 
in relation to the following dimensions: reliability, validity, responsiveness, precision, 
interpretability, acceptability and feasibility. These dimensions were identified as important in 
a report commissioned by the Health Technology Assessment board for evaluating patient 
based outcome measures (Fitzpatrick et al., 1998). The electronic databases were searched 
using the following terms:  validity.mp.; appropriateness.mp.; exp "Reproducibility of 
Results"/ or reliability.mp.; exp "Sensitivity and Specificity"/ or accuracy.mp.;  precision.mp.; 
responsiveness.mp.; exp Data Interpretation, Statistical/ or interpretability.mp.; 
acceptibility.mp.; exp Feasibility Studies/ or feasibility.mp.; floor effects.mp.; ceiling 
effect.mp. Reference lists of the relevant articles were also searched in order to locate further 
publications that were omitted from the initial search. The search was limited to articles 
published in English and relating to TIA populations. No results were generated therefore the 
search was widened to include stroke patients.  In total, 44 articles relating to the NEADL and 
92 articles relating to the HADS were identified. Of these, 29 were studied in full. The 
remaining articles were considered inappropriate based on their abstract. Of the 29 articles 
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studied in full, 15 were included in the critique, one being a review. To avoid repetition, 
articles that were identified by the search but also included in the published review (n=7) 
were only reported in the context of the review.     
The content of the chosen outcome measures and relevant findings of the review are discussed 
below: 
3.6.4.1 Nottingham Extended Activities of Daily Living Scale 
The Nottingham Extended Activities of Daily Living Scale (NEADL) is a self-report measure 
of level of activity actually performed. It was developed by Nouri and Lincoln (1987)  to 
assess activities which may be important to stroke patients who have been discharged home. 
The NEADL assesses function at a higher level than measures like the Barthel Index, which is 
limited to basic self-care tasks such as washing and dressing. The NEADL encompasses tasks 
such as shopping, housework and managing money which are important for functioning 
independently in a community and would therefore seam more suited to more able 
individuals. The questionnaire is composed of 22 items of higher functional self-care 
independence, each of which is scored on a four-point scale: 0 (when answered as “not at 
all”); 1 (“with help”) 2 (“on my own”) or 3 (“on my own with difficulty”). A higher total 
score indicates greater independence.  
A recent review of stroke outcome measures by Teale and Young (2010) concluded that the 
NEADL was one of 5 out of 36 instruments that had acceptable psychometric properties for 
postal administration in stroke populations. The authors reported response rates ranging from 
82-98% for patients recruited face-to-face and 46-88% for patients recruited by post. In 14 out 
of 15 included studies, 98-100% of NEADL questionnaires were well completed. Teale and 
Young suggest that telephone reminders reduce the volume of missing data. In terms of 
responsiveness a floor effect was observed in the mobility subscales in more dependant 
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institutionalized patients however this should not be a problem in our population. No ceiling 
effects were found. Variability in test-retest statistics suggest that the NEADL may be 
unreliable for detecting change in individual patients and therefore potentially limits the use 
of the NEADL to group rather than individual comparisons (Gompertz et al., 1993). The 
results of studies that were not included in review by Teale and Young are summarised in 
Table 6. The results confirm the variability in test-retest reliability (Green et al., 2001) 
identified by Teale and Young (2010) but emphasise the high validity and responsiveness of 
the NEADL, over and above related outcome measures (Jacob-Lloyd et al., 2005; Wu et al., 
2011). 
3.6.4.2 Hospital Anxiety and Depression Scale  
The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) was 
developed in the early 1980s as a tool to identify emotional disorders in non-psychiatric 
patients within a hospital setting. However it has since been shown to perform well in other 
populations. HADS is made up of an anxiety (HADS-A) and depression subscale (HADS-D), 
each comprising seven questions that relate to the patient’s emotional state over the last 7 
days. For each question the patient is asked to choose one response from the four given. 
Responses are scored from 0-3, with 3 points indicating maximum impairment. The authors 
recommended that a score above 8 on each individual scale should be regarded as a possible 
case and a score above 10 a probable case of anxiety or depression (Zigmond & Snaith, 
1983). 
The psychometric properties of the HADS are summarised in Table 6. One study (Aben et al., 
2002) observed ischaemic stroke outpatients in the UK, 1 month post-stroke (n=171), and 
found the optimal screening cut-off for major depression to be 8 (Se = 73.1, Sp =81.6) for 
HADS-D and 11 (Se = 91.7, Sp =65.3) for HADS-total. For major or minor depression, the 
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optimal screening cut-off was 7 (Se = 72.5 Sp =78.9) for HADS-D and 11 (Se = 86.8, Sp 
=69.9) for HADS-total. The other study (Tang et al., 2004) conducted in 100 Chinese geriatric 
patients with first-ever stroke, found the optimal cut-off point for any depression disorder  to 
be slightly lower at 6/7 on HADS-D (Se=0.88, Sp=0.53). Another study, published after the 
meta-analysis reported lower optimal cut-offs for HADS in 104 patients, 4 months after stroke 
(Sagen et al., 2009). For Depression, the optimal cut-off was 4 (Se=0.84, Sp=0.73) for 
HADS-D and 11 (Se=0.9, Sp=0.83) for HADS-total. For Anxiety, the optimal screening cut-
off was 4 (Se=0.83, Sp=0.65) for HADS-A and 6 (Se=0.83, Sp 0.60) for HADS-total. 
The HADS shows high levels of internal consistency and there is little evidence that removing 
items would improve it. Reported correlations between different items on the HADS-D, as 
measured by Cronbach’s α, have ranged from 0.70 to 0.85 in stroke populations (Aben et al, 
2002; Johnston et al., 2000; Sagen et al, 2009). For HADS-A, Cronbach’s α has ranged from 
0.76 to 0.89 (Johnston et al, 2000; Sagen et al, 2009) and for HADS-total Cronbach’s α has 
ranged from 0.79 to 0.91 (Johnston et al, 2000; Sagen et al, 2009). Confirmatory factor 
analyses confirmed the separation of anxiety and depression (Johnston et al, 2000).
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Table 6: Psychometric properties of NEADL and HADS 
Source N Validity Reliability Responsiveness Precision Interpretability Acceptability Feasibility Conclusions 
NEADL 
(Wu et al, 
2011) 
 
N=70 stroke 
patients 
(assessed 
before and after 
treatment) 
Good to excellent 
correlation 
With the Frenchay 
Activities Index  
(spearman p=0.8) and after 
treatment 
(p=0.8). 
Fair correlations with the 
stroke 
Impact scale 
 (p=0.3–0.4) 
 Standardized 
response mean 
= 0.9 
    The NEADLand Frenchay Activities 
index are both valid outcome measures 
but theNEADL is more responsive. 
(Jacob-
Lloyd et 
al, 2005) 
   The NEADL 
and the 
Rivermead 
mobility index 
were found to 
be more 
responsive than 
the Barthel 
Index and lower 
limb motricity 
index 
    The NEADL is more suitable than other 
measures for tracking change in function 
after discharge from hospital, for a wide 
case mix of people who have 
experienced a stroke. 
(Green et 
al, 2001) 
 
N=22 (15 
months post-
stroke; tested 
Twice at an 
interval of 1 
week) 
 Test-retest reliability  
Differences between 
the first and 
Second assessments 
were not significant 
 
Percentage agreement 
was >60% and kappa 
values 0.3-0.89 for 
individual 
Items  
     Measurements used to assess basic 
activities of daily living were more 
reliable in this study. 
  
51 
 
HADS 
(Sagen et 
al, 2009) 
 
N=101 
(4 months post 
stroke) 
 
For anxiety, the optimal 
screening cut-off was 4 
(se=0.83, sp=0.65) for 
HADS-A and 6 (se=0.83, sp 
0.60) for 
HADS-total 
For depression, optimal cut-
offs were 4 (se=0.84, 
sp=0.73) for HADS-D and 
11 (se=0.9, sp=0.83)  for 
HADS-total 
Internal consistency 
Cronbach’s α = 0.89 
for HADS-A, 0.83 
for HADS-D and 
0.91for HADS- total. 
     HADS-D and HADS-A perform 
acceptably for screening depression and 
anxiety after stroke. However, lower 
HADS cut-offs than recommended for 
the general population should be 
considered for stroke patients. 
(Tang et 
al, 2004) 
N=100 chinese 
stroke patients 
Optimal cut-off point of 
HADS was 6/7 (se=0.88, 
sp=0.53) 
      The optimal cut-off point for HADS was 
6/7 in chinese older adults. 
(Aben et 
al, 2002) 
 
N=171 
(1 month post-
stroke) 
For major depression, the 
optimal screening cut-off 
was 8 (se = 73.1, sp =81.6) 
for HADS-D and 11 (se = 
91.7, sp =65.3) for 
HADS-total 
 
For major& minor 
depression, the optimal 
screening cut-off was 7 (se 
= 72.5 sp =78.9) for HADS-
D and 11 (se = 86.8, sp 
=69.9) for 
HADS-total 
    Response  
rate= 84.7% 
 The recommended cut-off level of 8 for 
the depression subscale turned out to be 
optimal. 
(Johnston 
et al, 
2000) 
 
N=68 (1 month 
and 6 months 
post stroke 
discharge) 
 Internal consistency 
1 month cronbach’s α 
=  0.76 for HADS-A, 
0.70 for HADS-D 
and 0.79 for HADS-
total 
 
6 month  cronbach’s 
α =  0.87 for HADS-
A, 0.76 for HADS-D 
and 0.89 for HADS-
total 
 
     The HADS showed high levels of 
internal consistency and there was little 
evidence that removing items would 
improve it. 
Confirmatory factor analyses confirmed 
the separation of anxiety and depression. 
The objective of the HADS of 
measuring psychological states with 
minimal confounding by symptoms of 
somatic disease is adequately achieved. 
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3.6.4.3 Birmingham University Cognitive Screen  
The Birmingham University Cognitive Screen (BUCS) (Humphreys et al, 2007) is a new test 
instrument developed to screen patients for a ‘broad but shallow’ range of cognitive problems. 
The test takes one hour to administer and cover 5 domains:  
 
domain: impairment:  
 
Language  Speech impairment (3 items) 
Reading impairment (4 items) 
Writing impairment (1 item) 
Mathematical/Number abilities  Number reading (1 item) 
Number writing (1 item) 
Calculation (1 item) 
Praxis/control and planning of action  Visuo-constructive impairment (1 item) 
Gesture recognition, production and imitation (3 
items) 
Action organization (1 item) 
Memory  Orientation impairment (2 items) 
Episodic memory impairment (6 items) 
Attention and executive functions  Spatial attention impairment (14 items) 
Controlled attention impairment (including executive 
functions) (2 items) 
 
Each item on the BUCS is scored as “impaired” or “not impaired” using age-adjusted cut-off 
scores derived from a population-based healthy control sample. Cut-off scores were 
assembled across 3 decades (<64, 65-74, 75+), based on scores two Standard Deviations or 
more from the means of the “healthy” population. See Appendix 8. 
The BUCS was chosen above other cognitive outcome measures because of its ability to 
pinpoint specific areas of cognition. This was identified as important in the systematic review 
(chapter 2). The BUCS tests were also designed to be relatively difficult within their domain 
to increase the chance of identifying problems if they exist. This is important in TIA patients 
where impairments may not be outwardly noticeable. The BUCS was chosen over and above 
other comprehensive cognitive screening tools such as the Montreal Cognitive Assessment, 
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identified in the review (chapter 2),  as it was designed with stroke patients in mind. It is 
therefore laid out to be as neglect friendly’ and ‘aphasia friendly’ as possible. These design 
qualities are important in longitudinal studies of TIA patients where full stroke is often 
imminent. As the BUCS was developed at the University of Birmingham, collaboration and 
support from the BUCS team was also a huge asset. 
Performance of BUCS has been validated against standardized tests from the literature 
including: the AMT (to validate the BUCS orientation test); sentence reading from the BDAE 
(validate sentence reading), story recall from the WMS-R (validate story recall test, 
immediate and delayed), star cancellation (BIT), Rey figure (complex figure copy), elevator 
task from the Test of Everyday Attention (to validate our test of auditory sustained attention), 
the Brixton (to validate the Birmingham Frontal test), PALPA test of nonword reading (for 
the BUCS nonword reading), picture naming from BORB (for BUCS picture naming), BDAE 
writing short-form (BUCS writing), CAT calculation (number processing), spoken picture 
description (sentence construction).  
3.6.5 Addressing diversity 
The above mentioned questionnaires have not all been validated in different languages 
however, to make the results more pertinent the study population should reflect the cultural 
diversity of the West Midlands. Consequently we enclosed a brief cover letter, translated into 
several languages (Bengali, Guajarati, Punjabi, Hindu and Urdu), encouraging the participant 
to seek help in completing the questionnaires from a friend or family member if necessary. An 
English version of the cover letter can be found in Appendix 9. 
 For the cognitive screen, participants with language difficulties were encouraged to bring a 
friend or family member with them to act as a translator.   
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3.6.6 End points  
Participants remained in the study until TIA (groups C and D), stroke or death (all groups). 
Events were identified through a screening question on all postal questionnaires, and 
confirmed through GP records.  
3.7 Accrual and Analysis 
3.7.1 Statistical Methods 
After cleaning the database, summary statistics were produced for nominal variables. For each 
continuous variables (interval and ratio), the data were represented graphically (Appendix 10). 
This facilitated the interpretation of the distributions of data and provided an opportunity to 
double-check “outliers”, to see if they were data entry errors. It also allowed us to test the 
assumptions for statistical analysis (i.e. that linear relationships existed between exposure and 
outcome variables).  
For each questionnaire (NEADL and HADS) a total score was calculated from the individual 
item scores. For the HADS two component scores were also computed, giving rise to an 
anxiety and depression sub-score. The data collected on the NEADL and HADS were 
analyzed in SPSS for windows (SPSS Inc, 2006). Multiple regression was performed to 
examine whether the total scores (for NEADL, HADS-total, HADS-Anxiety and HADS-
depression) were influenced by exposure (diagnosis) after adjusting for age and gender 
differences. Missing or ambiguous responses to items on questionnaires were pro-rated.  
As the exposure variable was nominal and included more than two categories, dichotomous 
dummy variables were created (for example: TIA “mimic”/not TIA “mimic” and minor 
stroke/not minor stroke). A diagnosis of definite TIA was used as the constant variable, to 
which comparisons were made.     
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As mentioned previously the FACE TIA study is ongoing. For preliminary analysis, BUCS 
data was only available for the definite TIA group. Consequently, between-group analysis 
was not possible for this outcome. Instead, published cut-off scores, derived from a “healthy” 
population, were used to transform BUCS item scores into more meaningful “impaired”/ “not 
impaired” categories. Multiple regression was then performed to see whether number of 
cognitive impairments (as measured by the BUCS) or stroke risk (as measured by ABCD2 
score) influenced NEADL and HADS scores, after adjusting for age and gender. Interaction 
effects between HADS and NEADL were also assessed using multiple regression. The level 
of significance was set to 0.05. 
3.7.2 Sample size 
As there were no existing data for the NEADL and HADS in the desired TIA population, on 
which to base the sample size calculation, a target sample size of 600 for the full FACE-TIA 
cohort was defined by available resources. This sample size was reviewed and adjusted using 
the results of the pilot data, analysed in Chapter 4. Sample size predictions were calculated 
from the effect size of the difference in means between diagnostic groups for the HADS and 
NEADL, after adjusting for age and gender. Software (G*POWER, 2004) was used to 
perform the sample size calculation. 
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CHAPTER 4 
RESULTS 
The FACE TIA trial is ongoing. The results reported in this chapter relate to data collected 
before July 2011. This includes baseline data only. The results of the three, six and twelve-
month follow-up will be reported in subsequent publications.  
4.1 Participants 
To date, one hundred and eleven patients diagnosed with definite TIA have consented to 
participate in the FACE TIA trial. Patients diagnosed with possible TIA (n=74), TIA “mimic” 
(n=44), minor stroke (n=19), and 30 “healthy” controls have also agreed to take part.  
Furthermore, 40 participants out of 111 who had suffered a definite TIA have consented to 
participate in the Birmingham University Cognitive Screen (BUCS). The TIA “mimic” group 
included patients who were given a differential diagnosis to TIA, such as migraine, syncope, 
orthostatic hypotension, vertigo, transient global amnesia, transient speech arrest, lazy eye, 
dyspraxia and conversion syndrome.  
A flow diagram of all the participants is presented in Figure 3. 
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Figure 3: Flow diagram of participants  
 
Seven definite TIA participants were lost to follow-up before submitting their baseline 
questionnaire; two participants withdrew their consent without stating a reason, three 
participants failed to return their questionnaire and did not respond to telephone/postal 
TIA Clinics GP practices 
Definite 
TIAs  
Invited 
(n=?) 
Possible 
TIAs  
Invited 
(n=?) 
Consented 
to question-
naires 
(n=111) 
Consented 
to BUCS 
(n=40) 
Consented 
to ques-
tionnaires 
(n=74) 
Met inclusion criteria (n=?) 
Assessed in clinic for eligibility (n=?) 
TIA 
“mimics 
invited 
(n=?) 
Consented 
to question-
naires 
(n=44) 
“healthy” controls  
invited 
(n=299) 
Consented to questionnaires 
(n=30) 
 
 
Withdrawn/lost to follow-up 
(n=0) 
Minor 
strokes  
Invited 
(n=?) 
Consented 
to question-
naires 
(n=19) 
Question-
naires ana-
lysed 
(n=104) 
BUCS ana-
lysed 
(n=40) 
Question-
naires ana-
lysed (n=71) 
Question-
naires ana-
lysed 
(n=41) 
Questionnaires analysed 
(n=30) 
 
Question-
naires ana-
lysed 
(n=18) 
Withdrawn/
lost to fol-
low-up 
(n=7) 
Withdrawn/
lost to fol-
low-up 
(n=3) 
Withdrawn/
lost to fol-
low-up 
(n=1) 
With-
drawn/lost 
to follow-
up (n=3) 
? Number is currently unknown as reports from clinics have not yet been received  
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reminders and two participants were excluded as further investigation revealed that they had 
actually suffered a major stroke. Three participants diagnosed with possible TIA were lost to 
follow-up before submitting their baseline questionnaire; one participant became hospitalized 
and did not want to continue, one participant withdrew their consent as they needed assistance 
to complete the questionnaire and felt uncomfortable in doing so, and one participant 
withdrew their consent without stating a reason. Three participants diagnosed with TIA 
“mimic” were lost to follow-up before submitting their baseline questionnaire: two found the 
study irrelevant as they had not suffered a TIA and one withdrew their consent without stating 
a reason. One minor stroke patient also withdrew their consent without reason before 
submitting their baseline questionnaire. 
4.2 Baseline Characteristics 
The definite TIA group were significantly older than the possible TIA group, and included 
significantly fewer males than the control group. However they were comparable to the other 
groups in terms of age and gender. No significant differences were found between the definite 
TIA group and other groups with regards to ethnicity, living situation or formal education, 
with the exception of “other qualification/level unknown”, which was significantly higher in 
the control group.  In terms of stroke risk factors, no significant differences were found 
between the definite TIA group and other groups with regards to obesity and smoking status. 
However a significantly higher proportion of the “healthy” control group admitted to drinking 
alcohol on a regular basis, compared to the definite TIA group. The demographic 
characteristics of the study sample are presented by diagnosis in Table 7.  
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Table 7: Demographic characteristics  
 Definite TIA 
(n=111) 
Possible TIA 
(n=74) 
Mimic (n=44) Minor stroke 
(n=19) 
Healthy control 
(n=30) 
Age (mean ± SD; range) 74±14; 43-109 69±12; 31-88* 69±11; 41-91 70±12; 50-89 73±8; 61-89 
  (n)  (valid 
%)  
 (n) (valid 
%) 
 (n) (valid 
%) 
 (n) (valid 
%) 
 (n)  (valid 
%)   
Gender 
Male 
Missing 
 
56 
7 
 
(53.8%) 
 
33 
0 
  
(44.6%) 
 
25 
0 
 
(56.8%) 
 
10 
0 
  
(52.6%) 
 
25 
0 
  
(83.3%)* 
Ethnicity           
White 101 (97.1%) 70 (95.9%) 44 (100%) 18 (94.7%) 30  (100%) 
Black 2  (1.9%) 0  (0.0%) 0  (0.0%) 0  (0.0%) 0  (0.0%) 
Asian 
Missing 
1 
7 
 (1.0%) 3 
1 
 (4.1%) 0 
0 
 (0.0%) 1 
0 
 (5.3%) 0 
0 
 (0.0%) 
Education           
No formal qualification 38 (37.3%) 22 (30.6%) 7 (15.9%) 10 (55.6%) 6 (20.0%) 
GCSE or equivalent 27 (26.5%) 26 (36.1%) 19 (43.2%) 1 (5.6%) 4 (13.3%) 
A’level or equivalent 10 (9.8%) 11 (15.3%) 4  (9.1%) 3 (16.7%) 2 (6.7%) 
Degree 7 (6.9%) 6 (8.3%) 7 (15.9%) 1 (5.6%) 1 (3.3%) 
Postgraduate qualification 2 (2.0%) 1 (1.4%) 4 (9.1%) 0 (0.0%) 3 (10.0%) 
Other 
Missing 
18 
9 
(17.6%) 6 
2 
(8.3%) 3 
0 
(6.8%) 3 
1 
(16.7%) 14 
0 
(46.7%)* 
Lives with           
Spouse/partner 63 (60.6%) 44 (60.3)% 32 (72.7)% 17 (89.5)% 24 (80.0)% 
Dependents 2 (1.9%) 2  (2.7)% 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Alone 34 (32.7%) 24 (32.9)% 10 (22.7)% 2 (10.5)% 5 (16.7)% 
Other 
Missing 
5 
7 
(4.8%) 3 
1 
(4.1)% 2 
0 
(4.5)% 0 
0 
(0.0%) 1 
0 
 (3.3)% 
Residence           
Domestic 98 (94.2%) 70 (95.9%) 40 (90.9%) 19 (100%) 30 (100%) 
Sheltered 2 (1.9%) 2 (2.7%) 4 (9.1%) 0 (0.0%) 0 (0.0%) 
Residential 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Nursing 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Other 
Missing 
4 
7 
(3.8%) 1 
1 
(1.4%) 0 
0 
(0.0%) 0 
0 
(0.0%) 0 
0 
(0.0%) 
Anxiety and Depression          
Anxious (HADS-A>4) 
Depressed (HADS-D>4) 
Missing 
53 
31 
8 
(51.5%) 
(30.1%) 
43 
23 
3 
(60.6%) 
(32.4%) 
22 
11 
3 
(53.7%) 
(26.8%) 
11 
7 
2 
(64.7%) 
(41.2%) 
7 
6 
0 
(23.3%) 
(20.0%) 
Health 
Obese 
Missing 
 
24 
30 
 
(29.6%) 
 
10 
21 
  
(18.9%) 
 
15 
4 
  
(37.5%) 
 
4 
6 
  
(30.8%) 
 
8 
1 
 
 (27.6%) 
Lifestyle 
Smokes 
 
14 
 
(13.6%) 
 
7 
  
(9.9%) 
 
3 
 
 (7.3%) 
 
2 
 
(11.1%) 
 
0 
 
 (0.0%) 
Drinks alcohol 
Missing 
61 
8 
(59.2%) 39 
3 
(55.7%) 33 
3 
(80.5%) 12 
1 
(66.7%) 27 
0 
(90.0%)* 
* Significantly different to definite TIA group (p<0.05) 
 
Additional clinical findings for the four patient groups are presented in Table 8. 
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Table 8: Clinic findings 
 Definite TIA 
(n=111) 
Possible TIA 
(n=74) 
Mimic  
(n=44) 
Minor stroke 
(n=19) 
Days to consent 
(median: IQR) 
4: 1-8 7: 4-11 6: 3-7 4: 1-11 
 (n) (valid 
%)  
(n) (valid 
%) 
(n) (valid 
%) 
(n) (valid 
%)   
Referral source         
A&E 49 (45.8%) 21 (28.4%) 13 (29.5%) 8 (42.1%) 
GP 47 (43.9%) 48 (64.9%) 29 (65.9%) 6 (31.6%) 
Other 
Missing 
11 
4 
(10.3%) 5 
0 
(6.8%) 2 
0 
(4.5%) 5 
0 
(26.3%) 
Duration symptoms         
≤ 1 hour 70 (71.4%) 43 (71.7%) 29 (80.6%) 4 (36.4%) 
1-24 hours  28 (28.6%) 16 (26.7%) 6 (16.7%) 3 (27.3%) 
24-48 hours 0 (0.0%) 1 (1.7%) 0 (0.0%) 3 (27.3%) 
> 48 hours 
Missing 
0 
13 
(0.0%) 0 
14 
(0.0%) 1 
8 
(2.8%) 1 
8 
(9.1%) 
Symptoms         
Right weakness 31 (27.9%) 17 (23.0%) 12 (27.3%) 5 (26.3%) 
Left weakness 45 (40.5%) 21 (28.4%) 4 (9.1%) 9 (47.4%) 
Bilateral weakness 4 (3.6%) 9 (12.2%) 12 (27.3%) 0 (0.0%) 
Speech 12 (10.8%) 5 (6.8%) 8 (18.2%) 4 (21.1%) 
Visual  9 (8.1%) 6 (8.1%) 9 (20.5%) 0 (0.0%) 
Other 
Missing 
7 
0 
(6.3%) 4 
0 
(5.4%) 1 
0 
(2.3%) 2 
0 
(10.5%) 
ABCD2  
≥4 (high risk of stroke) 
Missing 
 
44 
25 
 
(51.2%) 
 
18 
25 
 
(36.7%) 
 
16 
4 
 
(40.0%) 
 
7 
10 
 
(77.8%) 
 
The proportion of patients at high risk of future stroke, as measured by the ABCD2 score, was 
greatest in the minor stroke group (77.8%), followed by the definite TIA group (51.2%). 
Fewer patients diagnosed with possible TIA and TIA “mimic” were considered to be at high 
risk of stroke (36.7% and 40.0% respectively). 
In accordance with the time-based definition of TIA, the symptoms recalled by all definite 
TIA patients lasted less than 24 hours. The majority of TIAs (71.4%) actually lasted less than 
1 hour. Although the number of participants in the minor stroke group was small, less than 
half of the group reported symptoms lasting more than 24 hours. This emphasises the 
discrepancy between the arbitrary cut-off time between TIA and minor stroke, and clinical 
judgement.  
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4.3 Outcome Results 
4.3.1 Extended Activities of Daily Living 
After adjusting for age and gender, the minor stroke group scored significantly lower than the 
definite TIA group on the NEADL (mean: -5.05 points, CI: -9.63 to -4.63). The results 
suggest that patients diagnosed with minor stroke are likely to be more dependent in extended 
activities of daily living, than patients diagnosed with TIA. All other groups had similar mean 
NEADL scores to the definite TIA group (Table 9).  
Table 9: Differences in NEADL score, compared to the definite TIA group† 
Constant: Definite TIA (n=104)    
 B SE (B) 95% CI (B) Sig (B) 
Comparison group     
Healthy Control (n=30) 2.14 1.93 -1.66 to 5.93 0.268 
Mimic(n=41) 1.44 1.70 -1.90 to 4.79 0.396 
Possible TIA (n=71) -0.02 1.43 -2.84 to 2.80 0.990 
Minor Stroke (n=18) -5.05 2.33 -9.63 to -0.46 0.031 
† age and gender adjusted model  
B = regression coefficient 
Note: R2 = 0.075 
Lower NEADL score = greater dependence in ADL 
4.3.2 Anxiety and Depression 
After adjusting for age and gender, the HADS-total scores (Table 10) of the “healthy” control 
group were significantly lower than the HADS-total scores of the definite TIA group (mean: 
2.90 points higher, CI: 0.24 to 5.55). After dividing the HADS into its component anxiety and 
depression sub-scores, the “healthy” control group were found to have significantly less 
feelings of depression than the definite TIA group (mean: -1.35 points, CI: -2.65 to -0.06), as 
shown in Table 12. The anxiety scores were not significantly different between the “healthy” 
controls and definite TIA group; however there appears to be a trend towards less anxiety in 
the “healthy” control group (Table 11). The other patient groups (possible TIAs, TIA 
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“mimics” and minor stroke) scored similarly to the definite TIA group in terms of anxiety 
(Table 11) and depression (Table 12). 
Table 10: Differences in HADS-Total score, compared to the definite TIA group† 
Constant: Definite TIA (n=104)    
 B SE (B) 95% CI (B) Sig (B) 
Comparison group     
Healthy Control (n=30) -2.90 1.35 -5.55 to -0.24 0.033 
Mimic(n=41) -0.60 1.19 -2.94 to 1.75 0.617 
Possible TIA (n=71) 0.62 1.00 -1.35 to 2.60 0.534 
Minor Stroke (n=18) 2.08 1.67 -1.21 to 5.37 0.215 
† age and gender adjusted model  
B = regression coefficient 
Note: R2 = 0.081 
Lower HADS-total score = less anxious/depressed mood 
 
Table 11: Differences in HADS-Anxiety score, compared to the definite TIA group† 
Constant: Definite TIA (n=104)    
 B SE (B) 95% CI (B) Sig (B) 
Comparison group     
Healthy Control (n=30) -1.54 0.84 -3.19 to 0.12 0.067 
Mimic(n=41) -0.16 0.74 -1.61 to 1.23 0.830 
Possible TIA (n=71) 0.70 0.62 -0.53 to 1.93 0.263 
Minor Stroke (n=18) 1.14 1.04 -0.91 to 3.12 0.273 
† age and gender adjusted model  
B = regression coefficient 
Note: R2 = 0.141 
Lower HADS-anxiety score = less anxious mood 
 
Table 12: Differences in HADS-Depression score, compared to the definite TIA group† 
Constant: Definite TIA (n=104)    
 B SE (B) 95% CI (B) Sig (B) 
Comparison group     
Healthy Control (n=30) -1.35 0.66 -2.65 to -0.06 0.041 
Mimic(n=41) -0.44 0.58 -1.58 to 0.71 0.452 
Possible TIA (n=71) -0.08 0.49 -1.04 to 0.89 0.878 
Minor Stroke (n=18) 0.94 0.82 -0.67 to 2.54 0.251 
† age and gender adjusted model 
B = regression coefficient  
Note: R2 = 0.044 
Lower HADS-depression score = less depressed mood 
 
The order of outcome was similar across all measures, with the minor stroke group having the 
worst outcome (most dependence; most anxiety and most depressed mood), followed by the 
possible TIA group, then the definite TIA group, then the TIA “mimics” and finally the 
“healthy” controls. 
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4.3.3 Cognition 
Cognitive impairment, scored as “impaired” or “not impaired” on the BUCS was determined 
using cut-off scores, based on scores two Standard Deviations or more from the means of the 
“healthy” population (Humphreys et al, 2007). From Table 13 it can be seen that, on several 
items (highlighted in grey), 5-21% of definite TIA participants were impaired. This equates to 
5-21% of definite TIA participants scoring within the bottom 5% of the normal population. 
Thus, indicating that definite TIA patients might be more impaired than “healthy” controls in 
these areas of cognition.  
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Table 13: Cognitive impairments in the definite TIA group (n=40) 
  Assessed (n) Impaired (n) Impaired (%) 
LANGUAGE      
Speech Instruction comprehension 39 0 0.0% 
 Picture naming 40 2 5.0% 
 Sentence construction 40 4 10.0% 
Reading Nonwords – accuracy 39 1 2.6% 
 Nonwords – time 39 0 0.0% 
 Sentence – accuracy 39 4 10.3% 
 Sentence – time 39 1 2.6% 
Writing Words + nonword 39 1 2.6% 
NUMBER      
Reading Total 39 0 0.0% 
Writing Total 39 2 5.1% 
Calculation Total 39 0 0.0% 
PRAXIS      
visuo-constructive Figure copy 39 3 7.7% 
Limb Multi-step 39 0 0.0% 
 Gesture production 39 1 2.6% 
 Gesture recognition 39 0 0.0% 
 Imitation 39 8 20.5% 
LONG-TERM MEMORY     
Orientation Personal 40 0 0.0% 
 Time and space (MC) 40 1 2.5% 
Episodic Story - immediate recall 39 6 15.4% 
 Story – immediate recognition 39 3 7.7% 
 Story – delayed recall 39 3 7.7% 
 Story – delayed recognition 39 1 2.6% 
ATTENTION      
Spatial Apple cancellation -total 37 1 2.7% 
 Apple asymmetry - full 37 0 0.0% 
 Apple asymmetry - incomplete 37 0 0.0% 
 Left visual neglect 39 1 2.6% 
 Right visual neglect 39 0 0.0% 
 Left visual bilateral 39 1 2.6% 
 Right visual bilateral 39 0 0.0% 
 Left tactile neglect 39 2 5.1% 
 Right tactile neglect 39 1 2.6% 
 Left tactile bilateral 39 0 0.0% 
 Right tactile bilateral 39 1 2.6% 
 Auditory – WM2 – recall 39 2 5.1% 
 Auditory – accuracy 39 5 12.8% 
Control Auditory – sustained attention 39 4 10.3% 
 B’ham – rule finding - accuracy 39 7 17.9% 
 B’ham – rule finding - rules 39 3 7.7% 
 
Sentence construction was impaired in 10% of TIA participants, compared to 5% in the 
normal population. In this task participants were instructed to construct a sentence which 
describes what a person is doing in a photograph, incorporating 2 given words. Difficulty with 
65 
 
this task suggests problems in semantic and syntactic processes, along with problems in 
articulation. Sentence reading accuracy was impaired in 10.3% TIA participants, compared to 
5% in the normal population. This is unlikely to be a reflection on neglect or visual 
disorientation as sentences are presented across several lines in central alignment. Again, it is 
more likely to reflect problems in syntactic processes and articulation. Over one fifth of TIA 
participants were impaired in the imitation task, compared to one in twenty in the normal 
population. In this task participants were asked to “mimic” four meaningless hand gestures. 
Difficulties with this task suggest problems with proprioception and coordination. Immediate 
story recall was impaired in 15.4% of TIA participants compared to 5% in the normal 
population. This suggests that TIA patients have more problems with episodic memory for 
newly learned verbal information. In the auditory attention task, over 10% of TIA participants 
demonstrated impairments in sustaining their attention, and storing items in their memory 
over the short-term, when engaged in another activity (a measure of working memory). This 
is more than double the proportion of impairments found in the normal population on this 
task. A higher proportion of TIA participants than “healthy” norms also demonstrated 
impairments in the rule finding and switching test, which measures the participant’s ability to 
find an abstract rule and to switch the rule across stimuli within and across dimensions. 
4.3.4 Predictors of functional, emotional and cognitive outcomes 
4.3.4.1 Predictors of functional outcome 
After adjusting for age, gender and diagnosis, the HADS-total score was found to be a strong 
predictor of the NEADL score. An increase of one in the HADS-total predicted a decrease of 
0.35 (CI: -0.52 to -0.17) in the NEADL (Table 14). A higher score on the HADS reflects 
greater anxiety and feelings of depression, and a lower score on the NEADL reflects less 
66 
 
independence. Therefore the negative correlation between scores indicates that as anxiety and 
feelings of depression increase, independence decreases.   
The number of BUCS impairments was not a significant predictor of NEADL scores in the 
definite TIA group, after adjusting for age and gender (mean: 1.72, CI: -0.18 to 3.61). This 
suggests that cognitive impairment is not related to independence in extended daily activities 
in this population.  
In the definite TIA group, after adjusting for age and gender, an increase of one on the 
ABCD2 score resulted in a significant decrease in the NEADL (mean: -1.78, CI: -3.59 to 
0.04), showing that increased stroke risk is linked to reduced independence (Table 14). 
Table 14: Predictors of the NEADL score 
Predictor variable B SE (B) 95% CI (B) Sig (B) 
BUCS ¶ (n=40) 1.72 0.93 -0.18 to 3.61 0.075 
HADS† (n=264) -0.35 0.09 -0.52 to -0.17 0.000 
ABCD2 ¶ (n=234) -1.78 0.91 -3.59 to 0.04 0.054 
B = regression coefficient 
† all groups (age, gender and diagnosis adjusted models) 
¶ TIA group only (age and gender adjusted) 
Note: R2 (BUCS) = 0.111; R2 (HADS) = 0.119; R2 (ABCD2) = 0.117 
Lower NEADL score = greater dependence in ADL 
4.3.4.2 Predictors of emotional outcomes 
After adjusting for age, gender and diagnosis, the NEADL was found to be a strong predictor 
of the HADS score. An increase of one in the NEADL score predicted a decrease of 1.17 (CI: 
-0.26 to -0.09) in the HADS-total score (Table 15). A higher score on the NEADL reflects 
greater independence and a lower score on the HADS reflects a less anxious/depressed mood. 
Therefore the negative correlation between scores indicates that as independence increases, 
anxiety and feelings of depression decrease.   
In the definite TIA group, after adjusting for age and gender, an increase of one impairment 
on the BUCS resulted in a significant increase in the HADS-Total score (mean: 1.60, CI: 0.27 
to 2.92), HADS-Anxiety score (mean: 0.87, CI: 0.13 to 1.60) and HADS-Depression score 
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(mean: 0.73, CI: 0.08 to 1.38). These results are presented in Tables 15, 16 and 17 
respectively. The results suggest a positive correlation between cognitive impairment and 
anxiety and depression.  
In the definite TIA group, an increase of one on the ABCD2 score did not influence the 
HADS-total score (Table 15) or HADS sub-scores (Tables 16-17) after adjusting for age and 
gender. This suggests that stroke risk is unrelated to feelings of anxiety and depression.  
Table 15: Predictors of the HADS-Total score 
Predictor variable B SE (B) 95% CI (B) Sig (B) 
BUCS ¶ (n=40) 1.60 0.65 0.27 to 2.92 0.020 
NEADL† (n=264) -1.17 0.04 -0.26 to -0.09 0.000 
ABCD2 ¶ (n=234) -0.06 0.65 -1.35 to 1.23 0.932 
B = regression coefficient 
† all groups (age, gender and diagnosis adjusted models) 
¶ TIA group only (age and gender adjusted) 
Note: R2 (BUCS) = 0.215; R2 (NEADL) = 0.135; R2 (ABCD2) = 0.033 
Lower HADS-total score = less anxious/depressed mood 
 
Table 16: Predictors of the HADS-Anxiety score 
Predictor variable B SE (B) 95% CI (B) Sig (B) 
BUCS ¶ (n=40) 0.87 0.36 0.13 to 1.60 0.022 
NEADL† (n=264) -0.08 0.03 -0.13 to -0.03 0.004 
ABCD2 ¶ (n=234) -0.03 0.37 -0.77 to 0.71 0.939 
B = regression coefficient 
† all groups (age, gender and diagnosis adjusted models) 
¶ TIA group only (age and gender adjusted) 
Note: R2 (BUCS) = 0.233; R2 (NEADL) = 0.169; R2 (ABCD2) = 0.072 
Lower HADS-anxiety score = less anxious mood 
 
Table 17: Predictors of the HADS-Depression score 
Predictor variable B SE (B) 95% CI (B) Sig (B) 
BUCS ¶ (n=40) 0.73 0.32 0.08 to 1.38 0.029 
NEADL† (n=264) -0.09 0.02 -0.13 to -0.05 0.000 
ABCD2 ¶ (n=234) -0.03 0.32 -0.66 to 0.60 0.932 
B = regression coefficient 
† all groups (age, gender and diagnosis adjusted models) 
¶ TIA group only (age and gender adjusted) 
Note: R2 (BUCS) = 0.203; R2 (NEADL) = 0.337;R2 (ABCD2) = 0.048 
Lower HADS-depression score = less depressed mood 
 
4.3.4.3 Predictors of cognitive outcomes 
 
An increase of one on the HADS-total score predicted a significant increase in number of 
BUCS impairments, after adjusting for age and gender (Table 18). This suggests that patients 
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with a more anxious/depressed mood are likely to exhibit more cognitive impairments. A 
trend towards more cognitive impairments with increased NEADL and ABCD2 scores was 
also demonstrated (Table 18), suggesting that increased stroke risk and greater independence 
in extended daily activities could be associated with increased cognitive impairment. 
Table 18: Predictors of BUCS impairments 
Predictor variable B SE (B) 95% CI (B) Sig (B) 
NEADL¶ (n=40) 0.05  -0.01 to 0.11 0.075 
HADS¶ (n=40) 0.09  0.02 to 0.17 0.020 
ABCD2¶ (n=40) 1.30  -0.18 to 2.79 0.083 
¶ TIA group only (age and gender adjusted) 
Note: R2 (NEADL) = 0.119; R2 (HADS) = 0.182; R2 (ABCD2) = 0.184 
4.4 Sample size calculations 
Based on the effect size of the NEADL (r=0.274) and a significance level of 0.05, a total 
sample size of 458 participants would be needed to achieve 90% power. For the HADS 
(r=0.285), only 424 participants would be needed to achieve 90% power at the 0.05 level of 
significance. As the full FACE TIA study continues, attrition rates would need to be 
considered and the target sample size of 458 should be adjusted accordingly.    
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CHAPTER 5 
DISCUSSION AND EPILOGUE 
5.1 Discussion 
This cohort study was designed to analyse functional, cognitive and emotional outcomes in 
patients diagnosed with their first TIA, compared to “healthy” individuals. The study also 
sought to analyse how patients with suspected TIA faired after being given a differential 
diagnosis, compared to those whose TIA diagnosis was confirmed. Although the study is 
under-powered at this stage, the preliminary findings of the ongoing FACE TIA study 
demonstrate some strong emerging themes. 
Previous research has found TIA to have no impact on basic activities of daily living (Duncan 
et al, 1997). In this study we sought to examine the effect of TIA on extended activities of 
daily living, which require increased interaction with the environment than basic ADL, and 
appear to be a prerequisite for independent living in the community. The results provide no 
evidence to suggest that extended ADL are compromised in TIA patients compared to 
controls. However, minor-stroke patients were significantly more impaired in this area than 
TIA patients. This evidence supports the classic understanding of TIA, distinguishing it from 
stroke, as “symptoms that resolve without obvious lasting damage” (Department of Health, 
2007b). A strong trend was found between the ABCD2 score and NEADL suggesting that 
clinical populations at high risk of stroke are likely to more impaired in extended activities of 
daily living, than patients at lower risk of stroke.  
It is generally accepted, by health professionals, that patients make a complete recovery after 
TIA. However recent findings into depression and cognition after TIA suggest otherwise 
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(Bossema et al, 2006; Charoenkitkarn et al, 2009; Guyomard et al, 2011; Hickie et al, 2003; 
Rao et al, 1999; Rao et al, 2001; Rao, 2002; Walters et al, 2003; Xin-rong et al, 2005). 
The HADS-depression score is largely related to the loss of pleasure responses (anhedonia) 
which is one of the two required components of the official definition of 'major depressive 
disorder' (Snaith, 2003). In this study, patients diagnosed with TIA scored significantly worse 
on the depression component of the HADS than “healthy” controls. This finding suggests that 
TIA is associated with depression, and is consistent with previous research (Bossema et al, 
2006; Rao et al, 2001). Although an association between feelings of depression and TIA is 
evident, the temporal relationship is unclear. Our findings, of depressed mood in TIA patients, 
is also consistent with subjective accounts of depression reported by TIA patients in 
qualitative research (Spurgeon, 2011).  
Depression has been linked to low physical activity and smoking, that may increase vascular 
risk (Jonas & Mussolino, 2000). Depressive symtoms have also been shown to be an 
independent risk factor for incident stroke/TIA in a community-based study (Salaycik et al., 
2007). These findings suggest that depression may provoke TIA, rather than TIA being the 
causative factor. Interestingly, our results found the ABCD2 score to be a poor predictor of 
depression. In addition, mean depression scores were similar between TIA patients and 
patients who were referred to TIA clinics, but given an alternative diagnosis. This suggests 
that depression may be related to the experience of suffering a stressful event, whether that is 
stroke, TIA or another condition entirely. This finding implies a need to explore the potential 
for psychological screening and support in all patients attending TIA clinics, regardless of 
their final diagnosis. 
In previous research Duncan et al (1997) found that depression significantly impacted on the 
quality of life, family functioning and psychological health of all concerned. Our research 
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supports this. A significant correlation was found between the HADS and NEADL, with 
feeling of anxiety and depression increasing with reduced independence. A significant 
correlation was also found between the HADS and BUCS, with feeling of anxiety and 
depression increasing with increasing cognitive impairment. This finding suggests that 
addressing depression could have an all-round impact on the patients’ health.   
Although not statistically significant, an emerging trend towards increased anxiety in definite 
TIA patients, compared to “healthy” controls, is evident. This trend should not be dismissed, 
especially as the results of the preliminary analyses were underpowered.  Furthermore, 
anxiety emerged as a strong theme in qualitative research (Spurgeon, 2011).   
In the FACE TIA study, preliminary analysis revealed that certain types of cognitive 
impairment were more prevalent in definite TIA patients than in the normal “healthy” 
population. The impact of TIA on cognitive functioning has already been documented by 
several authors and although different test batteries were used, the areas of impairment seem 
to be consistent.  Impaired language has been reported by Bossema et al (2006) and 
Guyomard et al (2011); impaired memory has been reported by Xin-rong et al (2005), 
Bossema et al (2006), Charoenkitkarn et al (2009) and Guyomard et al (2011); visuo-spatial 
impairement has been reported by Guyomard et al (2011) and attention deficits have been 
reported by Rao et al (1999; 2002), Xin-rong et al (2005), Bossema et al (2006) and 
Guyomard et al (2011). In addition, Rao et al (1999; 2002) and Guyomard et al (2011) 
identified impairments in areas of calculation and orientation respectively.  To date, no 
substantial impairments in these two dimensions have been identified in the FACE TIA 
cohort. In previous research some authors have demonstrated a possible correlation between 
cardio vascular risk factors and cognition. This theme was explored in the FACE TIA cohort 
using the ABCD2 score, as a measure of stroke risk, to predict cognitive impairment.  
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Although not statistically significant, a positive correlation was observed between stroke risk 
and number of cognitive impairments. This emerging trend suggests that higher risk patients 
attending TIA clinics may benefit from cognitive screening. 
No significant relationship was found between cognition and extended activities of daily 
living in this study however there was a positive correlation between the BUCS and HADS 
suggesting that cognitive impairments may provoke feelings of anxiety and depression. Green 
and King (2007) imply that this may result from the implication of reduced cognition on 
employment and social activities. Although not the topic of this research, cognitive 
impairments could impact on the patient’s ability to attend to, learn, understand and remember 
new information and adopt new health behaviours. This could potentially have an effect on 
patient management. If patients are unable to comprehend the severity of TIA or respond and 
adhere to stroke prevention strategies, such as lifestyle advice and preventative medication, it 
could increase their risk of future stroke. Finding ways to manage cognitive decline could 
have a huge impact on patient prognosis. 
5.2 Strengths and Limitations 
5.2.1 Extrapolating the results to a wider population 
The results have been adjusted for age and gender to reduce any effects resulting from 
differences in the demographics between groups. In terms of the population studied, 
participants were recruited from a wide geographical area within the UK, reflecting a variety 
of urban and rural locations, ranging in levels of socioeconomic status. However, the sample 
was predominantly White British, perhaps reflecting that this ethnic group is more likely to 
seek medical attention for TIA-like symptoms or perhaps reflecting a greater willingness to 
participate in research. Researchers should be aware of this and make additional arrangements 
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to engage and facilitate involvement of people form ethnic minorities in research. Care should 
also be taken when extrapolating the results of this study to ethnic minority groups.  
Participants were grouped according to their clinical diagnosis. However to increase 
consistency of diagnoses between clinicians some additional constraints were enforced; for 
example, minor stroke patients were differentiated from major stroke patients based on length 
of admission to hospital. These constrains were formed in collaboration with stroke 
consultants.  Radiographic evidence was used to inform diagnoses at the discretion of stroke 
consultant assessing the patient. This was a practical decision by the research team to ensure 
that the results were relevant to current practice where scans are not mandatory and are often 
deemed unnecessary. 
5.2.2 Study design 
Only baseline results of the FACE TIA study are reported in this thesis. However, as 3, 6 and 
12 month follow-up data are collected and analysed, the results will provide a more insightful 
account of the course of TIA, and provide a greater understanding of the prognosis after TIA. 
This will add to the current evidence base, not only in terms of time-to-stroke and survival, 
but also in terms of patients’ perceptions of their physical and mental health after TIA, and 
how this changes over time. The latter has scarcely been reported before (Hickie et al, 2003). 
In terms of recruitment, patients meeting the inclusion criteria were recruited from TIA clinics 
consecutively to eliminate selection bias. “Healthy” control patients from GP practices were 
identified as suitable matches for TIA patients using anonymous databases containing 
essential information only (year of birth, GP postcode, gender and unique ID). “Healthy” 
control patients were then selected at random using a quasi-computerised random number 
generator in Microsoft Office Excel (Microsoft Corporation, 2007). 
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The main limitation of the results reported here stems from the small sample size, which has a 
huge implication on the effect size and power of the results. Consequently the preliminary 
findings need to be interpreted with caution. From the sample size calculation, yielded from 
this analysis, a sample size of 458 (almost double) is needed to achieve 90% power at a 0.05 
level of significance.  
5.2.3 Response rates 
From the results it can be seen that the recruitment rate of “healthy” controls was very low. 
Only one in ten individuals consented to participate. In part this may be due to the recruitment 
method. Controls were invited by post rather than face-to face, by a medical professional 
whom they trust. The low recruitment rate may also reflect reduced incentive; as they have 
not suffered a cerebrovascualr event they may be less interested in the results of the study. 
There is a chance that the small proportion of “healthy” individuals that did respond reflected 
the “worried-well” population, especially given that the prevalence of anxiety in this group 
exceeded 20% (HADS-A > 4). The “worried-well” have an obsessional preoccupation with 
the idea or the thought that they are currently (or will be) experiencing a physical illness 
(Criqui et al., 1979). Consequently self-reflection on their health is likely to be more negative. 
To reduce the chances of obtaining a “worried-well” control group in the future, participants 
could be screened for hyphochondriasis. Alternatively, a more representative sample could be 
achieved by recruiting in person or by phone. Recruitment could be performed during routine 
check-up appointments at the GP practice. However patients should not be recruited during 
GP consultations resulting from self-referral, as the latter would favour an un-well population. 
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5.2.4 Outcome measures 
So far the BUCS has only been administered to participants who have a confirmed TIA. No 
BUCS data is currently available for “healthy” control participants who have been recruited to 
the study. Consequently the effect of TIA on cognition has been assessed using published cut-
off scores for “healthy” controls, collected as part of a previous study, rather than actual 
scores. In addition, although the BUCS is highly standardised in terms of administration and 
scoring, inter-rater reliability has not been formally assessed. Certain measures were 
undertaken to try and maximise inter-rater reliability; BUCS administers were all required to 
attend a 2-day training course, refresher courses were also provided and assessments were 
chosen at random for triple-marking and any discrepancies/inconsistencies were discussed 
with all BUCS assessors to encourage uniform marking.  
Although some scientists are sceptical about the use of patient-based outcome measures, 
patients’ perspectives of their own health are being recognised as increasingly important in 
research. This is illustrated by the World Health Organisation (1947), who describe health as 
“a state of complete physical, mental and social well-being and not merely the absence of 
disease or infirmity”. Patients’ perspectives are particularly relevant to health related quality 
of life, which “in clinical medicine represents the functional effect of an illness and its 
consequent therapy upon a patient, as perceived by the patient” (Schipper et al., 1996). The 
psychometric theory e.g. validity, reliability etc. of patient-based measures provides further 
theoretical support for their use. The psychometric properties of the HADS and NEADL in 
stroke patients have been discussed chapter 3. The measures appear to perform well in the 
population studies here, with no obvious ceiling effects.  
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5.2.5 Statistical methods 
To avoid selective reporting, pre-specified predictor variables were entered into multiple 
regression models using forced entry, rather than getting the computer software to search for 
predictors based on mathematical criteria, which takes advantage of random sampling 
variation. Meaningful predictor variables were chosen based on study aims, previous research 
and theoretical reasoning: Thus, minimising statistical biases.  
5.3 Epilogue 
The increasing evidence base emerging from quantitative and qualitative research offers 
insights into the impact of TIA on different dimensions of health status including 
psychological well-being, cognitive functioning and physical functioning.  
The baseline data collected from the FACE TIA cohort to date supports previous research 
suggesting that patients diagnosed with TIA are likely to be more depressed and more 
cognitively impaired than the general population. It is unclear how much of the observed 
association between cerebrovascular disease and cognitive dysfunction and/or depression is 
mediated by cardiovascular risk factors, and/or whether TIA has a direct causal relationship.  
However it is likely that TIA patients would benefit from targeted health education campaigns 
and active management. Strong interactions between cognition, feelings of anxiety and 
depression and activities of daily living, infer that improving one outcome could potentially 
improve other outcomes. 
The FACE TIA study aims to follow-up participants at 3, 6 and 12 months after their 
diagnosis. It will be interesting to see how depressed mood and cognitive impairments in TIA 
patients change over time, compared to other clinical groups and “healthy” controls. It will 
also be interesting to see how these outcomes affect participants’ health in terms of service 
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use (contact with health-care providers) and the occurrence of clinically significant events 
including stroke. 
5.3.1 Future research 
Patients with suspected TIA are routinely screened for stroke risk, and are managed according 
to this risk. The visible neurological symptoms associated with TIA should not only act as an 
alarm for impending stroke but could be used as an opportunity to screen for depression and 
cognitive function. Attending to and treating such conditions is important. Not only could this 
improve patients’ quality of life after TIA but it could also improve compliance to medical 
management and behaviour modification aimed at reducing stroke risk. Future research could 
be aimed at developing and evaluating interventions such as cognitive reappraisal and 
developing effective coping strategies.  
Modest changes in a large proportion of the population can have a greater impact on public 
health compared to dramatic changes in a smaller “high-risk” population (Rose, 1988). 
Consequently, a large proportion of the general population experiencing minor deficits 
associated with TIA may pose a significant public health burden through a shift of a 
substantial proportion of the population to lower levels of health status.  
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APPENDICES 
  
Appendix 1: Systematic review search strategy (formulated in Ovid MEDLINE) 
1 exp *Ischemic Attack, Transient/ep, mo, pc, rh, th, co, di, nu [Epidemiology, Mortality, Prevention & Control, Rehabilitation, Therapy, Complications, Diagnosis, Nursing]  
2 exp "Activities of Daily Living"/ 
3 exp "Quality of Life"/ 
4 exp Depression/ 
5 exp Fatigue/ 
6 exp Emotions/ 
7 exp Cognition/ 
8 disab$.ab,hw,ot,ti,nm.  
9 handicap$.ab,hw,ot,ti,nm.  
10 function$.ab,hw,ot,ti,nm.  
11 dependen$.ab,hw,ot,ti,nm.  
12 mobil$.ab,hw,ot,ti,nm.  
13 exp Dysarthria/ 
14 exp Aphasia/ 
15 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 
16 1 and 15 
17 exp brain ischemia/ or exp stroke/ or exp brain infarction/ 
18 "TIA".ab,hw,ot,ti.  
19 (transient adj3 ischem$).ab,hw,ot,ti.  
20 18 or 19 
21 1 or 17 
22 20 and 21 
23 15 and 22 
24 23 and 1991:2012.(sa_year).  
25 24 and "Humans" [Subjects]  
26 
exp epidemiologic studies/ or exp case-control studies/ or exp retrospective studies/ or exp 
cohort studies/ or exp longitudinal studies/ or exp cross-sectional studies/ or exp control 
groups/ 
27 25 and 26 
28 (transient adj3 isch?emi$ adj3 (brain$ or cerebral or attack)).ab,hw,ot,ti.  
29 18 or 28 
30 21 and 29 
31 15 and 30 
32 26 and 31 
33 32 and 1991:2012.(sa_year).  
34 33 and "Humans" [Subjects]  
Appendix 2: Data extraction forms 
  
Reference: (Bos et al., 2007) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, population-based, cohort  1 
Location 
Urban/rural? 
Country? 
Holland (Rotterdam) 1  
Sampling frame  
(period of recruitment, follow-up) 
1990-1993 
3 follow-up surveys (1993-1995, 1997-1999, and 2002-2004) 
1  
Study group 
  
Sample size 282 focal TNA (TIA); 228 non-focal TNA, and 38 mixed TNA 1  
source of participants   
(e.g. community, hospital, GP practice) 
community-dwelling Rotterdam Study participants 
 
1  
recruitment method 
Consecutive or random? 
Population (all inhabitants of Ommoord district, Rotterdam) 1 1 
Inc/exc criteria ≥55 years; free from stroke, myocardial infarction, and dementia at baseline 1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
 
Variable - consulted a neurologist, GP or another physician, or reported event 
at research centre 
Clinical diagnoses verified by experienced stroke neurologist 
No brain-imaging therefore not able to rule out possible stroke 
1 1 
Time of recruitment relative to TIA Pre-TIA (although participants with TNA before baseline were not excluded)  1  
Control group 
Sample size 5514 non-stroke/TIA controls 1  
source of participants   
(e.g. community, hospital, GP practice) 
community-dwelling Rotterdam Study participants 
 
1  
recruitment method 
Consecutive or random? 
Population (all inhabitants of Ommoord district, Rotterdam) 1 1 
Inc/exc criteria 
 
≥55 years; free from TNA, stroke, myocardial infarction, and dementia at 
baseline 
1  
Measurement of outcome 
Outcome Measures and end-points  
 
Outcome measures: Alzheimers disease; vascular dementia (diagnosis made 
by criteria by a panel consisting of a neurologist, a neuropsychologist, and a 
research physician  in accordance with internationally accepted criteria, and in 
combination with information from general practitioners, the Regional 
1  
Institute for Outpatient Mental Health Care, the municipality, and the 
hospitals) 
 
End-points: Stroke, ischemic heart disease, dementia and death 
Were all subjects assessed using the same 
procedure? 
Yes  1 
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
Criteria for diagnosing and classifying dementia are internationally accepted 
(references given)  
 
 1 
 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
Yes. The panel had “no adequate information on TNAs at baseline.”  1 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
6125 invited, 6062 consented 1  
N Lost to follow-up + reasons: 
Similar between groups?  
 
High retention (follow-up completed for 96.2% of potential person-years) 
Reasons for loss to FU not given 
1/2 1 
Missing data (n for each outcome) 
Similar between groups?  
 
Data appears to be complete 0 1 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
 
n/a  n/a 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
Age, gender, BP, Intima-media thickness, C-reactive protein, Cholesterol, High-
density lipoprotein, Uric acid, Waist-hip ratio, BMI, Mini-Mental State 
Examination, smoking history,  Atrial fibrillation, Diabetes mellitus, 
Hypertension,  heart surgery, Angina pectoris, education 
1 1 
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
Neither P values nor CI reported at baseline 
 
Both groups ≥55 years and free from myocardial infarction, and dementia at 
0 1 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
baseline (selection criteria) 
 
Associations between baseline characteristics and risk of TNA assessed with 
adjusted Cox proportional hazards models 
 
 
Interpretation of results – other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
No evidence of sample size/ power calculation  0 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 1 
What statistical test was used to measure effect? Hazard Ratios for the Association Between Incident TIA and Risk of Subsequent 
Dementia 
1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
Yes 1  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
 
 
 
Reference: (Bossema et al., 2006) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, case-control 
cross-sectional analysis therefore not able to infer causal relationship 
 0 
Location 
Urban/rural? 
Country? 
Holland (Nieuwegein, Utrecht) 1  
Sampling frame  
(period of recruitment, follow-up) 
Not specified 0  
Study group 
Sample size 41 1  
source of participants   
(e.g. community, hospital, GP practice) 
Symptomatic patients on waiting list for unilateral Carotid endarterectomy 
(symptoms inc ≥1 episode of hemispheric/ retinal TIA)  
1  
recruitment method 
Consecutive or random? 
Not clear 0 9 
Inc/exc criteria No history of minor or major stroke (evident from medical records) 1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
 
Degree of carotid stenosis assessed with duplex ultrasonography  
TIA diagnostic criteria not specified 
No brain-imaging therefore not able to rule out possible stroke 
1 9 
Time of recruitment relative to TIA Not reported (1 day before CEA) 0  
Control group 
Sample size 44 non-stroke/TIA controls 1  
source of participants   
(e.g. community, hospital, GP practice) 
Advert in local paper  1  
recruitment method 
Consecutive or random? 
Controls rewarded for participation (possible source of incentive bias) 
 
1 0 
Inc/exc criteria No history of Cerebrovascular or psychiatric disease 1  
Measurement of outcome 
Outcome Measures and end-points  
 
Battery of neuropsychological tests: 
Attention and working memory –Digit Span forward and backward Tests and 
Dichotic Listening Test  
Verbal memory - Word Learning Test and The Doors Test  
Verbal Fluency  
Psychomotor speed and executive functioning - Trail Making Test parts A and B 
1  
and the Motor Planning test 
Manual dexterity  - The Finger Tapping Test  
Visuospatial function - Line Orientation Test 
 
 Dutch shortened Profile of Mood States (POMS) - measures anger, tension, 
depression, vigor, and fatigue 
Were all subjects assessed using the same 
procedure? 
Yes      
 
 1 
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
All tests were referenced 
 
Reliability: Reproducibility enhanced as all administrators  trained by 
experienced neuropsychologist 
 
 1 
 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
Doesn’t appear so as patients and controls examined in different locations 
(Tests are interviewer-administered therefore blinding is important) 
 0 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
Not reported 0  
N Lost to follow-up + reasons: 
Similar between groups?  
 
n/a – cross sectional n/a n/a 
Missing data (n for each outcome) 
Similar between groups?  
 
11 patients and 4 controls did not complete Dichotic listening test due to 
hearing problems  (used linear regression analysis to impute scores) 
3 patients did not complete Trail making test (replaced with arbitrary high 
scores) 
1 1 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
n/a – cross sectional  n/a 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
Age, gender, education, hypertension,  Hypercholesterolaemia, Diabetes 
mellitus, Heart disease  
 
1 1 
Were p values and confidence intervals reported 
at baseline? 
P values reported for age, gender and education, but not CV risk factors. No CI 
reported at baseline. 
1/2 1 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
 
Age, gender & education were comparable between groups at baseline. 
 
Hypertension, hypercholesterolaemia, diabetes mellitus, and heart disease 
greater in patient group (analyzed with multiple post-hoc comparisons using 
the Bonferroni correction). Also corrected for significant differences in mood 
scores by entering these as covariates in the analyses (MANCOVA and 
ANCOVA) 
 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
No evidence of sample size/ power calculation  0 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 1 
What statistical test was used to measure effect? MANOVA and ANOVA 1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
No 0  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
 
Reference: (Charoenkitkarn et al., 2009) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, cohort  1 
Location 
Urban/rural? 
Country? 
Thailand, (Bangkok & Ayutthaya) 1  
Sampling frame  
(period of recruitment, follow-up) 
Year of recruitment not specified. TIA group recruited at admission & followed 
up 3, 10 and 30 days after TIA or minor surgery (controls) 
1/2  
Study group 
Sample size 52 1  
source of participants   
(e.g. community, hospital, GP practice) 
Outpatient and emergency departments of 4 tertiary hospitals 1  
recruitment method 
Consecutive or random? 
“convenience” 
 
1 9 
Inc/exc criteria 
 
≥24 years; able to read & write; able to take/ respond to tests/questions; 
without hearing loss, eye problems, history of substance abuse/dependency, 
Cancer, HIV/AIDS, head injury, ADHD or any other neurological disorder other 
than TIA; Not on meds to alter cognitive processing; Not depressed 
1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
Clinical diagnosis confirmed by neurologist 
No brain-imaging therefore not able to rule out possible stroke 
1 1+ 
Time of recruitment relative to TIA At admission for TIA 1  
Control group 
Sample size 52 non-vascular (minor-surgery) controls 1  
source of participants   
(e.g. community, hospital, GP practice) 
Outpatient departments 1  
recruitment method 
Consecutive or random? 
 
“identified by way of their patient record, while they were being seen in an 
outpatient’s department” 
Susceptible to bias 
1 0 
Inc/exc criteria 
 
Minor surgery patients; no known hypertension, diabetes, vascular disease or 
Hx stroke/TIA  
1  
Measurement of outcome 
Outcome Measures and end-points  
 
ATTENTION 
Distractibility 
Necker Cube Pattern control test (NCPCT) 
1  
digit span forward (DSFT) 
trail making A test (TMAT) 
Impulsivity 
Barratt impulsiveness scale (BIS) 
Irritability 
visual analogue scale (VAS) 
MEMORY 
Working Memory 
digit symbol substitution test (DSST) 
digit span backward (DSBT) 
Learning and Memory 
Hopkins verbal learning test-revised (HVLT-R) 
Were all subjects assessed using the same 
procedure? 
Yes 
 
 1 
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
English versions of cognitive tests are referenced 
 
All instruments translated into Thai. 
 
Reliability/acceptability: Pilot run to assess test-retest reliability (all acceptable 
r=0.812-0.985). Reproducibility enhanced as tests appear to have been 
administered to all by same assessor 
 
Validity: Content and face validity of Thai versions assessed and modified 
accordingly.  
 1 
 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
No (Tests are interviewer-administered therefore blinding is important)  0 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
Not reported 0  
N Lost to follow-up + reasons: 
Similar between groups?  
4 TIA participants had stroke within 30 days. They were subsequently removed 
from analysis with their matched controls and replaced. 
1 1 
Missing data (n for each outcome) 
Similar between groups?  
Not reported 0 9 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
n/a  n/a 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics Gender, age, education 1 0 
given (list) 
All necessary baseline characteristics reported?  
 
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
Neither p-values nor CIs reported at baseline 
 
Controls matched to TIA group by age, gender and education 
 
Authors state that, “no significant differences were found among the 
demographics between those who had experienced a TIA and those who had 
experienced minor surgery” 
 
 
0 1 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
Power calculation to .8, p=.05, effect size of .25 carried out  1 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 1 
What statistical test was used to measure effect? Repeated measures ANOVA 1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
No 0  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
 
Reference: (Duncan et al., 1997) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective case-control 
cross-sectional analysis therefore not able to infer causal relationship 
 0 
Location 
Urban/rural? 
Country? 
USA (Kansas, North Carolina, New York) 1  
Sampling frame  
(period of recruitment, follow-up) 
1992 
 
1  
Study group 
Sample size 184  1  
source of participants   
(e.g. community, hospital, GP practice) 
Academic Medical Center Consortium records (inpatients); United HealthCare 
records (inpatients and outpatients); Bowman Gray site of the Cardiovascular 
Health Study (community sample) 
1  
recruitment method 
Consecutive or random? 
A percentage of individuals who met the inclusion criteria were selected, to 
ensure equal sample groups 
Not clear if random 
1 9 
Inc/exc criteria History of TIA but not stroke 1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
 
ICD-9 codes (verified by medical record review), supplemented by information 
from prospective follow-up 
No brain-imaging therefore not able to rule out possible stroke 
1 1 
Time of recruitment relative to TIA Not specified 0  
Control group 
Sample size 654 asymptomatic individuals at a high-risk of stroke 1  
source of participants   
(e.g. community, hospital, GP practice) 
As TIA group 1  
recruitment method 
Consecutive or random? 
 
A percentage of individuals who met the inclusion criteria were selected, to 
ensure equal sample groups 
Not clear if random 
1 9 
Inc/exc criteria 
 
Asymptomatic individuals without neurological insult, at high-risk of stroke 
(based on ICD-9 codes) 
1  
Measurement of outcome 
Outcome Measures and end-points  
 
Activities of daily living: Barthel Index (BI) 
 
1  
Depression: Medical Outcomes Study Short Form 36 (MOS-36)  
 
Health status: Centre for Epidemiological Studies Depression Scale (CES-D) 
 
Utility for current health state: Time Trade-off utility (TTO)  
Were all subjects assessed using the same 
procedure? 
No (participants from one database were interviewed face-to-face; others 
were interviewed by phone) 
 
To ensure that responses from the two interview methods were comparable, 
telephone interviews were conducted on a 10% sample of CHS respondents. 
Responses did not differ significantly between telephone and in-person 
interviews. However phone interviews may have omitted individuals with 
language or cognitive dysfunction, leading to possible sampling bias. 
 0 
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
All measures were referenced 
 
Appropriateness/responsiveness: Breadth and ceiling effects taken into 
account 
 
 
1 1 
 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
Not stated (Tests are interviewer-administered therefore blinding is 
important) 
 9 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
Consented 1253; invited 2247 1  
N Lost to follow-up + reasons: 
Similar between groups?  
n/a – cross-sectional n/a n/a 
Missing data (n for each outcome) 
Similar between groups?  
Not reported 0 9 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
n/a – cross-sectional  n/a 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
Gender, race, education, living arrangement, employment status, social 
support & co-morbid diseases 
 
1 1 
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
P-values reported. CI not reported. 
 
 “Asymptomatic group was older and included a relatively higher percentage of 
whites” 
“The TIA group had relatively less social support” 
“TIA group were more likely to have diabetes, ischemic heart disease, 
peripheral vascular disease, chronic obstructive pulmonary disease, renal 
disease, and rheumatoid arthritis” than the asymptomatic group 
 
Regression analysis was used to determine whether patient group (stroke, TIA, 
asymptomatic), other comorbid diseases, and/or Barthel scores were 
predictive of responses to any of the eight different domains of the MOS-36 
and/or the CESD 
1/2 1 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
No evidence of sample size/ power calculation  0 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 1 
What statistical test was used to measure effect? Groups were compared with 2 statistics for categorical variables and ANOVA 
for continuous variables 
1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
No  0  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
Referencce: (Guyomard et al., 2011) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, case-control  
cross-sectional analysis therefore not able to infer causal relationship 
1 0 
Location 
Urban/rural? 
Country? 
UK (East of England) 1  
Sampling frame  
(period of recruitment, follow-up) 
Aug 2008 – Nov 2008 1  
TIA group 
Sample size 68 1  
source of participants   
(e.g. community, hospital, GP practice) 
Neurovascular clinic, Norfolk & Norwich University Hospital 1  
recruitment method 
Consecutive or random? 
invitation letter sent by post from the out-patient department to patients 
attending TIA clinic for suspected TIA (supplementary material) 
1 1 
Inc/exc criteria 
 
First ever TIA; aged ≥ 45; No pre-existing cognitive impairment and/or 
depression; no history of stroke 
1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
 
Focal neurological deficit < 24 hours duration of presumed vascular origin, 
confirmed by highly experienced stroke physician 
No brain-imaging therefore not able to rule out possible stroke 
1 1+ 
Time of recruitment relative to TIA Recruited at clinic (assume within 1 week of symptom onset based on current 
national guidelines) 
0  
Control group 
Sample size 68 non-vascular controls 1  
source of participants   
(e.g. community, hospital, GP practice) 
Dermatology and neurology clinics, Norfolk & Norwich University Hospital 1  
recruitment method 
Convenience, consecutive, random? 
 
identified age  and sex-matched controls from urology and dermatology clinic 
lists, and invited potential controls prior to their clinic appointment 
(supplementary material) 
1 1 
Inc/exc criteria 
 
No vascular risk factors or evidence of vascular disease; No pre-existing 
cognitive impairment and/or depression 
1  
Measurement of outcome 
Outcome Measures and end-points  
 
Cognition: MoCA (Montreal Cognitive Assessment) 
 
1  
Were all subjects assessed using the same 
procedure? 
Yes 
 
 1 
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
MoCA referenced 
 
Appropriateness: Authors acknowledge that MoCA lacks breadth 
 
Reliability: Reproducibility enhanced as MoCA administered to all by same 
assessor and specific instructions provided to standardize assessment. 
 
Responsiveness: Authors cite that MoCA is more specific and sensitive in 
detecting early cognitive decline than other measures such as MMSE  
 1 
 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
Not reported (MoCA is interviewer-administered therefore blinding is 
important) 
 0 
Interpretation of results - completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
146 invited, 136 consented (5 declined in each group) 
Reasons not reported 
1  
N Lost to follow-up + reasons: 
Similar between groups?  
n/a – cross sectional n/a n/a 
Missing data (n for each outcome) 
Similar between groups?  
Not reported 0 9 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
Cross-sectional.  n/a 
Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
Age, gender, hypertension, hypercholesterolaemia, diabetes, atrial fibrillation, 
family history of TIA/stroke, history of MI, smoking status. 
 
1 1 
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
P-values reported. CI not reported. 
 
Control group matched to TIA group by age (+/- 1 year), gender  
 
No pre-existing cognitive impairment and/or depression in both groups 
(inclusion criteria) 
 
Association between cog impairment and vascular risk factors assessed using 
Chi-squared tests. 
1/2 1 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
Yes (only adequate to detect overall group differences. Underpowered for sub-
group analysis) 
 1 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 
 
 
 1 
What statistical test was used to measure effect? Group comparison with student t-test 1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
No  0  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
 
  
Reference: (Hickie et al., 2003) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, cohort     1 
Location 
Urban/rural? 
Country? 
Australia (Dubbo region) 1  
Sampling frame  
(period of recruitment, follow-up) 
Baseline measures 1988-1989; Follow-up in 1998 
 
1  
Study group  
Sample size 19 1  
source of participants   
(e.g. community, hospital, GP practice) 
Community 1  
recruitment method 
Consecutive or random? 
Not stated 
 
0 9 
Inc/exc criteria 
 
Non-institutionalized residents born before 1930 
Those who had a clinical stroke in the intervening decade were excluded. 
1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
Hospital discharge coding against usual criteria 
No brain-imaging therefore not able to rule out possible stroke 
1 1 
Time of recruitment relative to TIA Pre-TIA 1  
Control group 
Sample size 89 ( 44- hypertensive; 45 – normotensive) controls 1  
source of participants   
(e.g. community, hospital, GP practice) 
Community 1  
recruitment method 
Consecutive or random? 
Not stated 
 
0 9 
Inc/exc criteria 
 
Non-institutionalized residents born before 1930 
Hypertensive: using hypertensive medication at baseline 
Normotensive: systolic BP<140mmHg and diastolic BP<90mmHg at baseline 
Those who had a clinical stroke in the intervening decade were excluded. 
1  
Measurement of outcome 
Outcome Measures and end-points  
 
Depression: Centre for Epidemiological Studies Depression Scale (CES-D),  
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-lV) 
codes, Mixed Depression and Anxiety Score (MDAS) 
1  
Were all subjects assessed using the same Yes although DSM-IV only reviewed if participants responded positively when  0 
procedure? asked about symptoms of depression 
NB. Different measures used to assess depression at baseline and FU. 
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
References given for outcome measures 
 
Responsiveness: Identifies on-going debate with DSM-lV threshold – as 
justification of using @ least one of two key features for at least 2 weeks 
 1 
 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
No (may result in unintentional biases when scoring participants/ forming 
diagnoses) 
 0 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
Not reported 0  
N Lost to follow-up + reasons: 
Similar between groups?  
 
TIA=3/19 
Hypertensive=6/44 
Normotensive=5/45 
Reasons not given 
1/2 1 
Missing data (n for each outcome) 
Similar between groups?  
Not reported 0 9 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
n/a  n/a 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
Age, gender, diabetes, prior coronary heart disease, cholesterol, smoking 
status, depression 
 
1 1 
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
Significance recorded as p<0.05 or p<0.01(specific p-values and CI not 
reported) 
 
Reporting of potential confounding factors for depression is limited however 
one could assume equal distribution between groups due to chance (potential 
confounders that are likely to vary between groups due to cardiovascular 
origin are reported) 
 
Diabetes, heart disease and smoking status are significantly different between 
1/2 0 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
groups at baseline. This is not accounted for in the analysis. 
 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
No evidence of sample size/ power calculation  0 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 1 
What statistical test was used to measure effect? Descriptive statistics 
Significance assessed using Chi-squared 
1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
No 0  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
 
Reference: (Howard et al., 2007) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, case-control 
cross-sectional analysis therefore not able to infer causal relationship 
 0 
Location 
Urban/rural? 
Country? 
USA (nationwide) 
Twenty percent of the sample was selected from the “buckle” of the Stroke 
Belt (coastal plain region of NC, SC, and Ga), 30% from the Stroke Belt states 
(remainder of  NC, SC, and Ga plus Ala, Miss, Tenn, Ark, and La), and the 
remaining 50% from the other 48 contiguous United States. 
1  
Sampling frame  
(period of recruitment, follow-up) 
Jan 2003 – Mar 2006 1  
Study group 
Sample size 818 1  
source of participants   
(e.g. community, hospital, GP practice) 
Subset of REGARDS cohort study (commercially available lists of residents) 1  
recruitment method 
Consecutive or random? 
all eligible individuals approached to participate 
 
1 1 
Inc/exc criteria 
 
Not reporting stroke but self reporting TIA (“Were you ever told by a physician 
that you had a mini-stroke or TIA, also known as a transient ischemic attack?”) 
1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
Self-report 1 0 
Time of recruitment relative to TIA Assume variable based on recruitment methods 0  
Control group 
Sample size 16,090 non-stroke/TIA controls 1  
source of participants   
(e.g. community, hospital, GP practice) 
Subset of REGARDS cohort study (commercially available lists of residents) 1  
recruitment method 
Consecutive or random? 
all eligible individuals approached to participate 
 
1 1 
Inc/exc criteria Those not reporting stroke, TIA, or stroke symptoms 1  
Measurement of outcome 
Outcome Measures and end-points  
 
physical function (PCS-12)  
 
Mental function (MCS-12) 
1  
Were all subjects assessed using the same Yes  1 
procedure?  
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
All measures referenced 
 
Validity: “well-validated and widely used indices” 
 
Interpretability: “Relatively small differences in these scores are associated 
with substantial health impacts” 
 
 
 1 
 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
Not reported (Tests are interviewer-administered therefore blinding is 
important) 
 9 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
21959 invited, 21803 consented (participants who refused to answer 
questions relating to stroke history/symptoms, or answered “don’t know” 
were removed from the analysis) 
NB. These figures include stroke patients who formed another study group 
1  
N Lost to follow-up + reasons: 
Similar between groups?  
n/a – cross sectional n/a n/a 
Missing data (n for each outcome) 
Similar between groups?  
Not reported 0 9 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
n/a – cross sectional  n/a 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
Ethnicity, Hypertension, Diabetes, Smoking status, Lipoproteins, Heart disease, 
Atrial fibrillation, Exercise, BMI, Income, Education 
 
1  
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
sensitivity analysis to correct, control or adjust 
P-value stated but CI not reported 
 
Baseline characteristics sufficiently detailed to account for many potential 
confounding factors. Authors indentify 4 classes of potential confounders 
(demographic, cerebrovascular, physical fitness & socioeconomic) 
Adjustments made in set of incremental linear regression models with 
additional analyses at each stage 
 
  
1/2 1 
for confounding factors. 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
No evidence of sample size/ power calculation  1 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 1 
What statistical test was used to measure effect? Type of analysis not disclosed.  0  
Were confidence intervals provided in the main 
and subsidiary analyses?    
Yes, 95% CI reported 1  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
 
Reference: (Iddon et al., 1997) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, cohort however only pre-surgery scores meet review criteria 
therefore cross-sectional analysis (not able to infer causal relationship) 
 0 
Location 
Urban/rural? 
Country? 
UK (Cambridge & Newcastle) 1  
Sampling frame  
(period of recruitment, follow-up) 
Not specified 0  
Study group  
Sample size 30 1  
source of participants   
(e.g. community, hospital, GP practice) 
TIA patients admitted to Addenbrooke’s Hospital for unilateral carotid 
endarterectomy 
1  
recruitment method 
Consecutive or random? 
Not stated 0 9 
Inc/exc criteria 
 
Severe carotid artery stenosis (≥70%) 
no history of stroke, no depression or dementia at baseline 
1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
Not specified 0 9 
Time of recruitment relative to TIA Not reported (48–72 h before CEA) 0  
Control group 
Sample size 30 Healthy volunteers 1  
source of participants   
(e.g. community, hospital, GP practice) 
Not stated 0  
recruitment method 
Consecutive or random? 
Not stated 0 9 
Inc/exc criteria Healthy volunteers with no depression or dementia at baseline 1  
Measurement of outcome 
Outcome Measures and end-points  Cambridge Neuropsychological Test Automated Battery (CANTAB)  1  
Were all subjects assessed using the same 
procedure? 
Yes  1 
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
CANTAB is referenced  
 
Reliability/Validity: Evidence given for validity and test-retest reliability 
 1 
 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
Not reported (although CANTAB is computerised the experimenter controlled 
the computer therefore blinding is important) 
 9 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
Not stated 0  
N Lost to follow-up + reasons: 
Similar between groups?  
n/a – cross-sectional n/a n/a 
Missing data (n for each outcome) 
Similar between groups?  
Numbers reported in table 1 (missing data equal between groups) 1 1 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
n/a – cross-sectional  n/a 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
None reported 0 0 
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
Baseline/demographic characteristics not listed 
 
Controls matched to TIA group by age and IQ 
 
None of the patients included were demented or depressed at baseline as 
measured by MMSE and Beck depression index 
 
CV risk factors not measured (have been associated with increased cognition 
in other studies) 
0 9 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
No evidence of sample size/ power calculation  0 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 1 
What statistical test was used to measure effect? Comparisons between preoperative scores and control scores using 
unmatched t-tests 
1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
No 0  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
 
Reference: (Rao et al., 1999; Rao et al., 2001; Rao, 2002) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, case-control 
cross-sectional analysis therefore not able to infer causal relationship 
 0 
Location 
Urban/rural? 
Country? 
UK (London) 1  
Sampling frame  
(period of recruitment, follow-up) 
Not specified 0  
Study group  
Sample size 25 1  
source of participants   
(e.g. community, hospital, GP practice) 
Community within catchment of inner city teaching hospital, on waiting list for 
carotid endarterectomy 
1  
recruitment method 
Consecutive or random? 
“consecutive patients aged 65 years or older who were on the waiting list for 
carotid endarterectomy” 
1 1 
Inc/exc criteria 
 
History of  ≥ 1 TIA and stenosis >70% on 1 or both internal carotid arteries; on 
waiting list for carotid endarterectomy; no history of stroke or clinical evidence 
of stroke during preoperative screening; no history of PVD, drug or alcohol 
misuse, Parkinson’s disease, head injury, epilepsy, carcinomatosis or 
uncontrolled metabolic, endocrine, or respiratory disorders; >65 yrs 
1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
Not stated 0 9 
Time of recruitment relative to TIA affect of time since first TIA (categorised as more/less than 5 years) on 
outcomes reported in analysis but exact numbers not presented 
0  
Control group 
Sample size 25 vascular & 25 orthopaedic controls  1  
source of participants   
(e.g. community, hospital, GP practice) 
Community within catchment of inner city teaching hospital  
On waiting list for femoropopliteal bypass (vascular) or elective THR/TKR for 
OA (orthopaedic) 
1  
recruitment method 
Consecutive or random? 
Authors specify PVD group recruited consecutively.  
Recruitment method of orthopaedic controls not explicit. 
1 1/2 
Inc/exc criteria 
 
Vascular (PVD): On waiting list for femoropopliteal bypass Orthopaedic: 
elective THR/TKR for OA (6-12 months before interview); no history of PVD 
All: no history of stroke/TIA, drug/alcohol misuse, Parkinson’s, head injury, 
1  
epilepsy, carcinomatosis, uncontrolled metabolic/endocrine/respiratory 
disorders; not considered by GP or interviewer to be too frail, cognitively 
impaired, uncommunicative; >65 yrs 
Measurement of outcome 
Outcome Measures and end-points  
 
1999 & 2002  
CAMCOG: (1) abstract thinking, (2) attention, (3) calculation, (4) language, (5) 
memory, (6) orientation, (7) praxis, (8) perception (recognition), and (9) 
MMSE; Trail-Making Test; BDCS; Controlled Word Association Test.  
 
2001  
Depression: Hamilton rating Scale for Depression (HRSD), Fifteen-item 
Geriatric Depression Scale (GDS-15), Diagnostic and Statistical Manual of 
Mental Disorders, 4th Edition (DSM-IV) codes, wish to die and suicidal ideation 
in past year 
 
Handicap:  London Handicap scale 
Social support: Social support scale  
1  
Were all subjects assessed using the same 
procedure? 
Yes 
 
 1 
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
References given for all outcome measures 
 
Reliability: Reproducibility enhanced as all participants were interviewed by 
the same assessor 
 1 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
No (Tests are interviewer-administered therefore blinding is important) 
 
 0 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
Invited 155; Consented 100 
 
1  
N Lost to follow-up + reasons: 
Similar between groups?  
n/a – cross-sectional n/a n/a 
Missing data (n for each outcome) 
Similar between groups?  
Not reported 
 
0 9 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
n/a – cross-sectional  n/a 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
Age, sex, marital status, education, race, handedness, physical illness scale 
score, BP reported in table. 
Others e.g. diabetes, drug intake not reported in tables but used to test for 
associations in results. 
1 1 
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
Significance recorded as p<0.05 (specific p-values and CI not consistently 
reported) 
 
No significant difference in mean age, gender, educational status, racial origin, 
or handedness found between groups 
 
Exclusion criteria comparable between groups 
 
Variables entered in logistic regression (in descending order of P value) 
including  verbal fluency (F); diastolic blood pressure; verbal fluency (A); Trail-
Making B time; verbal fluency (S); systolic blood pressure; BDCS; age; suicidal 
thinking; depression (per Diagnostic and Statistical Manual of Mental 
Disorders); diabetes; cardiovascular disease, hyperlipidemia. 
1/2 1 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
Powered to .8 for GDS and HRS (Rao, 2001)  1 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 1 
What statistical test was used to measure effect? ANOVA 1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
Yes 1  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
Reference: (Walters et al., 2003) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, cohort  1 
Location 
Urban/rural? 
Country? 
UK (London) 1  
Sampling frame  
(period of recruitment, follow-up) 
Year of recruitment not specified. TIA group recruited within 15 days of event 
& followed up at 6 and 12 months 
½  
Study group 
  
Sample size 60 1  
source of participants   
(e.g. community, hospital, GP practice) 
Neurovascular clinic 1  
recruitment method 
Consecutive or random? 
Not stated 
 
0 9 
Inc/exc criteria 
 
First, isolated TIA; MMSE ≥ 28/30); no evidence of general/focal atrophy on 
MR imaging; no clinical/ radiological evidence of established stroke; Alcohol 
consumption ≤ 3 units daily; no severe hypertension, significant ischaemic 
heart disease, peripheral vascular disease, or carotid stenosis 
1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
Consultant neurologist with special interest in cerebrovascular disease; 
reinforced by neuro-imaging 
1 1++ 
Time of recruitment relative to TIA Within preceding 15 days 1  
Control group 
Sample size 26 non-vascular controls 1  
source of participants   
(e.g. community, hospital, GP practice) 
Not stated 0  
recruitment method 
Consecutive or random? 
Not stated 
 
0 9 
Inc/exc criteria 
 
No history of stroke or TIA; no evidence of general/focal atrophy on MR 
imaging; no clinical/ radiological evidence of established stroke; Alcohol 
consumption ≤ 3 units daily; no severe hypertension, significant ischaemic 
heart disease, peripheral vascular disease, or carotid stenosis.  
1  
Measurement of outcome 
Outcome Measures and end-points  Dementia: Mini-Mental State Examination (MMSE) 1  
  
(new lesion occurrence & atrophy rates also recorded through MRI) 
Were all subjects assessed using the same 
procedure? 
Yes  1 
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
Reference given for MMSE 
 
Responsiveness: MMSE has a known ceiling effect in this population 
 
 0 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
Not clear (MMSE is interviewer-administered therefore blinding is important)  9 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
Not reported 
 
0  
N Lost to follow-up + reasons: 
Similar between groups?  
Not reported 
 
0 9 
Missing data (n for each outcome) 
Similar between groups?  
Not reported 
 
0 9 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
Not reported 
 
 9 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
Age, gender, BP 
 
1 1 
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
Significance recorded as p<0.001 (specific p-values and CI not consistently 
reported) 
 
Controls matched to TIA group by age & gender 
 
Exclusion criteria comparable between groups 
 
Patients had non-significantly higher systolic and diastolic blood pressure than 
controls however regression techniques were used to demonstrate any 
1 1 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
relation between atrophy and blood pressure in the patient group  
 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
No evidence of sample size/ power calculation  0 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 1 
What statistical test was used to measure effect? Descriptive stats for MMSE 
t-tests for imaging outcomes 
1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
CI only reported for imaging outcomes 0 (1 for 
imaging 
outcomes) 
 
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
 
Reference: (Xin-rong et al., 2005) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, case-control 
cross-sectional analysis therefore not able to infer causal relationship 
 0 
Location 
Urban/rural? 
Country? 
China 
 
1  
Sampling frame  
(period of recruitment, follow-up) 
Jan 2002-June 2003 1  
Study group  
Sample size 35 1  
source of participants   
(e.g. community, hospital, GP practice) 
Geriatric department, Urumqi General Hospital (inpatients and outpatients) 1  
recruitment method 
Consecutive or random? 
Not stated 
 
0 9 
Inc/exc criteria 
 
Right-handed male TIA patients with no other inter-cranial disease visible on 
CT; normal visual and auditory functions; independent; no mental disorder, 
severe heart, lung, liver or kidney disease 
1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
 
Diagnosis conformed to classification & diagnostic criteria for Chinese National 
conference of cerebral vessels diseases; head CT excluded other intracranial 
diseases 
1 1++ 
Time of recruitment relative to TIA within 72 hours of symptom onset 1  
Control group 
Sample size 33 healthy controls 1  
source of participants   
(e.g. community, hospital, GP practice) 
Patients visiting hospital for physical examination 1  
recruitment method 
Consecutive or random? 
Not stated 
 
0 9 
Inc/exc criteria Healthy right-handed male volunteers; no history of mental disorder 1  
Measurement of outcome 
Outcome Measures and end-points  Scale of elderly cognitive function (SECF) 1  
Were all subjects assessed using the same 
procedure? 
Yes 
 
 1 
Have appropriateness, reliability, Not clear. No justification for outcome measure choice or references given   9 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
Doesn’t appear so as patients and controls examined in different locations 
(SECF is interviewer-administered therefore blinding is important) 
0 0 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
Not reported 0  
N Lost to follow-up + reasons: 
Similar between groups?  
n/a – cross sectional n/a n/a 
Missing data (n for each outcome) 
Similar between groups?  
None 1 1 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
n/a – cross sectional  n/a 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
gender, handedness (selection criteria) 
age (mean, range and SD), education (cases) given for both groups 
 
 0 
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
P values & CI not reported at baseline but control group matched to TIA group 
by age, gender, education & handedness 
 
Inclusion criteria state no history of mental disorder (both groups) 
 
Inclusion criteria less strict for control group (normal visual and auditory 
functions, independence, and no severe heart, lung, liver or kidney disease 
only specified for TIA group) 
 
BP not reported but possible confounder (has been identified as a risk factor 
for cognitive decline in other studies) 
0 9 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
No evidence of sample size/ power calculation  0 
Was a sample size calculation or power 
calculation performed?     
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
No. Not all SECF item results reported.  0 
What statistical test was used to measure effect? T-test 1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
No 0  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
 
Reference: (Zinn et al., 2007) 
 Quality of 
reporting* 
 
Quality of 
design, 
conduct & 
analysis† 
Design Prospective, case-control 
cross-sectional analysis therefore not able to infer causal relationship 
 0 
Location 
Urban/rural? 
Country? 
USA (South East) 1  
Sampling frame  
(period of recruitment, follow-up) 
Recruitment over 2..5 year period (exact years not specified) 1/2  
Study group 
Sample size 9 1  
source of participants   
(e.g. community, hospital, GP practice) 
Inpatient wards at veterans affairs medical centre 1  
recruitment method 
Consecutive or random? 
“Consecutive” 
 
1 1 
Inc/exc criteria 
 
ruled out for acute stroke; no prior stroke  
Stroke risk factors “included hypertension, diabetes, hyperlipidemia, 
cardiovascular disease, peripheral vascular diseases, migraine, smoking, 
cocaine or alcohol dependence, and sleep apnea.” 
1  
Case diagnoses How/who assessed this?  
(standard criteria, definition, clinical judgement) 
 
Clinical examination, chart review and CT scan by neurologist (where possible 
diffusion weighted MRI also performed) 
“Stroke was confirmed by diffusion-weighted MRI, or in several cases where 
MRI was precluded or inconclusive, from clinical examination, chart review 
and computed tomography scan by a neurologist. Recruitment of the TIA 
sample was similar” 
1 1++ 
Time of recruitment relative to TIA within 10 days of event 1  
Control group 
Sample size 10 “at risk of stroke” controls 1  
source of participants   
(e.g. community, hospital, GP practice) 
Inpatient wards at veterans affairs medical centre 1  
recruitment method 
Consecutive or random? 
“convenience” 
 
1 9 
Inc/exc criteria 
 
Patients ruled out for stroke and TIA, who had several stroke risk factors 
(supplemented with additional inpatients, recruited from inpatient general 
1  
medical wards, with a minimum of 3 stroke risk factors.) 
Measurement of outcome 
Outcome Measures and end-points  
 
Battery of neuropsychological tests:  
• Digit span and picture arrangement subtests from the Wechsler Adult 
Intelligence Scale, Third Edition 
• Symbol Digit Modalities Test (SDMT, oral version) 
• The design fluency and trail making subtests from the Delis-Kaplan 
Executive Function System (DKEFS) 
• The Hopkins Verbal Learning Test-Revised  (HVLT) 
1  
Were all subjects assessed using the same 
procedure? 
yes 
 
 1 
Have appropriateness, reliability, 
validity, responsiveness, precision, 
interpretability, 
acceptability and feasibility been considered in 
relation to the outcome measures?(consider 
citations, measurement to exposure in different 
ways, inter/intra-rater reliability checks, 
measures of internal consistency e.g. cronbach’s 
alpha) 
References given for tests 
 
Appropriateness: “Selection of particular tests was guided in part by clinical 
experience with vascular disease patients”. “Battery was deliberately 
multidimensional in order to measure the various components of executive 
functioning through multiple tasks, making it possible to obtain at least partial 
measurement of executive functioning on every patient irrespective of focal 
symptoms”  
 
Reliability/ Validity: “tests all have well-established validity and reliability.” 
Administrators trained in standard administration of the instruments, 
enhancing inter-rater reliability. 
 
Cut-off scores used for analysis (N.B. problems of being borderline) 
 1 
 
Were interviewers and data collectors blind to 
the case/control status of study subjects and to 
the hypothesis being tested? Does this matter?    
No (tests are interviewer-administered therefore blinding is important)  0 
Interpretation of results – completeness 
What percentage of eligible individuals agreed to 
participate? (consented/invited) 
325 screened, 83 enrolled + 6 (additional controls), 66 completed test battery 
(9 didn’t meet inclusion criteria, 2 became too ill and 8 refused testing or were 
discharged prior to testing) 
 
NB. These figures include stroke patients who formed another study group 
 
One TIA patient had several severely impaired test scores that were outliers, 
suggestive of a “silent” stroke, and was subsequently excluded from the 
analyses. 
1  
N Lost to follow-up + reasons: n/a - cross-sectional n/a n/a 
Similar between groups?  
Missing data (n for each outcome) 
Similar between groups?  
 
Missing data was as follows: 
Digit span, 0 missing; HVLT, 1 missing (stroke); design fluency, 11 missing (10 
stroke, 1 TIA); picture arrangement, 15 missing (13 stroke, 1 TIA, 1 risk)); 
SDMT, 21 missing (18 stroke, 2 TIA, 1 risk); and trail making, 25 missing (20 
stroke, 4 TIA, 1 risk). 
 
“Completion of testing was sometimes precluded by clinical treatment 
procedures, patient fatigue, or hospital discharge. Sequelae of stroke, such as 
paresis, aphasia or visual dysfunction, also precluded administration of certain 
instruments to particular patients.” 
“We assessed whether there was a difference in executive function test 
performance between those who completed the battery and those who did 
not complete it, using a t test on the composite impairment ratio (CIR). We 
also examined whether stroke severity affected battery completion by 
examining the relationship of severity and number of tests completed.” 
” tests administered toward the end of the battery were less likely to be 
completed. There was no relationship between stroke severity and number of 
tests completed, nor was there any difference in the CIR between those who 
completed the battery and those who did not, for whatever reason”. 
1 1 
If loss-to-follow-up exceeded 20% was this 
accounted for in the analysis?  
n/a n/a n/a 
 Interpretation of results – confounding bias 
Demographic and other baseline characteristics 
given (list) 
All necessary baseline characteristics reported?  
Age,  Years of education, IQ, ethnicity, No. of stroke risk factors, ability to 
follow commands, ADLs prior to stroke, IADLs prior to stroke  
1 1 
Were p values and confidence intervals reported 
at baseline? 
Were groups comparable on all important 
confounding factors including demographic 
characteristics, co-morbid conditions etc? NB. 
Take into account matching of control group 
OR have authors taken account of the 
confounding factors in the analysis?  
E.g. Modeling, stratified-, regression-, or 
sensitivity analysis to correct, control or adjust 
for confounding factors. 
Neither p-values nor CI reported at baseline 
 
Authors state that, “The groups did not differ significantly on any of the listed 
characteristics”  
 
 
 
0 1 
Interpretation of Results – Other 
Was the study designed to have sufficient power 
to detect the effect(s) of interest?  
Was a sample size calculation or power 
calculation performed?     
Target was 100 stroke patients – never achieved. 
“Original target enrolment was 100 stroke patients, funding and administrative 
considerations prevented the extension of our enrollment period when 
recruitment rates fell below our predictions.” 
 0 
Did the report avoid selective reporting of results 
or inappropriate use of methods to achieve a 
stated or implicit objective?  
E.g. were the major results directly related to the 
a priori hypothesis under investigation? Are both 
significant and non-significant results reported in 
a balanced fashion? If, protocol available, do 
intended and reported analyses match up?   
Yes. Major results directly related to the a priori hypothesis under 
investigation. Both significant and non-significant results reported in a 
balanced fashion. 
 
 1 
What statistical test was used to measure effect?  “We calculated the composite impairment ratio as the percentage of tests 
failed divided by the number of tests completed”. ANOVA was used to 
compare CIR across groups. 
Cut-off scores used for analysis (N.B. problems of being “borderline”) 
1  
Were confidence intervals provided in the main 
and subsidiary analyses?    
No 0  
* 1=reported, 0=not reported, 9=n/a 
† 1=Y, 2=N, 9=”unclear” 
 
 
 
 
  
Appendix 3: Participant Information Sheet
  
 
A Study of Functional, cognitive and emotional outcomes after “mini stroke” 
 
PARTICIPANT INFORMATION SHEET 
Invitation 
You are being invited to take part in a research study. Before you decide, it is important for you 
to understand why the research is being done and what is involved. Please take time to read 
the information below carefully, and discuss it with friends, relatives, and your GP if you want to. 
If there is anything that is not clear, or if you would like more information, please ask us.  
 
What is the purpose of the study?  
A transient ischemic attack (TIA), also known as “mini stroke,” produces stroke-like symptoms that 
usually resolve within 24 hours. Symptoms can include: numbness or weakness in the face, arm or 
leg, especially on one side of the body; confusion or difficulty in talking or understanding speech; 
trouble seeing; difficulty walking, dizziness, or loss of balance and coordination. It is assumed that 
quality of life improves and functional problems (e.g. difficulty in carrying out normal 
domestic/leisure activities) resolve as these medical symptoms subside. However some research 
has reported that this is not the case. 
The aim of this study is to investigate whether or not patients have a reduced quality of life and/or 
residual functional problems that adversely influence day to day living, after being diagnosed with 
TIA. The study will also examine the costs associated with TIA, including personal economic losses 
e.g. time off work due to illness, and health and social care service provision.  
 
Why have I been invited?  
You have been chosen either because: 
a) You were referred to a TIA clinic with a suspected TIA.  
OR  b) Your medical records show that you have never suffered a stroke or TIA and you are 
a suitable match (in terms of age, gender and place of residence) for someone who has 
recently suffered a TIA. A group of individuals that closely resemble the group of interest 
(those with suspected TIA) have an essential role in the study: They serve as a 
comparison group when the results are evaluated. 
Attach Trust Logo 
In total we aim to recruit 600 individuals to take part in this study. 
 
Do I have to take part?  
No, it is up to you. Take time to read this information sheet and decide whether or not you would like 
to participate. You may wish to discuss your views with friends or family members. If you have any 
questions feel free to contact a member of the study team (details below). 
If you decide you would like to take part please complete the consent form and return it to the 
University of Birmingham in the pre-paid envelope. You would be free to withdraw at any time and 
without reason if you later decide that you no longer wish to participate. Your decision would not 
affect your normal medical care or future access to healthcare in any way.   
 
What would happen to me if I take part?  
If you chose to take part we would ask you to complete 4 questionnaires (listed below) and return 
them to us in a pre-paid, stamped, addressed envelope. In total you would be asked to complete the 
questionnaires 4 times: straight away and then 3 months, 6 months and 12 months after agreeing to 
take part. Each set of questionnaires should take no longer than 30 minutes to complete. We might 
contact you by telephone to answer questions that have been left blank.  
The set of questionnaires would include: 
i. Nottingham Extended ADL Scale: A measure of independence in performing domestic and 
leisure activities. 
ii. Hospital Anxiety and Depression Scale: A measure of emotion. 
iii. Client service receipt inventory: A questionnaire yielding information on use of health and 
social care services, economic impacts (such as time off work due to illness) and socio-
demographic aspects (such as living arrangements).  
iv. Cardiovascular risk factors (questions on exercise, smoking and alcohol intake)  
 
In addition to completing these questionnaires we would ask you to take part in cognitive screening. 
This would include a series of simple tasks to measure your communication, memory, perception 
and attention skills.  The cognitive screen would be administered by a member of the research team 
that has been trained to conduct the assessment. We would ask you to complete 2, 1 hour sessions 
at your home, GP practice, hospital or the University of Birmingham, at times convenient to you 
(within the 1st month after consenting to participate and approximately 12 months later). You would 
be reimbursed for any travel expenses incurred. 
 
 
What are the possible benefits of taking part?  
Through dissemination of study findings, participants diagnosed with symptoms suggestive of TIA 
would find out more about the holistic implications of their condition that could have previously been 
overlooked. Findings could also change future practice and healthcare provision. 
 
Expenses and payments  
All of the questionnaires would be sent out with a pre-paid, stamped, addressed return envelope. 
For the cognitive screening, we would reimburse you for any travel expenses incurred. For travel by 
car, mileage would be reimbursed at a rate of 40 pence per mile. 
 
What are risks of taking part?  
This study does not involve any testing of drugs, devices or procedures therefore there are no real 
risks or side-effects of taking part. Some of the questionnaires enquire about potentially sensitive 
issues. You would have the option to refrain from answering these questions. You might wish to 
contact a member of the research team if you find any of the questions particularly difficult or 
distressing to answer. Each case would be reviewed and managed on an individual basis.  
 
What if something goes wrong?  
If you wish to complain, or have any concerns about any aspect of the way you might have been 
approached or treated during the course of this study, the normal National Health Service and 
University complaints mechanisms would be available to you. 
 
Foreseeable circumstances under which the subject’s participation might be terminated  
The maximum length of participation in the study would be 12 months. As the study is looking at a 
specific group of people, you would no longer be required participate if you experience a stroke or 
TIA during the follow-up period. The questionnaires you might have completed would remain in the 
analysis providing that you were still happy for us to use them. 
 
What happens when the research study stops?  
After having completed the last set of questionnaires your participation in the study would end. If 
you are interested in the study findings we would be happy to send you a report.   
 
Would my taking part in this study be kept confidential?  
Yes, all information that is collected about you during the study would be kept strictly 
confidential.  
Your contact details (needed for mail-outs and follow-up telephone calls) would be stored in a 
locked filing cabinet in a secure, restricted access building in the department of Primary care 
Clinical Sciences at the University of Birmingham. Information stored electrically would be saved 
as password protected documents on network restricted computers.  
Other personal information such as past medical history and results of TIA clinic assessments (if 
applicable), would have your name and address removed so that you cannot be identified from 
it – we use a unique code instead. The questionnaires and results of cognitive screening would 
also be anonymised.  
No identifying information would appear in our published results. 
With your permission your GP will be notified of your participation in the study. 
 
Who might have access to my personal information?  
Named members of the study team would have access to the information that is collected about you 
during the study.  
To monitor the quality and conduct of research, studies might be chosen at random for audit. There 
is a chance that this study would be subject to review, in which case members of the Independent 
Review Board / Research Ethics Committee (REC) / regulatory authorities would be granted direct 
access to your personal information for verification of clinical trial procedures and/or data collection. 
These authorities would treat any information about you as strictly confidential. 
 
What would happen to the results of the research study? 
The results of this study are likely to be presented to other health professionals and 
researchers. The results may also be published in medical or scientific journals and used as 
part of PhD theses. You would not be identified in any of the presentations or publications. If 
you would like copies of the publications please let a member of the study team know. Contact 
details are provided below. 
 
Who is organising and funding the research? 
The research has been funded by the West Midlands Strategic Health Authority. It has been 
designed and will be implemented by the University of Birmingham.  
 
Who has reviewed the study? 
The study has been reviewed and ethical approval has been granted by the Local Research Ethics 
Committee (LREC). Research ethics committees safeguard the rights, safety, dignity and well-being 
of research participants, independently of research sponsors. 
 
Contact details for further information  
If you have any questions or queries relating to the study please contact the study coordinator: 
 
Ms Jenny O’Donnell & Ms Grace Turner 
Primary Care Clinical Sciences Department 
School of Health and Population Sciences 
University of Birmingham 
Edgbaston campus, 
Birmingham 
B15 2TT 
Tel. 0121 414 5465/ 0121 414 5463 
Office hours: Monday to Friday 8.30am-4.30pm (or leave a message on the answer phone) 
 
For general independent advice about taking part in research please contact PALS (The Patient 
Advice and Liaison Service) on____________________________. 
 
 
Thank you for reading this 
 
 
  
Appendix 4: Consent form
 Patient Identification Number for this Trial:                                 
 
CONSENT FORM 
 
A study of functional, cognitive and emotional outcomes after “mini stroke” 
Chief Investigator: Professor Catherine Sackley (University of Birmingham) 
Principal Investigator:  
 
Initial box 
  
1. I confirm I have read and understand the information sheet dated 21/06/2010 
(version 3) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily.  
  
2. I understand my participation is voluntary and I am free to withdraw at any time 
without giving a reason, without my medical care or legal rights being affected.  
  
3. I understand that relevant sections of my medical notes and data collected 
during the study may be looked at by individuals conducting the trial at the 
University of Birmingham, by regulatory authorities or by the NHS Trust, where it 
is relevant to my taking part in this research. I give permission for these 
individuals to have access to my records. 
  
4. I agree to my GP being informed of my participation in the study (optional).    
5. I agree to take part in the above study (postal questionnaires and cognitive 
screen).  
OR I agree to take part in the above study (Postal questionnaires only). 
  
 
__________________________  _ _/_ _ _/_ _ _ _ ____________________ 
Name of Participant    Date    Signature  
 
__________________________  _ _/_ _ _/_ _ _ _ _____________________ 
Name of Person taking consent   Date    Signature  
 
                                                             Trust Logo 
Appendix 5: GP Letter
GP Address        UoB Letter headed 
paper 
Date: 
 
Dear Dr ____________ 
 
RE: Functional, cognitive and emotional outcomes after Transient 
Ischemic Attack: A prospective, controlled cohort study to inform future 
rehabilitative interventions  
 
Patient Name: _____________________ DOB: _ _/_ _ _/_ _ 
 
The above patient has recently consented to enter a prospective cohort study analysing 
whether TIA patients have residual functional impairment and/or psychosocial issues 
compared to; 
a) Patients referred to TIA clinics and given a differential diagnosis, and  
b) Healthy age/gender/postcode matched controls.  
In total the study aims to recruit 600 individuals from NHS trusts throughout the West 
Midlands. 
Patients will be asked to complete a series of postal questionnaires at 0, 3, 6 and 12 months, 
yielding data on activities of daily living, handicap, quality of life, service use and vascular 
events. A subset of the study population will also undergo cognitive screening.  
This is purely an observational study. Although some of the questionnaires enquire about 
potentially sensitive issues, the study will not involve testing of drugs or any prophylactic, 
diagnostic or therapeutic procedures; therefore it does not pose any real risk to the 
participant. 
Please find enclosed a patient information sheet for your enlightenment. If you have any 
queries about the trial please contact Nicola Brittle (details below). 
 
Yours sincerely,  
 
Ms Nicola Brittle 
Primary Care Clinical Sciences Department 
School of Health and Population Sciences 
University of Birmingham 
Edgbaston campus, 
Birmingham 
B15 2TT 
Email: n.brittle@bham.ac.uk 
Tel: 0121 414 5483 
 
  
Appendix 6: Clinic data collection form
Patient Identification Number for this Trial:                                 
 
CLINIC DATA COLLECTION FORM 
 
               
Patient Telephone: _________________ 
GP Address: ______________________________________________________________________ 
 
1. Date of incident: _ 
d 
_ 
d 
/ _ 
m 
_ 
m 
/ _ 
y 
_ 
y 
_ 
y 
_ 
y 
 
          Time (if known): _ 
h 
_ 
h 
: _ 
m 
 
_ 
m 
 
 
2. Date of referral to TIA 
clinic: 
_ 
d 
_ 
d 
/ _ 
m 
_ 
m 
/ _ 
y 
_ 
y 
_ 
y 
_ 
y 
 
 Time (if known): _ 
h 
_ 
h 
: _ 
m 
 
_ 
m 
 
 
3. Date seen in TIA 
clinic: 
_ 
d 
_ 
d 
/ _ 
m 
_ 
m 
/ _ 
y 
_ 
y 
_ 
y 
_ 
y 
 
 Time (if known): _ 
h 
_ 
h 
: _ 
m 
 
_ 
m 
 
       
4. Referral source:  A&E   GP   Other, please specify 
  
5. Duration of symptoms: ………......hours 
 
6. Symptomatic side:  Left    Right    Both 
 
7. Handedness:  Left    Right  
 
8. Have imaging or other investigations been performed or requested?  
 Date performed or scheduled 
for (_ _ / _ _ / 20_ _) 
Result (if known) 
Imaging 
 CT   
 MRI   
 Carotid scan   
 Other, please specify   
 No imaging   
Investigations 
 BP  ............./………..mmHg 
 Cholesterol  …………………..mg/dL 
 BMI  ….……………..kg/m2 
 ABCD2 score  …………………...points 
 Other, please specify  …………………… 
 No investigations   
Affix hospital sticker here  
(Patient name, address, postcode, DOB, GP name) 
 
9. Final clinic diagnosis:  
 
 Stroke 
 Definite TIA 
 Possible TIA, treated as TIA  OR non-TIA  
 TIA mimic, please specify ………………………………………………….. 
 
10. Medical Management:    
On at time  
of incident 
Started by 
referrer 
Started   
in clinic 
Intolerant 
of drug 
     
Aspirin 75-150mg          
Dipyridamole 200mg MR (2 years)        
Clopidogrel 75mg           
Warfarin (if in AF)          
ACE inhibitor (inc ARBs)         
Thiazide diuretic          
Statin / lipid lowering agent         
Other antihypertensive          
 
 
11. Has/will the patient been referred? 
 
 Cardiology 
 Neurology  
 Neurosurgery  
 Vascular surgery 
 Falls / Syncope clinic 
 Other, please specify ……………………………………………………………… 
 
 
12. Has the patient ever suffered a TIA or stroke prior to this incident? 
 
 Yes, Stroke 
 Yes, TIA  
 No 
 
 
 
Thank you 
 
 
  
 
Appendix 7: Demographic questionnaire
Patient Identification Number for this Trial:                                 
 
A Study of Functional, cognitive and emotional outcomes after “mini stroke” 
Primary Care Clinical Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT   
(Telephone: 0121 414 5483) 
 
DEMOGRAPHIC QUESTIONNAIRE 
CONFIDENTIAL 
 
Please answer the following questions about your social background and medical history. 
This information will help us interpret the results of the study. All the information you provide 
will remain anonymous and strictly confidential. Thank you for your co-operation. 
 
1. What is your 
date of birth? 
 
_ 
d 
_ 
d 
/ _ 
m 
_ 
m 
/ _ 
y 
_ 
y 
_ 
y 
_ 
y 
 
 
2. What is your Gender? (Please 
   
  male    female 
 
3. What is your Ethnicity? (Please tick one box) 
  White    Black    Asian 
  Mixed    Other, please specify……………………….. 
 
4. What is the highest qualification you have attained? (Please tick one box) 
 GCSE, CSE, ‘O’ level or equivalent   School Certificate   A’ level or equivalent 
 Higher school certificate   Degree   Postgraduate qualification e.g. Masters degree, PhD, 
PGCE 
 No formal qualification   Other qualification/ level unknown 
 
5.  Who do you live with? (Please tick all that apply) 
  Spouse/partner    Dependants (e.g. children under 18 yrs, elderly relatives) 
  I live alone    Other, please specify………………………………………. 
 
6.  What is your primary place of residence? (Please tick one box) 
 
 Domestic housing (e.g. house, flat)    Sheltered housing     Residential home 
  Nursing home    Other, please specify………………………………………. 
  
 
Please turn over
7. Have you ever been diagnosed with any of the following medical conditions? 
(Please tick all that apply) 
 
 Arthritis (rheumatoid and osteoarthritis) 
 Osteoporosis 
 Asthma 
 Chronic obstructive pulmonary disease (COPD), acquired respiratory distress 
syndrome (ARDS) or emphysema 
 Angina 
 Congestive heart failure (or heart disease) 
 Heart attack (myocardial infarct) 
 Neurological disease (such as multiple sclerosis or Parkinson's) 
 Stroke or TIA 
 Peripheral vascular disease 
 Diabetes types I and II 
 Upper gastrointestinal disease (ulcer, hernia, reflux) 
 Depression 
 Anxiety or panic disorders 
 Visual impairment (such as cataracts, glaucoma, macular degeneration) 
 Hearing impairment (very hard of hearing, even with hearing aids) 
 Degenerative disc disease (back disease, spinal stenosis or severe chronic back pain) 
 Obesity  
 
8. Please enter your height and weight below: 
 
Height: _____feet _____ inches  OR _____ metres _____ cm 
Weight: _____kg    OR _____lbs      
 
 
Thank you for your time. 
 
  
Appendix 8: BUCS cut-off scores (based on 5th percentile and smoothed across age groups)
     Cut off points  
  (impairment=less than given scores, unless specified) 
  ≤64  65 - 74 ≥75  
    (N=34) (N=33) (N=33) 
LANGUAGE   
 
  
speech Instruction comprehension 3 3 3 
 Picture naming 11 11 10 
 Sentence construction 8 8 6 
reading Nonwords – accuracy 5 4 4 
 Nonwords – time* >14 sec >14 sec >23 sec 
 Sentence – accuracy 42 42 41 
 Sentence – time* >23 sec >23 sec >23 sec 
writing Words + nonword 3 3 3 
          
NUMBER      
reading Total 8 8 8 
writing Total 5 5 3 
calculation Total 2 2 2 
          
PRAXIS      
visuo-
constructive 
Figure copy 42 41 37 
limb Multi-step 11 10 10 
 Gesture production 10 9 9 
 Gesture recognition 5 5 4 
 Imitation 9 9 9 
          
LTM      
orientation Personal 8 8 8 
 Time and space (MC) 6 6 6 
episodic Story - free recall 1 6 6 3 
 Story – recognition 1 13 13 11 
 Story – free recall 2 8 6 4 
 Story – recognition 2 13 13 12 
 Story – decay >1 >1 >1 
 Task – recognition 9 9 8 
          
ATTENTION      
spatial Apple cancellation -total 42 42 42 
 Apple asymmetry - full < -2 or >2  <-2 or >3 <-2 or >3 
 Apple asymmetry - 
incomplete 
<-1 or >1 <-1 or >1 <-1 or >1 
 Left visual neglect 4 4 4 
 Right visual neglect 4 4 4 
 Left visual bilateral 8 7 7 
 Right visual bilateral 8 8 8 
 Left tactile neglect 4 4 4 
 Right tactile neglect 4 4 4 
 Left tactile bilateral 7 7 7 
 Right tactile bilateral 8 8 7 
 Auditory – WM1- practice >1 >1 >1 
 Auditory – WM2 – recall 3 3 2 
 Auditory – accuracy 51 50 46 
control Auditory – sustained attention >1 >1 >2 
 B’ham – accuracy & rule accuracy <6 accuracy <5 accuracy<4 
  or rule <1 or rule <1 or rule <1 
          
* 2SD are used 
    
      
Appendix 9: Invitation to Participate
 
 
 
 
Trust Letter Headed paper 
 
 
 
 
 
 
Date: _ _ / _ _ / _ _ _ _ 
 
 
PRIVATE & CONFIDENTIAL 
 
 
Dear _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
Invitation to Participate in a Research Study 
 
You are being invited to take part in a research study investigating whether or not people have 
a reduced quality of life and/or residual functional problems that adversely influence day to day 
living, after being diagnosed with a TIA (mini-stroke). Being invited to take part does not mean 
that you have anything wrong with you. You may have been chosen to form part of a 
comparison group because you have never suffered a TIA. If you do decide to take part you 
would be asked to complete a series of questionnaires and return them by post in a pre-paid 
envelope. You would also be invited to take part in a face-to-face assessment with a member 
of the research team. The assessment would include a series of simple tasks to measure your 
communication, memory, perception and attention skills. If you have difficulty understanding 
English, you would be entitled to ask a friend or relative to help you.  
We have enclosed a lot of information about the study. If you need help to understand this 
information, or if you have any further questions, please get in touch with the study team who 
will do their best to assist you. You may wish to ask a friend or relative to help with translation 
if English is not your first language. Contact details for the study team are given on the 
participant information sheet. 
 
After reading the study information sheet, if you decide that you are happy to take part in this 
study, please complete the enclosed consent form and baseline questionnaire, and return 
them to Nicola Brittle at the University of Birmingham in the enclosed FREEPOST envelope. 
 
Thank you in anticipation. 
 
Yours sincerely 
 
Nicola Brittle 
Study coordinator 
 
FACE TIA. Invitation to Participate. Version 1.  07/12/2009. 
  
Appendix 10: Graphical representation of demographic and outcome data 
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Appendix 11: Cohort Analyses 
 
Nottingham Extended Activities of Daily Living 
Between Groups Analysis 
 
 
 
 
 
Variables Entered/Removed b
gender,
stroke, age
at consent,
mimic,
control,
Poss_TIA
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables entered.a. 
Dependent Variable: NEADL_totalb. 
Model Summary
.274a .075 .053 9.045
Model
1
R R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), gender, s troke, age at consent,
mimic, control, Poss_TIA
a. 
ANOVAb
1642.797 6 273.799 3.347 .003a
20290.285 248 81.816
21933.082 254
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), gender, s troke, age at consent, mimic , control, Poss_TIAa. 
Dependent  Variable: NEADL_totalb. 
Coefficientsa
61.033 4.008 15.228 .000 53.139 68.927
-.018 1.432 -.001 -.013 .990 -2.839 2.803
1.442 1.697 .057 .850 .396 -1.901 4.785
-5.045 2.327 -.139 -2.168 .031 -9.628 -.463
2.139 1.927 .074 1.110 .268 -1.656 5.933
-.166 .050 -.203 -3.286 .001 -.265 -.066
1.882 1.175 .101 1.602 .110 -.432 4.196
(Constant)
Poss_TIA
mimic
stroke
control
age at  consent
gender
Model
1
B Std. Error
Unstandardized
Coeffic ients
Beta
Standardized
Coeffic ients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent  Variable: NEADL_totala. 
Hospital Anxiety and Depression Scale: Total score 
Between Groups Analysis 
 
 
 
 
 
  
Variables Entered/Removed b
gender,
age at
consent,
stroke,
mimic,
control,
Poss_TIA
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables entered.a. 
Dependent Variable: HADS_totalb. 
Model Summary
.285a .081 .059 6.343
Model
1
R R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), gender, age at consent, stroke,
mimic, control, Poss_TIA
a. 
ANOVAb
882.167 6 147.028 3.654 .002a
9977.974 248 40.234
10860.141 254
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), gender, age at consent, s troke, mimic , control, Poss_TIAa. 
Dependent  Variable: HADS_totalb. 
Coefficientsa
7.638 2.811 2.717 .007 2.102 13.174
.624 1.003 .043 .622 .534 -1.351 2.600
-.595 1.188 -.034 -.501 .617 -2.936 1.745
2.080 1.672 .079 1.244 .215 -1.213 5.372
-2.895 1.349 -.143 -2.147 .033 -5.551 -.239
-.025 .035 -.043 -.699 .485 -.094 .045
2.318 .824 .176 2.812 .005 .695 3.941
(Constant)
Poss_TIA
mimic
stroke
control
age at  consent
gender
Model
1
B Std. Error
Unstandardized
Coeffic ients
Beta
Standardized
Coeffic ients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent  Variable: HADS_totala. 
Hospital Anxiety and Depression Scale: Anxiety sub-score 
Between Groups Analysis 
 
 
 
 
Variables Entered/Removed b
gender,
age at
consent,
stroke,
mimic,
control,
Poss_TIA
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables entered.a. 
Dependent Variable: HADS_Ab. 
Model Summary
.376a .141 .120 3.941
Model
1
R R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), gender, age at consent, stroke,
mimic, control, Poss_TIA
a. 
ANOVAb
632.735 6 105.456 6.791 .000a
3850.850 248 15.528
4483.584 254
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), gender, age at consent, s troke, mimic , control, Poss_TIAa. 
Dependent  Variable: HADS_Ab. 
Coefficientsa
6.515 1.746 3.731 .000 3.076 9.955
.699 .623 .075 1.122 .263 -.528 1.927
-.159 .738 -.014 -.215 .830 -1.613 1.295
1.141 1.039 .068 1.099 .273 -.904 3.187
-1.543 .838 -.119 -1.841 .067 -3.193 .107
-.059 .022 -.160 -2.680 .008 -.102 -.016
2.154 .512 .255 4.207 .000 1.146 3.163
(Constant)
Poss_TIA
mimic
stroke
control
age at  consent
gender
Model
1
B Std. Error
Unstandardized
Coeffic ients
Beta
Standardized
Coeffic ients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent  Variable: HADS_Aa. 
Hospital Anxiety and Depression Scale: Depression sub-score 
Between Groups Analysis 
 
 
 
 
 
 
 
Variables Entered/Removed b
gender,
age at
consent,
stroke,
mimic,
control,
Poss_TIA
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables entered.a. 
Dependent Variable: HADS_Db. 
Model Summary
.209a .044 .021 3.094
Model
1
R R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), gender, age at consent, stroke,
mimic, control, Poss_TIA
a. 
ANOVAb
108.519 6 18.086 1.890 .083a
2373.583 248 9.571
2482.102 254
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), gender, age at consent, s troke, mimic , control, Poss_TIAa. 
Dependent  Variable: HADS_Db. 
Coefficientsa
1.123 1.371 .819 .414 -1.578 3.823
-.075 .489 -.011 -.153 .878 -1.039 .888
-.436 .580 -.051 -.753 .452 -1.578 .705
.938 .815 .075 1.151 .251 -.668 2.544
-1.353 .658 -.140 -2.056 .041 -2.648 -.057
.034 .017 .125 1.980 .049 .000 .068
.164 .402 .026 .408 .684 -.628 .956
(Constant)
Poss_TIA
mimic
stroke
control
age at  consent
gender
Model
1
B Std. Error
Unstandardized
Coeffic ients
Beta
Standardized
Coeffic ients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent  Variable: HADS_Da. 
Interaction effects: The effect of cognitive impairment on NEADL score 
 
 
 
 
 
 
 
Variables Entered/Removedb,c
number_
impaired,
gender,
age at
consent
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables  entered.a. 
Dependent  Variable: NEADL_totalb. 
Models  are based only  on cases for which TIA =  1c. 
Model Summary
.333a .111 .030 9.906
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), number_impaired, gender, age
at consent
a. 
ANOVAb,c
404.246 3 134.749 1.373 .268a
3238.565 33 98.138
3642.811 36
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), number_impaired, gender, age at consenta. 
Dependent  Variable: NEADL_totalb. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
51.309 12.218 4.199 .000 26.451 76.167
-.075 .154 -.081 -.486 .630 -.388 .238
.898 3.388 .044 .265 .793 -5.994 7.790
1.715 .932 .307 1.841 .075 -.180 3.611
(Constant)
age at consent
gender
number_impaired
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: NEADL_totala. 
Selecting only cases for which TIA =  1b. 
Interaction effects: The effect of cognitive impairment on HADS-Total score 
 
 
 
 
Variables Entered/Removedb,c
number_
impaired,
gender,
age at
consent
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables  entered.a. 
Dependent  Variable: HADS_totalb. 
Models  are based only  on cases for which TIA =  1c. 
Model Summary
.464a .215 .146 7.003
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), number_impaired, gender, age
at consent
a. 
ANOVAb,c
458.079 3 152.693 3.113 .039a
1667.632 34 49.048
2125.711 37
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), number_impaired, gender, age at consenta. 
Dependent  Variable: HADS_totalb. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
2.664 8.636 .309 .760 -14.886 20.215
-.016 .108 -.022 -.146 .885 -.235 .204
3.496 2.378 .225 1.470 .151 -1.337 8.328
1.596 .653 .379 2.446 .020 .270 2.922
(Constant)
age at consent
gender
number_impaired
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: HADS_totala. 
Selecting only cases for which TIA =  1b. 
Interaction effects: The effect of cognitive impairment on HADS-Anxiety score 
 
 
 
 
 
Variables Entered/Removedb,c
number_
impaired,
gender,
age at
consent
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables  entered.a. 
Dependent  Variable: HADS_Ab. 
Models  are based only  on cases for which TIA =  1c. 
Model Summary
.483a .233 .166 3.879
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), number_impaired, gender, age
at consent
a. 
ANOVAb,c
155.681 3 51.894 3.449 .027a
511.583 34 15.047
667.263 37
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), number_impaired, gender, age at consenta. 
Dependent  Variable: HADS_Ab. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
6.094 4.783 1.274 .211 -3.627 15.815
-.064 .060 -.162 -1.063 .295 -.185 .058
1.789 1.317 .206 1.358 .183 -.888 4.465
.865 .361 .366 2.394 .022 .131 1.600
(Constant)
age at consent
gender
number_impaired
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: HADS_Aa. 
Selecting only cases for which TIA =  1b. 
Interaction effects: The effect of cognitive impairment on HADS-Depression score 
 
 
 
 
Variables Entered/Removedb,c
number_
impaired,
gender,
age at
consent
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables  entered.a. 
Dependent  Variable: HADS_Db. 
Models  are based only  on cases for which TIA =  1c. 
Model Summary
.451a .203 .133 3.447
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), number_impaired, gender, age
at consent
a. 
ANOVAb,c
102.945 3 34.315 2.888 .050a
403.924 34 11.880
506.868 37
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), number_impaired, gender, age at consenta. 
Dependent  Variable: HADS_Db. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
-3.430 4.250 -.807 .425 -12.067 5.208
.048 .053 .140 .900 .374 -.060 .156
1.707 1.170 .225 1.459 .154 -.671 4.085
.731 .321 .355 2.276 .029 .078 1.383
(Constant)
age at consent
gender
number_impaired
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: HADS_Da. 
Selecting only cases for which TIA =  1b. 
Interaction effects: The effect of ABCD2 score on NEADL score 
 
 
 
 
 
 
Variables Entered/Removedb,c
ABCD2_
result,
gender,
age at
consent
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables  entered.a. 
Dependent  Variable: NEADL_totalb. 
Models  are based only  on cases for which TIA =  1c. 
Model Summary
.342a .117 .077 9.687
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), ABCD2_result, gender, age at
consent
a. 
ANOVAb,c
832.115 3 277.372 2.956 .039a
6287.603 67 93.845
7119.718 70
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), ABCD2_result, gender, age at consenta. 
Dependent  Variable: NEADL_totalb. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
67.764 8.067 8.400 .000 51.662 83.867
-.141 .111 -.159 -1.273 .208 -.363 .080
.093 2.396 .005 .039 .969 -4.690 4.876
-1.777 .908 -.249 -1.958 .054 -3.589 .035
(Constant)
age at consent
gender
ABCD2_result
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: NEADL_totala. 
Selecting only cases for which TIA =  1b. 
Interaction effects: The effect of ABCD2 on HADS-Total score 
 
 
 
 
 
 
Variables Entered/Removedb,c
ABCD2_
result,
gender,
age at
consent
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables  entered.a. 
Dependent  Variable: HADS_totalb. 
Models  are based only  on cases for which TIA =  1c. 
Model Summary
.181a .033 -.010 6.916
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), ABCD2_result, gender, age at
consent
a. 
ANOVAb,c
110.176 3 36.725 .768 .516a
3252.269 68 47.827
3362.444 71
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), ABCD2_result, gender, age at consenta. 
Dependent  Variable: HADS_totalb. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
7.375 5.754 1.282 .204 -4.106 18.857
-.026 .079 -.043 -.327 .744 -.184 .132
2.414 1.705 .174 1.416 .161 -.987 5.815
-.055 .646 -.011 -.086 .932 -1.345 1.234
(Constant)
age at consent
gender
ABCD2_result
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: HADS_totala. 
Selecting only cases for which TIA =  1b. 
Interaction effects: The effect of ABCD2 score on HADS-Anxiety score 
 
 
 
 
 
 
 
Variables Entered/Removedb,c
ABCD2_
result,
gender,
age at
consent
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables  entered.a. 
Dependent  Variable: HADS_Ab. 
Models  are based only  on cases for which TIA =  1c. 
Model Summary
.268a .072 .031 3.957
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), ABCD2_result, gender, age at
consent
a. 
ANOVAb,c
82.270 3 27.423 1.751 .165a
1064.841 68 15.659
1147.111 71
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), ABCD2_result, gender, age at consenta. 
Dependent  Variable: HADS_Ab. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
8.508 3.292 2.584 .012 1.938 15.077
-.073 .045 -.206 -1.613 .111 -.163 .017
1.413 .975 .174 1.448 .152 -.534 3.359
-.028 .370 -.010 -.076 .939 -.766 .709
(Constant)
age at consent
gender
ABCD2_result
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: HADS_Aa. 
Selecting only cases for which TIA =  1b. 
Interaction effects: The effect of ABCD2 score on HADS-Depression score 
 
 
 
 
 
 
 
Variables Entered/Removedb,c
ABCD2_
result,
gender,
age at
consent
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables  entered.a. 
Dependent  Variable: HADS_Db. 
Models  are based only  on cases for which TIA =  1c. 
Model Summary
.218a .048 .006 3.383
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), ABCD2_result, gender, age at
consent
a. 
ANOVAb,c
39.004 3 13.001 1.136 .341a
778.107 68 11.443
817.111 71
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), ABCD2_result, gender, age at consenta. 
Dependent  Variable: HADS_Db. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
-1.132 2.814 -.402 .689 -6.748 4.483
.047 .039 .157 1.217 .228 -.030 .124
1.001 .834 .147 1.201 .234 -.662 2.665
-.027 .316 -.011 -.086 .932 -.658 .603
(Constant)
age at consent
gender
ABCD2_result
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: HADS_Da. 
Selecting only cases for which TIA =  1b. 
Interaction effects: The effect of NEADL score HADS-Total score 
 
 
 
 
 
 
Variables Entered/Removed b
control,
NEADL_
total,
stroke,
gender,
age at
consent,
mimic,
Poss_TIA
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables entered.a. 
Dependent Variable: HADS_totalb. 
Model Summary
.368a .135 .111 6.173
Model
1
R R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), control, NEADL_total, s troke,
gender, age at consent, mimic, Poss_TIA
a. 
ANOVAb
1468.488 7 209.784 5.505 .000a
9374.729 246 38.109
10843.217 253
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predictors: (Constant), control, NEADL_total, stroke, gender, age at consent, mimic,
Poss_TIA
a. 
Dependent Variable: HADS_totalb. 
Coefficientsa
18.151 3.818 4.754 .000 10.631 25.671
-.051 .035 -.090 -1.464 .144 -.121 .018
2.590 .807 .197 3.209 .002 1.000 4.180
-.173 .044 -.242 -3.950 .000 -.259 -.087
.601 .978 .041 .615 .539 -1.325 2.527
-.375 1.160 -.021 -.324 .746 -2.660 1.909
1.367 1.637 .052 .835 .405 -1.858 4.592
-2.575 1.318 -.127 -1.954 .052 -5.171 .021
(Constant)
age at consent
gender
NEADL_total
Poss_TIA
mimic
stroke
control
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: HADS_totala. 
 Interaction effects: The effect of HADS-Total score on NEADL score 
 
 
 
 
  
Variables Entered/Removed b
HADS_
total,
mimic, age
at consent,
stroke,
gender,
control,
Poss_TIA
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables entered.a. 
Dependent Variable: NEADL_totalb. 
Model Summary
.345a .119 .094 8.732
Model
1
R R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), HADS_total, mimic, age at
consent, stroke, gender, control, Poss_TIA
a. 
ANOVAb
2539.838 7 362.834 4.758 .000a
18757.488 246 76.250
21297.327 253
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predictors: (Constant), HADS_total, mimic, age at consent, s troke, gender, control,
Poss_TIA
a. 
Dependent Variable: NEADL_totalb. 
Coefficientsa
63.566 3.927 16.188 .000 55.831 71.300
-.169 .049 -.210 -3.466 .001 -.265 -.073
2.506 1.154 .136 2.171 .031 .232 4.780
.219 1.384 .011 .159 .874 -2.506 2.945
1.229 1.639 .049 .750 .454 -2.000 4.458
-3.260 2.310 -.089 -1.411 .159 -7.809 1.289
1.069 1.878 .038 .569 .570 -2.630 4.767
-.345 .087 -.246 -3.950 .000 -.518 -.173
(Constant)
age at consent
gender
Poss_TIA
mimic
stroke
control
HADS_total
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: NEADL_totala. 
Interaction effects: The effect of NEADL score on HADS-Anxiety score 
 
 
 
 
Variables Entered/Removed b
control,
NEADL_
total,
stroke,
gender,
age at
consent,
mimic,
Poss_TIA
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables entered.a. 
Dependent Variable: HADS_Ab. 
Model Summary
.411a .169 .145 3.890
Model
1
R R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), control, NEADL_total, s troke,
gender, age at consent, mimic, Poss_TIA
a. 
ANOVAb
755.215 7 107.888 7.131 .000a
3721.966 246 15.130
4477.181 253
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predictors: (Constant), control, NEADL_total, stroke, gender, age at consent, mimic,
Poss_TIA
a. 
Dependent Variable: HADS_Ab. 
Coefficientsa
11.397 2.406 4.738 .000 6.659 16.136
-.071 .022 -.194 -3.224 .001 -.115 -.028
2.285 .509 .270 4.492 .000 1.283 3.286
-.080 .028 -.175 -2.910 .004 -.134 -.026
.693 .616 .074 1.125 .262 -.520 1.906
-.052 .731 -.005 -.071 .944 -1.491 1.388
.815 1.032 .049 .790 .430 -1.217 2.847
-1.387 .831 -.107 -1.670 .096 -3.023 .249
(Constant)
age at consent
gender
NEADL_total
Poss_TIA
mimic
stroke
control
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: HADS_Aa. 
Interaction effects: The effect of NEADL score on HADS-Depression score 
 
 
 
 
 
Variables Entered/Removed b
control,
NEADL_
total,
stroke,
gender,
age at
consent,
mimic,
Poss_TIA
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables entered.a. 
Dependent Variable: HADS_Db. 
Model Summary
.337a .113 .088 2.990
Model
1
R R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), control, NEADL_total, s troke,
gender, age at consent, mimic, Poss_TIA
a. 
ANOVAb
281.046 7 40.149 4.492 .000a
2198.548 246 8.937
2479.594 253
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predictors: (Constant), control, NEADL_total, stroke, gender, age at consent, mimic,
Poss_TIA
a. 
Dependent Variable: HADS_Db. 
Coefficientsa
6.753 1.849 3.653 .000 3.112 10.395
.020 .017 .073 1.172 .242 -.014 .053
.305 .391 .049 .781 .436 -.465 1.075
-.092 .021 -.271 -4.369 .000 -.134 -.051
-.092 .473 -.013 -.194 .846 -1.025 .840
-.324 .562 -.038 -.576 .565 -1.430 .783
.552 .793 .044 .696 .487 -1.010 2.113
-1.188 .638 -.123 -1.861 .064 -2.445 .069
(Constant)
age at consent
gender
NEADL_total
Poss_TIA
mimic
stroke
control
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: HADS_Da. 
Interaction effects: The effect of ABCD2 score on BUCS score 
 
 
 
 
Variables Entered/Removedb,c
gender,
age at
consent,
stroke_risk
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables  entered.a. 
Dependent  Variable: number_impairedb. 
Models  are based only  on cases for which TIA =  1c. 
Model Summary
.429a .184 .103 2.016
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), gender, age at consent, stroke_
risk
a. 
ANOVAb,c
27.542 3 9.181 2.258 .102a
121.987 30 4.066
149.529 33
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), gender, age at consent, s troke_riska. 
Dependent  Variable: number_impairedb. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
6.928 2.675 2.590 .015 1.465 12.391
1.303 .726 .306 1.794 .083 -.180 2.786
-.072 .034 -.352 -2.114 .043 -.142 -.002
-.165 .719 -.039 -.230 .820 -1.635 1.304
(Constant)
stroke_risk
age at consent
gender
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: number_impaireda. 
Selecting only cases for which TIA =  1b. 
Interaction effects: The effect of NEADL score on BUCS score 
 
 
 
 
Variables Entered/Removed b,c
gender,
NEADL_
total, age
at consent
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables entered.a. 
Dependent Variable: number_impairedb. 
Models  are based only on cases for which TIA =  1c. 
Model Summary
.345a .119 .039 1.762
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), gender, NEADL_total, age at
consent
a. 
ANOVAb,c
13.835 3 4.612 1.485 .237a
102.489 33 3.106
116.324 36
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), gender, NEADL_total, age at consenta. 
Dependent  Variable: number_impairedb. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
.008 2.692 .003 .998 -5.470 5.485
.054 .029 .304 1.841 .075 -.006 .114
-.017 .027 -.105 -.634 .531 -.073 .038
.291 .601 .080 .485 .631 -.932 1.514
(Constant)
NEADL_total
age at consent
gender
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: number_impaireda. 
Selecting only cases for which TIA =  1b. 
Interaction effects: The effect of HADS score on BUCS score 
 
 
 
 
 
Variables Entered/Removedb,c
gender,
age at
consent,
HADS_
total
a
. Enter
Model
1
Variables
Entered
Variables
Removed Method
All requested variables  entered.a. 
Dependent  Variable: number_impairedb. 
Models  are based only  on cases for which TIA =  1c. 
Model Summary
.426a .182 .109 1.697
Model
1
TIA =  1
(Selected)
R
R Square
Adjusted
R Square
Std. Error of
the Estimate
Predictors: (Constant), gender, age at consent, HADS_
total
a. 
ANOVAb,c
21.750 3 7.250 2.516 .075a
97.961 34 2.881
119.711 37
Regression
Residual
Total
Model
1
Sum of
Squares df Mean Square F Sig.
Predic tors:  (Constant), gender, age at consent, HADS_totala. 
Dependent  Variable: number_impairedb. 
Select ing only cases for which TIA =  1c. 
Coefficientsa,b
2.451 2.053 1.194 .241 -1.722 6.624
.094 .038 .395 2.446 .020 .016 .172
-.021 .026 -.128 -.817 .420 -.074 .032
.049 .594 .013 .082 .935 -1.159 1.257
(Constant)
HADS_total
age at consent
gender
Model
1
B Std. Error
Unstandardized
Coefficients
Beta
Standardized
Coefficients
t Sig. Lower Bound Upper Bound
95% Confidence Interval for B
Dependent Variable: number_impaireda. 
Selecting only cases for which TIA =  1b. 
